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Abstract 
 
Background 
 Previous research demonstrated that maladaptive illness perceptions 
contribute to poor psychological outcomes in CHD. Cardiac interventions are 
effective in changing illness perceptions. However, it is unclear whether 
interventions targeting illness perceptions can also contribute to positive changes 
in symptoms of depression and anxiety. It is unclear whether interventions with 
psychological components lead to more reduction in inaccurate illness 
perceptions. 
 
Objective 
 The current thesis aims to determine if psychological interventions are 
more efficacious in changing illness perceptions compared to interventions 
without these components. Another goal is to assess whether cardiac interventions 
can also contribute to positive changes in anxiety and depression. Finally, the 
present investigation assesses the impact of type of illness and age on the efficacy 
of cardiac interventions.  
 
Methods 
 Using meta-analytic design English databases, relevant journals and 
references lists were searched for randomised controlled trials of interventions 
designed to change illness perceptions.  The outcomes included illness 
perceptions, and symptoms of depression and anxiety.  
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Participants with CHD were included in the current meta-analysis.  Effect sizes 
were expressed as Hedges’s g.  
 
Results 
 All cardiac interventions yield a small but consistent effect in reduction of 
maladaptive illnesses perceptions. However, interventions with psychological 
component are not significantly more efficacious in changing maladaptive illness 
perception (Hedges’s g = .248) compared to interventions that do not contained 
psychological components (Hedges’s g = .224). Interventions designed to change 
illness perceptions contribute to significant positive change in symptoms of 
anxiety (Hedges’s g = .204), but not symptoms of depression (Hedges’s g = -
.089). Participants with chronic illness report larger reduction in inaccurate illness 
representations compared to participants with acute illness.    
 
Conclusions 
 All components (psychological and non-psychological) of cardiac 
interventions can lead to small but positive reduction in maladaptive illness 
perceptions and symptoms of anxiety. While some interventions components (e.g. 
information giving) might work on the cognitive level, other techniques (e.g. 
active listening) might be more efficacious in addressing issues in emotional 
processing of CHD.  Further, depressive symptoms and acute nature of illness 
might complicate process of change because of higher levels of emotional 
distress. 
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1. Introduction 
 
1.1. Chapter Overview  
 This chapter aims to present a theoretical and empirical context of the 
current investigation. In the first instance, a general overview of the research field 
is presented. This is followed by a discussion of theoretical context of the current 
meta-analysis. Next, the findings from previous studies linking illness perceptions 
and psychosocial outcomes are critically evaluated. The consecutive section 
contains critical evaluation of individual studies of interventions designed to 
change illness perceptions. Following from this, previous systemic reviews and 
meta-analyses are discussed. Finally, conclusions are drawn and resulting research 
gaps identified. The final section of this chapter contains research questions of the 
current meta-analysis.  
 
1.2. General Overview  
 Coronary Heart Disease (CHD) is an umbrella term for medical conditions 
that involve narrowing of coronary arteries through gradual build-up of fatty 
material (atheroma) within their walls (Capewell et al., 2008). The accumulation 
of these fats leads to a narrowing of arteries, restricting blood flow into the heart. 
This can cause angina and consequently lead to myocardial infarction (Townsend 
et al., 2012). CHD typically includes medical conditions, such as angina (stable 
and unstable), coronary artery disease (CAD), myocardial infraction (MI), and 
conditions that require revascularisation procedures (e.g. coronary artery bypasses 
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graft (CABG) and percutaneous coronary interventions (PCI). PCIs include 
stenting and coronary angioplasty which are procedures designed to improve 
blood supply to the heart.  
 Despite CHD being largely a collection of preventable diseases, CHD is 
believed to be the biggest UK’s killer. CHD contributes to approximately 80,000 
UK deaths (most of these premature) and 7 million deaths worldwide every year 
(Townsend et al., 2012; World Health Organisation, 2013).  CHDs put substantial 
pressures on the National Health System (NHS) services in the UK For instance, 
there were 469,800 inpatient episodes related to CHD and it is estimated that 
around 81,000 PCIs are carried out every year in the UK- three times more than a 
decade ago (Townsend et al., 2012). CHD also contributes to considerable 
economical and societal costs. For example, it has been estimated that CHD costs 
the UK health care system around £8.7 billion and the UK economy £19 billion 
(Liu, Maniadakis, Gray, & Rayner, 2002; Townsend et al., 2012; Vilahur, 
Badimon, Buguardini, & Badimon, 2014). 
 Given the large societal and economic costs of CHD, there has been an 
increased scientific interest in exploring risk and protective factors that might 
contribute to reducing the rates of CHD and associated adverse outcomes, such as 
premature death, poorer quality of life and/or engagement with treatment (e.g. 
Bajekal et al., 2012; Smolina, Wright, Rayner, & Goldacre, 2012).  For decades 
researchers have focused their attention on physical health factors, such as 
obesity, smoking, hypertension, hyperlipidemia, genetic predispositions and/or 
diabetes (Blumenthal, 2005). These more traditional factors, however, are 
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insufficient to explain mechanisms involved in development and treatment of 
CHD. This is mainly because CHD involves a more complex than previously 
thought interplay between biological and psychosocial mechanisms (Luengo-
Fernandez, Leal, Gray, & Rayner, 2006). In addition to physical health risk 
factors, many individuals with CHD have a wide range of psychosocial 
vulnerabilities, such as high levels of negative affect (e.g. trait hostility, 
depression, anxiety) and/or poor social support (Smith & Ruiz, 2002). These 
factors play an important role in emergence and maintenance of CHD, for 
example, through maladaptive stress response (Smith & Ruiz, 2002). These 
maladaptive stress responses can reduce blood flow in arteries and/or increase 
inflammation (i.e. by increasing cortisol to harmful levels) (Kanel, 2012; Pereira, 
Cerqueira, Palha, & Sousa, 2013). Individuals with emotional and cognitive 
vulnerabilities associated with CHD are more likely to appraise contextual 
stressors more negatively and to respond to them with greater reactivity (e.g. 
Smith & Ruiz, 2002). Prolonged over-reactivity can perturb physiological 
mechanisms underlying stress responsiveness (e.g. cortisol production) and 
consequently lead to CHD (Smith & Ruiz, 2002).  The experience of CHD (e.g. 
MI), in turn, might reinforce pre-existing psychosocial vulnerability factors, such 
as depression, anxiety, greater social isolation and poorer quality of life (Reid, 
Ski, & Thompson, 2013).  
 Researchers and clinicians, therefore, have been showing more interest in 
the role of psychosocial factors in a development and maintenance of CHD (e.g. 
Blumenthal, 2005; Platt, Green, Jayasinghe, & Morrisey, 2014). These factors 
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include social support, uptake of healthy life-style, self-efficacy, locus of control, 
coping strategies, mood and/or representations of illness (Helgeson, 2003; Lett et 
al., 2004; Smith & Ruiz, 2002).    
 A number of psychological factors, such as representations of illness, are 
thought to be particularly important in CHD because high percentages of 
individuals with CHD (approximately 83%) develop maladaptive illness 
cognitions (Foxwell, Morley, & Frizelle, 2013). Dysfunctional representations 
about illness develop in response to the nature of cardiac events, which often are 
sudden and unexpected (Petrie & Weinman, 2012). As such the unpredictable 
nature of CHD often leads to catastrophic and maladaptive appraisal of illness and 
apprehension of vulnerability. When maladaptive illness cognitions are left 
unchallenged they may adversely impact psychosocial outcomes and treatment 
adherence. For example, participants who believe that their illness have serious 
personal consequences might find it more difficult to return to their life before 
CHD episode (Foxwell et al., 2013).  
 Maladaptive illness representations can be modified via focused 
psychological interventions, such as cognitive behavioural therapies and/or 
motivational interviewing (Peterson & Kim, 2011). These treatment approaches 
are shown to be effective in a wide range of chronic and acute health problems, 
including diabetes, asthma, hypertension, chronic pain and cancer (e.g. Halm, 
Mora & Leventhal, 2006; Horne &Weinman, 2002). It is beyond the scope of this 
thesis to review studies that evaluate psychological interventions targeting illness 
representations in other disease. However, it is recognised such interventions can 
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substantially aid the adjustment process, improve recovery and treatment 
adherence, reduce mortality and morbidity and increase utilization of 
rehabilitation (Hagger & Orbell, 2003; McAdrew et al., 2008; Petrie, Jago, & 
Devcich, 2007; Weardon & Peters, 2008).  
 Research into the efficacy of psychological interventions for individuals 
with CHD has shown significant improvement in mental and physical health. 
Several large-scale research programmes have been designed to investigate the 
effects of psychological interventions on changing maladaptive illness 
representations and improving outcomes for participants with CHD. For example, 
Enhancing Recovery in Coronary Heart Disease (ENRICH) or Angina Plan 
(ENRICH Investigators, 2000; Lewin, Furze, Robinson, Griffith, Wiseman, Pye, 
& Boyle, 2002). Research into these programmes (as well as other smaller scale 
interventions) is promising because it broadens patients’ treatment options, offers 
more holistic approach to treatment and improves their recovery outcomes.  
 The findings from the individual studies, however, have so far been 
inconsistent. While some studies have demonstrated that psychological 
interventions have the potential to successfully change maladaptive illness 
cognitions and improve psychosocial outcomes in CHD, other studies have failed 
to do so (e.g. Cooper, Lloyd, Weinman, Jackson, 1999; O’Rourke & Hampson, 
2010; Saab et al., 2009). Additionally, some studies have reported negative 
results, demonstrating that other treatments conditions are more beneficial in a 
controlled trial environment (e.g. Bolman, Brug, Bar, Martinali, & van den Borne, 
2005). Mixed and contradictory results from individual studies hamper 
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development of conclusions that can be made about the efficacy of psychological 
interventions. These contradictory findings may be related to a number of factors, 
such as methodological differences between studies, differences in the content and 
theoretical frameworks of the interventions and/or variations in characteristics of 
research participants.  
 Inconsistent results from individual studies are to be expected, but 
nonetheless this level of variation in approach and outcome does little to achieve a 
scientific consensus over the benefits of psychological interventions. While single 
studies are still important they are also prone to a number of methodological 
limitations, such as sampling error, low statistical power and/or measurement 
error (Schmidt, 1996).  One way to overcome these difficulties is by aggregating 
findings by combining individual studies using the methodology of meta-analysis. 
By successfully addressing methodological shortcomings of individual studies the 
methodology of meta-analysis enables the researcher to be more confident in 
making scientifically sound conclusions (Schmidt, 1996).  
 Meta-analysis methodology might be particularly helpful in making sense 
of conflicting findings within the research into the effectiveness of psychological 
interventions targeting illness representations in CHD. This is because there are 
discrepancies in findings from the individual studies. These discrepancies make it 
difficult to ascertain what interventions might work for which group of 
individuals with CHD and under what circumstance. Additionally, applying a 
meta-analysis to accumulate findings from single studies can contribute to better 
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understanding of CHD and development of more effective models of treating 
CHD. 
 
1.3. Aims of the Current Meta-analysis 
 The overall aim of the current study is to assess the efficacy of 
psychological interventions in changing maladaptive illness perceptions in 
participants with CHD by using the methodology of meta-analysis.  Another goal 
is to determine whether interventions designed to change illness perceptions 
contribute to positive changes in symptoms of depression and anxiety. The 
findings of the present meta-analysis may have implications for practice of health 
professionals working with individuals with CHD.  The findings may also 
contribute to increasing understanding of psychological mechanisms involved in 
changing illness perceptions. Consequently outcomes may have some 
implications for improving already existing treatment programmes for individuals 
with CHD. The overview of the strategy adopted for the present literature search 
can be found in Appendix A.  
 
1.4. Theoretical Link between Illness Perceptions and Psychological 
Outcomes  
 Psychological factors have become increasingly important in 
understanding and guiding adjustment and recovery of individuals with CHD. 
Amongst these factors, illness beliefs have been identified to be particularly 
important in CHD (Petrie & Weinman, 2012).  Positive participants’ beliefs about 
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their illness improve their mental and physical health outcomes, treatment 
adherence and/or reduction of emotional distress (Petrie & Weinman, 2012). In 
addition, factors that were previously believed to be important have been recently 
showed to be relatively poor predictors of recovery and less susceptible to change 
through interventions (Blumenthal, 2005; Leventhal & Cameron, 1987). These 
factors include disease complexity, treatment duration or participants’ 
demographic and social characteristics (Blumenthal, 2005). 
 The link between illness perceptions and psychosocial outcomes has 
strong theoretical fundaments in self-regulation theories (Maes & Karoly, 2005). 
The relationship between psychosocial factors and illness perceptions has been 
explained by a wide range of models, including Health Beliefs Model or Theory 
of Planned Behaviour (Ajzen, 1991; Rosenstock, 1974). While these models have 
been widely applied in several health-related problems (e.g. smoking and /or 
breastfeeding), they have been found to be less relevant in explaining recovery 
and adjustment in participants with CHD (Harvey & Lawson, 2009). For example, 
the Theory of Planned Behaviour (TPB) upholds that six constructs (attitudes, 
behavioural intention, subjective norms, social norms, perceived power and 
perceived behavioural control) contribute to health related behaviours (Ajzen, 
1991). In this model, the person’s decision to engage in a particular behaviour 
(e.g. smoking) is directly linked to the intention of engaging in this behaviour 
(Ajzen 1991). Intention, on the other hand, is influenced by attitudes towards an 
outcome, the beliefs about behavioural control over the outcome, and normative 
beliefs about the outcome (e.g. social norms about smoking) (Ajzen 1991). While 
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this model is helpful in predicting and understanding a range of health behaviours 
in public health, its utility in more complex medical health problems is limited 
(Munro, Lewin, Swart, & Volmink, 2007). There are a number of reasons for this 
limitation, including not accounting for emotional processing that person engages 
in while making sense of their illness and a linear understanding of the 
relationship between the variables, which does not reflect a dynamic nature of 
behaviours (Harvey & Lawson, 2009; Munro et al., 2007).  
 More recent models, however, have considered cognitive and emotional 
processes in explaining the link between illness representations and psychosocial 
outcomes (Harvey & Lawson, 2009). Specifically, these models recognised that 
there is a dynamic relationship between emotional responses to the illness, illness 
representations and outcomes (Harvey & Lawson, 2009). Addressing this 
dynamic relationship allowed for explicitly recognising the impact of illness 
perceptions in recovery (Petrie & Weinman, 2012). Leventhal et al. (1987), for 
example, proposed the Common Sense Model (CSM) of understanding how 
people make sense of their illness. In this model Leventhal et al. (1987) propose 
that individual’s response to the illnesses is aimed at minimizing fear and avoid 
danger (Diefenbach & Leventhal, 1996; Leventhal & Cameron, 1987). In trying to 
achieve these two goals the individual construct ‘lay’ understandings of different 
dimensions of illness (called illness representations or perceptions). These illness 
representations guide patients’ coping and engagement in recovery process (e.g. 
adherence to medical treatments). In the CSM (see Figure 1.1) Leventhal et al. 
(1987) distinguish six dimensions of illness:  
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1) Identity: the name or the label given to the illness and the symptoms that 
are associated with it 
2) Cause: beliefs about the cause of the illness. These may include genetic, 
environmental and lifestyle factors. These beliefs may not always be 
medically accurate.  
3) Timeline: beliefs about the duration of the illness. This dimension includes 
patients’ beliefs about how acute and chronic their illness is. It is 
suggested that the beliefs about timeline of illness can change in response 
to changes in symptoms.  
4) Consequences: the beliefs about the consequences of patients’ illness and 
how these consequences impact on different aspects of their lives, 
including social, financial and psychological consequences.  
5) Curability/controllability: this is a set of beliefs about the extent to which 
patients perceive to have control over their illness and whether their 
condition can be cured. Controllability includes personal control (e.g. 
belief about a degree to which patients’ self-management might have an 
impact on the illness/symptoms) and treatment effectiveness.  
6) Emotional representations: negative emotions associated with an illness. 
 
 In the CSM people actively construct and re-construct beliefs about their 
illness (Leventhal & Cameron, 1987) (see Figure 1.1). This helps them to make 
sense of their illness (Leventhal & Cameron, 1987). In doing this people 
continuously relate dimensions of illness representations to their previous 
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personal and environmental experiences (Leventhal & Cameron, 1987). They also 
utilize currently available information, such as public health campaigns or 
hospital leaflets (Harvey & Lawson, 2009). In order to make sense of different 
features of illness they draw upon their experience of how they feel (emotional 
processing) and what they know about the different aspects of the disease 
(cognitive processing) (Harvey & Lawson, 2009). Figure 1.1 depicts a dual 
processing involved in making sense of illness. The dual (emotional and 
cognitive) processing takes place in three stages: 1) illness representations, 2) the 
coping/action plan to minimize this threat and 3) appraisal stage when the coping 
and progress are evaluated and modified if necessary (Diefenbach & Leventhal, 
1996).  
 The five dimensions of illness representations (see Figure 1.1) become a 
guide for health related decisions, behaviours and coping styles which are later 
evaluated (Diefenbach & Leventhal, 1996). If the person appraises these coping 
styles and behaviours as helpful in minimising danger and fear they are likely to 
be perpetuated (Diefenbach & Leventhal, 1996). For example, if an individual 
holds a belief that angina is caused by stress and worry than he is likely to adopt a 
maladaptive strategy of avoiding stress-inducing situations, paradoxically 
maintaining heightened levels of stress and anxiety. Avoidance in a short term 
may reduce stress levels and consequently the person is likely to appraise this 
strategy as helpful. Over time, however, avoidance may lead to increased social 
isolation, withdrawal, high levels of stress and anxiety with a significant negative 
impact on quality of life (Harvey & Lawson, 2009).
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 In the CSM coping mechanisms play central role because they are shaped 
by how individuals represent their illness.  Emotional responses to illness (e.g. 
avoidance, denial or expressing emotions) form part of passive coping 
mechanisms (Harvey & Lawson, 2009). These emotional coping mechanisms are 
linked with poorer psychosocial outcomes, including more symptoms of 
depression and anxiety (Harvey & Lawson, 2009; Maes & Karoly, 2005). On the 
other hand, active coping mechanisms, such as problem solving and seeking 
support are thought to improve outcomes (Harvey & Lawson, 2009). 
 The CSM model is particularly relevant for participants with cardiac 
problems because individuals with CHD can hold particularly maladaptive illness 
perceptions due to the unpredictable nature of the illness (Leventhal & Cameron, 
1987; Rigel, 1993). Some of the examples of these unhelpful illness 
representations might include: ‘it is dangerous for people with heart problems to 
argue’, ‘angina is caused by stress and worry’, ‘angina is caused by worn out 
heart’, or ‘it is not advisable for people with angina to exercise’ (Furze, Bull, 
Lewin, & Thompson, 2003; Goulding, Furze, & Birks, 2010).   
 The CSM has also strong empirical support (Diefenbach &Leventhal, 
1996). For example, Petrie, Weinman, Sharpe, & Buckley (1996) demonstrated 
support for the CSM model in participants who suffered heart attack. They found 
that beliefs about consequences and identity of the illness explained 20 percent of 
change in disability in social interactions. Participants who thought that they had 
less control over their illness and who thought that their illness has less serious 
consequences for their future were also less likely to attend cardiac rehabilitation 
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programmes. Interestingly, participants’ maladaptive beliefs about their heart 
attack were predictive of poor outcomes independently of psychological distress. 
These results might indicate that illness perceptions might be better predictors of 
outcomes than emotional distress itself (Petrie et al., 1996).  
 Subsequent studies have also found a link between illness representations 
and psychological and social outcomes in participants with CHD, further 
supporting the utility of the CSM model. For instance, Cooper et al. (1999) 
demonstrated that participants who believed that their symptoms of cardiac 
disease are controllable and caused by lifestyle factors were more likely to engage 
in treatment. The findings of this study are valuable, because the authors 
demonstrated that illness representations are important in treatment of individuals 
with different types of CHD.  Additionally, Cooper et al. (1999) have shown that 
participants’ knowledge of risk factors is insufficient to predict attendance at 
cardiac rehabilitation.   This finding is in line with results of other studies, for 
example, Zerwic, King, & Wlasowicz (1997) found that although participants 
with diagnosed and suspected CAD were able to identify risk factors for CAD in 
general, they failed to relate these factors to their own illness or identify risk 
factors that were documented in their medical records. These findings suggest 
illness perceptions play a specifically important role in CHD and that knowledge 
of risk factors by itself is insufficient to facilitate positive coping mechanisms.  
 A more recent study by Platt et al. (2014) evaluated the CSM model by 
comparing its utility with the Transtheoretical Model of Change in health-related 
behaviours (Prochaska & DiClemente, 1983).  Platt et al. (2014) found specific 
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dimensions of illness representations, such as illness consequence, emotional 
representation and timeline were predictive of adherence to exercise regimes and 
medication adherence in participants with CHD.  Overall, Platt et al., (2014) 
showed that both models can be equally beneficial in facilitating realistic and 
achievable treatment plans and outcomes. The CSM, however, was particularly 
useful in treatment adherence (specifically for those participants whose illness 
representations were more likely to be guided by emotional processes, such as 
avoidance or denial) (Diefenbach & Leventhal, 1996; Platt et al., 2014). 
 The CSM was chosen as a theoretical framework for the current 
investigation because it is a useful framework for capturing the relationship 
between psychosocial outcomes and illness beliefs in complex and unpredictable 
diseases, such as CHD. CSM, however, has been criticised in a context of self-
regulation theories as underestimating the role of broader social context in a 
development of health outcomes (Jakcson, McKenzie & Hobfoll, 2000). As a 
cognitive processing model the CSM is also difficult to apply in individuals with 
cognitive impairments because the ability to regulate their behaviour might be 
affected by cognitive difficulties (Vohs & Baumeister, 2011). Another criticism of 
CSM is that the model implicitly assumes that coping mediates the outcomes. 
However, the empirical evidence to support this is limited because a majority of 
previous research was correlational in nature (Hagger & Orbell, 2003).  
  Summary. The CSM model can add substantially to our understanding of 
how people with CHD make sense of their illness, recover and engage in 
treatment. This model is particularly useful because it represents the dynamic and 
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multidimensional nature of how people make sense of their illness and treatments. 
In addition, the empirical evidence supporting the utility of this model in 
individuals with CHD is relatively strong. The empirical findings demonstrate that 
what makes a difference to patients’ prognosis and treatment is how they make 
sense of their illness rather than just what they know about it.  
 
1.5. Illness Perceptions, Psychological Outcomes and Socio-demographic 
Moderating Factors  
 Numerous empirical studies demonstrated that maladaptive representations 
of CHD are linked with poor psychosocial outcomes, such as anxiety and 
depression (e.g. Cooper et al., 1999; Grace et al., 2005). A selection of these 
studies relevant to the current meta-analysis is presented in this section (a brief 
narrative summary can be also found in Table A1.1, Appendix B). For example, 
Whitmarsh, Koutantji, & Sidell (2003) in a cross-sectional study provide evidence 
that depression, anxiety and illness perceptions predict attendance at cardiac 
rehabilitation programmes in participants with MI. In addition, individuals who 
attended cardiac rehabilitation perceived fewer symptoms of their illness and were 
more likely to underestimate their seriousness. They were also more likely to use 
emotionally-focused coping mechanisms, such as denial and avoidance 
(Whitmarsh et al., 2003). These results corroborate the findings from previous 
studies which found that individuals who attended cardiac rehabilitation are more 
likely to feel anxious and depressed (e.g. Petrie et al, 1996). This interesting 
matrix of results might indicate that participants who experience more distress and 
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believe that their illness is serious and/or that they experience a lot of symptoms 
are more likely to engage in treatments. On the other hand, one needs to exercise 
caution when drawing conclusions about the nature of the relationship between 
psychological outcomes and illness representations based on the Whitmarsh et al. 
(2003) study. This is because Whitmarsh et al. (2003) did not investigate a direct 
relationship between illness representations, depression and anxiety. Instead 
Whitmarsh et al. (2003) focused on investigating whether depression and anxiety 
predicted attendance at cardiac rehabilitation. Another limitation of this study is 
its cross-sectional and retrospective design. A longitudinal design might have 
shed more light on how the relationship between depression, anxiety and illness 
representations develops over the course of illness.  
 Grace et al. (2005) address some of the limitations evident in the study by 
Whitmarsh et al. (2003). Grace et al.(2005) demonstrated a direct relationship 
between symptoms of illness representations and depression in participants with 
CHD. In addition, Grace et al. (2005) also showed that the relationship between 
illness representation and depression was affected by socio-demographic factors, 
including age and ethnicity. For instance, participants identified in the study as 
non-white and male reported more severe symptoms of depression, more chronic 
perception of illness and lower control over illness and treatment. Younger 
participants, on the other hand, were more likely to perceive their condition as 
more debilitating and reported more symptoms of depression (Grace et al., 
2005).The findings of this study support the relationship between depression and 
illness perceptions. Additionally, Grace et al. (2005) also demonstrated that the 
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association between illness perceptions and psychological outcomes is moderated 
by other factors, such as age.  
 Results produced by Grace et al. (2005) are important because of a number 
of strengths in the study design and sample stratification. Firstly, the study used 
well validated measures of psychological distress (Hospital Anxiety and 
Depression Scale-HADS) and illness perceptions (Illness Perception 
Questionnaire-Revised) (Moss-Morris, Weinman, Petrie, Horne, Cameron, & 
Buick, 2002; Zigmond & Snaith, 1983). Secondly, Grace et al. (2005) selected a 
sample of participants with different types of CHDs, including MI, angina and 
participants post PCI (Percutaneous Coronary Intervention) or CABG (Coronary 
Artery Bypass Grafting). This is a definite strength of this study as it indicates that 
the relationship between illness perceptions and depression is shared across all 
types of CHDs. Finally, the conclusions from Grace et al. (2005) study were 
strengthened by recruiting a relatively large sample (N= 661). 
 Despite these advantages, the study by Grace et al. (2005) has also some 
important limitations. Although the sample drawn in this study is fairly large, 
there are substantial inequalities in distribution of gender and depressive 
symptoms. For example, the data analysis was conducted on 504 male participants 
but only 157 female participants. These are potentially meaningful group 
differences that could have skewed the results, particularly in the context of 
statistical methods adopted to analyse the data (i.e. group analysis of variance 
based on gender) (Field, 2005). Another significant shortcoming of this study was 
that the majority of the participants (over 80%) did not report any symptoms of 
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depression. Hence, it is possible that the relationship between depressive 
symptoms and illness representations could be a false positive related to a small 
sub-sample of participants with depressive symptoms.  
 Despite the above-mentioned limitations, the study by Grace et al. (2005) 
corroborate the findings of other studies indicating the importance of a 
relationship between participants’ maladaptive illness perceptions and poor 
psychosocial outcomes. For example, Furze, Lewin, Murberg, Bull and Thompson 
(2005) found that participants with angina who reported unhelpful illness beliefs 
were also more likely to report an increased number of symptoms of depression 
and anxiety. Furze et al. (2005), however, went further in their investigation than 
Grace et al. (2005) by demonstrating participants’ illness beliefs changed over 
time. Participants who reported decrease in unhelpful maladaptive illness 
representations also reported fewer symptoms of anxiety and depression.  
Unlike Grace et al. (2005), however, Furze et al. (2005) were unable to 
demonstrate that any socio-demographic factors were linked to changes in illness 
representations and depression. This is important because it indicated a dynamic 
nature of illness perceptions which suggest that illness perceptions are 
changeable. This in turn concurs with an idea shared by many researchers and 
clinicians that illness perceptions could be changed via targeted interventions (e.g. 
Cooper et al., 1999; Petrie & Weinman, 2012; Whitmarsh et al., 2003). In 
addition, the findings of the study by Furze et al. (2005) are strengthened by the 
use of relatively well validated and reliable measures of psychological distress 
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(e.g. HADS) and illness perceptions (York Angina Beliefs Questionnaire) (Furze 
et al., 2003; Zigmond & Snaith, 1983).  
 There are, however, a number of limitations evident in the study by Furze 
et al. (2005). Firstly, the study was relatively low powered- it included a small 
sample of 105 participants with angina. The small sample might be one of the 
reasons why Furze et al.  (2005) did not detect an association between socio-
demographic variables (i.e. age, gender, social class) and changes in illness 
perceptions. Secondly, the participants in this study had received a targeted 
intervention (Angina Plan) prior to baseline data collection. It is possible that 
reported association between illness perceptions and psychological outcomes 
might be an artefact of residual effects of the intervention and/or small sample 
size.  
 Other studies have also attempted to address limitations identified in 
previous research (e.g. Stafford, Berk, & Jakson, 2009; Juergens, Seekatz, 
Moosdorf, Petrie, & Rief, 2010). For instance, Stafford et al. (2009) conducted a 
longitudinal study demonstrating that negative illness perceptions were associated 
with higher levels of depressive symptoms. The longitudinal design of this study 
and a moderately sized sample (N = 193) make a relatively strong case for the 
relationship between illness representations and psychosocial outcomes. 
 In terms of socio-demographic factors Stafford et al. (2009) found that the 
relationship between illness perceptions and psychosocial outcomes was 
associated with income and age, but not with gender. Thus, participants who were 
older and poorer were more likely to perceive their illness as out of their control. 
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This is an interesting finding which is only partially consistent with previous 
studies. It is also contradictory to some of the traditional views about socio-
demographic factors associated with CHD, such as that CHD mainly affects men 
(Lockyer & Bury, 2001). There could be a number of theoretical and 
methodological explanations for the inconsistency in findings between Stafford et 
al.(2009) study and previous research. Firstly, participants who are older and 
poorer might be more likely to have less social and financial resources and 
support and this might contribute to their perceptions that they have less control 
over their illness. Secondly, it is possible that the relatively small sample in this 
study contributed to insufficient statistical power to detect gender differences.  
 Similarly to Stafford et al. (2009), Juergens et al. (2010) also adopted a 
longitudinal design by assessing participants before and after  heart surgery. The 
findings of this study further support the idea that illness representations are 
associated with a range of psychosocial outcomes. Specifically, Juergens et al. 
(2010) showed that participants with maladaptive representations of their heart 
condition reported more symptoms of depression pre and post surgery. In line 
with previous research, in the Juergens et al. (2010) study depressive symptoms 
were associated with beliefs about chronic duration of illness and perception of 
symptoms as more serious (e.g. Grace et al., 2005). There are several possible 
explanations for this, including a relatively small sample (N = 56), use of 
statistical method (i.e. correlation) that makes it difficult to detect significant 
results with small sample size. Despite the aforementioned shortcomings, the 
findings of the study by Juergen et al. (2010) provide further support for the 
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conceptual premise that illness representations are linked with psychosocial 
outcomes.  
 Not all research, however, points towards the importance of illness 
representations in predicting psychosocial outcomes. In particular findings from 
research investigating the link between illness representations and health-related 
behaviours is more ambiguous. Byrne, Walsh, and Murphy (2005), for instance, 
were unable to demonstrate a direct link between illness perceptions and health-
related behaviours. In their study, exercise uptake was associated with higher 
levels of perceived control over illness and treatment, whereas medication 
adherence was linked with perception of illness chronicity (Byrne et al., 2005). 
Interestingly, the strongest association was found between emotional 
representation of illness and health-related behaviours. These findings may be 
explained by a number of different factors. For example, the fact that some of the 
findings do not corroborate with previous studies could be due to methodological 
limitations, such as self-report on behavioural data and cross-sectional design 
(French, Cooper, & Weinman, 2006; Podsakoff, MacKenzie, Lee, & Podsakoff , 
2003). On the other hand, it is possible that the results of the study by Byrne et al. 
(2005) reflect a complex and dynamic nature of the relationship between illness 
representations and psychosocial outcomes. That is, psychological distress may 
mediate the relationship between illness perceptions and health-related behaviours 
(Platt et al., 2014). This could explain lack of the empirical support for the 
relationship between illness representations and health-related behaviours but 
stronger support for the link between illness perceptions and psychological 
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outcomes (e.g. Platt et al., 2014). It is difficult, however, to drawn firm 
conclusions solely from Byrne et al. (2005) study, because the authors did not 
assess psychological distress.  
 More recent studies have tried to explore the complex relationship 
between illness representations and a wide range of psychosocial outcomes (e.g. 
Greco, et al., 2014; Steca et al., 2013). Specifically, these studies have undertaken 
an effort to empirically validate a comprehensive model depicting interplay 
between different illness-related factors, including illness perceptions and 
psychosocial outcomes, such as depression (e.g. Greco et al., 2014). Steca et al. 
(2013), for example, demonstrated that illness representations play an important 
role in maintaining depression (i.e. they found small link between illness 
representation and depression). These findings corroborate a great deal with 
previous work in this field, confirming that participants who perceive their illness 
as less negative are also less likely to suffer from depression (Barth, Schumacher, 
& Herrmann-Lingen, 2004). Steca et al. (2013) in explanation of the results 
suggested that participants who felt less depressed and had more positive illness 
perceptions might have been more capable of engaging in constructive health-
related behaviours (Steca et al., 2013). There are, however, a number of 
limitations evident in this study that suggest the caution in interpreting the results. 
For example, the sample of the study was relatively small (N = 172) in the context 
of a number of statistical comparisons made. Additionally, the sample included a 
broad spectrum of cardiovascular diseases with a different range of illness 
severity. The inclusion of a variety of heart diseases might have potentially 
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limited the generalizability of findings because other cardiovascular diseases (e.g. 
heart failure) have different aetiology, prognosis and treatment (French et al., 
2006). Due to these differences individuals with heart failure develop illness 
perceptions that are qualitatively different (Goulding et al., 2010). Furthermore, 
cross-sectional design in the Steca et al. (2013) study makes it difficult to draw 
certain conclusions about how the relationship between illness representations and 
depression develops over time.  
 In a partial replication of Steca et al. (2013) study, Greco et al.(2014) 
investigated the role of illness perceptions in maintaining depression . Their 
findings replicate results from study by Steca et al. (2013) and were elaborated by 
demonstrating that the relationship between illness perceptions and depression is 
sustained over time, although Greco et al. (2014) included a relatively short 
follow up period of 2 months. In particular, Greco et al. (2014) found participants 
who had a more adequate perception of their symptoms were less likely to be 
depressed (Greco et al., 2014).  While there are strengths between the studies of 
Greco et al. (2014) and Steca et al. (2013) as they share many methodological 
similarities, they also share many similarities in limitations. In terms of strengths 
both studies adopted similar robust psychometric indices to assess depression and 
illness perceptions.  Nevertheless, the use of depression measure here makes it 
difficult to relate the findings to previous studies that used different measures of 
depression. Although the samples were similar in characteristics the sample in 
Greco et al. (2014) study was significantly smaller (N = 75). This makes the 
conclusions by Greco et al. (2014) more prone to false positive error. The small 
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sample size is particularly relevant for the generalizability of the findings for these 
studies, because a statistical analysis in both studies included a relatively large 
number of comparisons across different variables (Field, 2005).  
 Based on the studies evaluated above, a fair amount of inconsistencies and 
gaps across studies investigating the relationship between illness perceptions and 
socio-demographic factors is noticeable. These gaps and inconsistencies may be 
related to methodological differences between studies, such as sample size and 
application of different measurement tools. 
 One relatively recent study, however, that explicitly addressed some of 
these inconsistencies was a study conducted by Aalto et al. (2005). In this study 
nearly 3000 participants with CHD were asked about their illness beliefs as well 
as socio-demographic and illness related factors. Aalto et al. (2005) investigated 
the link between socio-demographic variables, such as age and gender, and illness 
perceptions. Aalto et al. (2005) found that younger participants in comparison to 
older participants reported more negative illness perceptions. Interestingly, 
although the study demonstrated that there were some qualitative differences in 
illness perceptions between genders, this was not found to be significantly related 
to illness perceptions.  
 While the findings of this study make a relatively strong case for the 
importance of socio-demographic and illness related factors in CHD, it is still 
difficult to draw certain conclusions about which socio-demographic and illness 
related factors are particularly important in illness perceptions about CHD.   
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 As the evidence across individual studies is inconclusive and lacks 
consistency it might be necessary to accumulate the findings from different 
studies. Foxwell et al. (2013), for example, recently recognised the need for 
systematic review of studies looking at the relationship between illness 
perceptions and psycho-social outcomes. Subsequently, they conducted a 
systematic review of 21 empirical studies examining the relationship between 
illness perceptions, mood and quality of life (Foxwell et al., 2013). Overall, they 
demonstrated that participants with CHD who reported negative illness 
perceptions are significantly more likely to suffer from depression and anxiety 
(Foxwell et al., 2013).  Specifically, the results of this systematic review 
corroborate the findings of individual studies indicating that participants who have 
a poorer understanding of their symptoms, perceive their illness as more serious in 
consequences and more chronic, and themselves as being less in control of their 
illness are also more likely to experience from depression and anxiety (Foxwell et 
al., 2013). Although this systematic review provides consistent evidence for the 
relationship between illness perceptions and psychosocial outcomes, there are a 
number of reasons why these conclusions need to be treated with caution. Firstly, 
the review was limited to a narrative synthesis of findings. Therefore, the reader 
cannot make any conclusions about the theoretical and clinical importance of the 
relationship between illness perceptions and psychosocial outcomes (Schmidt, 
1996). Secondly, this systematic review has some important methodological 
shortcomings. For example, the authors included only published studies which are 
likely to significantly increase the publication bias. In addition to this, the authors 
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did not take into consideration any moderating variables. This is likely to be a 
significant shortfall because previous studies have shown that socio-demographic 
markers are likely to be important moderators of the relationship between illness 
perceptions and psychosocial outcomes (e.g. Aalto et al., 2005; Cooper et al., 
1999). 
 Summary. The findings from the individual studies and systematic review 
outlined above indicate that individuals with CHD who report maladaptive 
representations of their illness are more likely to suffer from depression and 
anxiety. Individuals with CHD who appraise their illness as more serious in 
consequences and chronic are particularly prone to experiencing psychological 
distress. Furthermore, some of the studies also showed that socio-demographic 
factors (e.g. gender and age) can influence the relationship between illness 
perceptions and psychosocial outcomes. In addition, individual studies also 
indicated that illness perceptions can change over time. This is an important 
finding because it suggests that maladaptive illness representations might be 
malleable to interventions. The studies outlined above, however, differ in design, 
sample characteristics, number of participants recruited, measured used to assess 
variables and types of statistical analysis applied. These shortcomings make it 
difficult to generalize the findings and draw certain conclusions about the 
importance of the relationship between illness perceptions and psychosocial 
outcomes.  
  
 
38 
 
1.6. Interventions Designed to Change Illness Perceptions 
 In light of the findings indicating that illness representation can change 
over time, there has been an increased interest in designing interventions that 
target illness perceptions. The fundamental assumption behind such interventions 
is that changing negative or inaccurate illness perceptions may directly improve 
psychological well-being. This is conceptually consistent with the Leventhal’s 
CSM (Diefenbach & Leventhal, 1996). 
 Although research into the effectiveness of interventions targeting illness 
representations is in relatively early stages, there has been steady and consistent 
increase in published trials that have attested the efficacy of such interventions 
(French et al., 2006). A range of these studies is critically discussed in the current 
section (a succinct narrative summary of these studies can also be found in Table 
1.1). 
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Table 1.1. 
  
Individual studies designed to change illness perceptions in CHD (in alphabetical order). 
 
Study 
authors, 
publication 
year, country
  
Sample characteristics (size, 
sex, age, CHD type) 
Details of the 
intervention  
Design/ 
Length of 
Follow-up 
(FU) 
Outcomes Assessed Results  
(brief summary)  
Bengtsson, 
1983 
Sweden 
N = 87 
M age = 55.3 
74M/13F 
Patients with MI 
Cardiac 
rehabilitation 
programme 
involving family 
members and 
physical training  
RCT design/  
14 months FU 
Patients’ physical 
functioning 
Social factors, e.g. finances, 
employment 
Psychological functioning-
depression & anxiety 
(Minnesota Multiphasic 
Personality Inventory) 
Questionnaire testing 
patients’ knowledge about 
illness (unspecified)  
 
No improvements in 
participants’ knowledge 
about illness and 
psychological well-being, 
Improvements in physical 
functioning, e.g. blood 
pressure  
Broadbent et 
al., 2009 
New Zealand 
N = 103 
52/51 (intervention/ 
control)  
M age for intervention 
group=54.9 
M age for control  
group = 54.6 
91M/12F 
Acute MI  
4 brief inpatients 
session that 
included psycho-
education and 
debunking illness 
misconceptions  
RCT design/ 
3 & 6 month 
FU  
Illness perceptions & Casual 
perceptions (Brief Illness 
Perception Questionnaire & 
Illness Perception-Revised) 
Health behaviours (smoking, 
exercise and diet) 
 
Participants in the 
intervention group reported 
improved illness coherence 
& increase in reuptake of 
exercise.  
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Furze et al.,  
2009 
UK  
N = 204; 
100/104(intervention/control) 
164F/40M 
M age = 55.61 
Patients waiting for CABG 
‘The HeartOp 
Programme’ 
targeted to change 
illness perceptions 
based on CBT 
principles + 
relaxation  
RCT/ ~8 
weeks post 
baseline data 
collection  
 
Cardiac misconceptions 
(York Cardiac Beliefs 
Questionnaire)  
Anxiety (State Trait Anxiety 
Scale) 
Depression (Cardiac 
Depression Scale)  
 
 
Significant improvements in 
cardiac beliefs and 
depression, but not in 
anxiety in the intervention 
group 
Janssen et al. 
2013  
Netherlands  
 
 
 
 
 
 
 
N = 158 
No comparison group 
M age = 58 
127F/31M 
Broad category of CHD  
 
 
Cardiac 
rehabilitation 
programme  
Cross-
sectional 
design  
Pre and post 
data  
Illness perception (Brief 
Illness Perception 
Questionnaire) 
Health-related quality of life 
(MacNew Heart Disease 
Health Related Quality of 
Life Questionnaire)  
Improvements in the 
following domains of illness 
perceptions: perception of 
fewer consequences & 
fewer symptoms of their 
cardiac disease, improved 
understanding of their 
illness, decreased emotional 
impact of the illness.  
Improvements in illness 
perceptions have also 
contributed to significant 
changes in emotional, social 
and physical quality of life. 
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Pozen et al  
1977  
USA 
N = 102 
M age = 58 
79M/23F 
Patients with acute MI 
Inpatient Cardiac 
rehabilitation 
programme 
aiming at 
increasing 
knowledge of 
patients about the 
illness, reducing 
anxiety and 
encouraging 
reintegration to 
everyday life 
 
RCT design/ 1 
month  FU 
after discharge 
Anxiety (IPAT anxiety 
scale),  
Physical functioning 
Knowledge Questionnaire 
derived for the purpose of the 
study 
 
Participants attending the 
programme demonstrated  
increased knowledge about 
the illness and social 
functioning, but no evidence 
of improvements in 
symptoms of anxiety 
O’Rourke and 
Hampson, 
1999 
UK 
N = 70 
M age for intervention group = 
57.7. 
M age for control group = 59.4  
52M/18F 
Patients with MI  
Edinburgh Heart 
Manual  
Longitudinal/ 
6 month FU 
Illness perceptions (IPQ) 
Anxiety and Depression 
(HADS) 
Utilisation of healthcare 
services 
 
Participants in programme 
based on the Heart Manual 
improved perceptions of 
their illness, e. g. greater 
sense of personal control 
and reported reduced 
symptoms of anxiety and 
depression. But no 
reduction in visits to GP. 
  
CHD-Coronary Heart Disease; MI-Myocardial Infraction; RCT-Randomised Controlled Trial ; IPQ-Illness Perception Questionnaire;  
HADS-Hospital Anxiety and Depression Scale 
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 Early studies into the efficacy of interventions focused on illness 
perceptions have produced a mixed pattern of results into the efficacy of 
multifaceted cardiac rehabilitation programmes in changing participants’ illness 
perceptions (e.g. Bengtsson, 1983; Pozen et al. 1977). Bengtsson (1983), for 
instance, demonstrated that comprehensive interventions consisting of physical 
examinations and counselling did not improve participants’ medical and 
psychological well-being. Pozen et al. (1977) showed that a multifaceted 
rehabilitation programme for participants with acute MI, improved their social 
functioning and knowledge about illness, but did not lead to positive changes in 
symptoms of anxiety. 
 These early studies, however, have a number of significant limitations that 
hinder the generalizability of their findings (Bengtsson, 1983; Posen et al., 1977). 
These limitations include lack of clear and consistent theoretical grounding of 
interventions, focusing primarily on physical functioning, use of different and 
often less stringent psychometric tools to assess psychological distress, poorly 
operationalized variables (primarily illness representations) and/or insufficiently 
described statistical analysis (e.g. lack of intention to treat analysis).  
 More recent studies have attempted to address some of these 
shortcomings. For instance, Furze et al. (2009) evaluated a comprehensive 
intervention programme, challenging participants’ unhelpful misconceptions 
about CABG, provided information about post-operation care, offered relaxation 
strategies and encouraged participants to set risk reducing treatment goals. The 
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multifaceted intervention by Furze et al. (2005) was compared against education 
and counselling intervention which did not directly address participants’ illness 
misconceptions. Overall, the findings of this trial were mixed, indicating that 
targeted intervention had positive impact on improving participants’ physical 
functioning and reducing depressive symptoms, but did not reduce anxiety. More 
importantly, Furze et al. (2009) found that participants in the intervention group 
reported significantly less misconceptions about their illness. This is an interesting 
set of results, because typically changes to depressive symptoms are associated 
with changes in anxiety, but this was not the case here. This combination of 
results could be due to a number of methodological characteristics of the study by 
Furze et al. (2009). Specifically, a lack of positive change in anxiety might have 
been due to recruitment of insufficient number of participants. Another factor 
might be related to the type of outcome measures used, specifically with regards 
to the measurement of anxiety (i.e. State Trait Anxiety Inventory). This measure 
has been shown to be less sensitive compared to other measures in identifying 
anxiety in participants with CHD (Bunevicius et al., 2013).  Although Furze et al. 
(2009) study has also some important methodological strengths (e.g. adopting a 
random allocation of participants), the shortcomings listed above might have 
significantly contributed to the mixed pattern of results.  
 In contrast to the study by Furze et al. (2009) other research has 
demonstrated that interventions targeting maladaptive illness perceptions can 
reduce anxiety. Broadbent et al. (2009) evaluated the efficacy of brief intervention 
targeted at changing maladaptive illness representations against standard hospital 
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care. The target intervention focused around addressing participants’ personal 
illness misrepresentations and designing idiosyncratic recovery plans. Overall, 
Broadbent et al. (2009) showed that participants in the intervention group had a 
greater understanding of their illness and more accurate beliefs about the causes of 
their illness. The study by Broadbent et al. (2009), however, did not find any 
effect of the target intervention on other domains of illness perceptions (i.e. illness 
timeline, consequences and control over illness). It is difficult to make sense of 
the findings from this study because there are limited statistical data available. 
There are particularly sparse statistical data on a relationship between illness 
perceptions and psychological distress. In turn, Broadbent et al. (2009) reported 
the results on the impact of the intervention on life style changes, such as uptake 
of exercise and rate of returning to work. While these findings are important, there 
is limited scope for a reader to make judgments about how targeted interventions 
can contribute to changes in illness perceptions. Foremost, it is also difficult to 
make judgments about how any potential changes in illness perceptions might be 
associated with improvements in psychological well-being. Establishing a link 
between illness perceptions and psychological distress, however, seems 
particularly important for two reasons. Firstly, such link might have a potential to 
be a bridge between illness perceptions and health behaviours. Secondly, it can 
aid our understanding of mechanisms involved in development and maintenance 
of maladaptive illness perceptions.  
 Janssen, Gucht, Exel and Maes (2013) overcome some of the 
shortcomings outlined above in the studies by Broadbent et al. (2005) and Furze et 
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al. (2009). A direct effect of multifaceted cardiac rehabilitation programme on 
illness perceptions in participants with myocardial infraction was examined by 
Janssen et al. (2013). By using well-validated measures of illness perceptions the 
authors demonstrated that comprehensive cardiac rehabilitation programme, 
incorporating psycho-education, physical exercise, relaxation and psychological 
consultation contributed to positive changes in illness perceptions. Specifically, 
participants in the interventions group perceived their illness as less severe in 
consequences and having reduced emotional impact on their live. Participants in 
the intervention group also had better understanding of their illness and greater 
perception of control over their illness and treatment. The findings from this study 
are particularly meaningful, because of its methodological and theoretical 
strengths. These strengths include: intervention grounded in self-regulation theory 
and use of measures with satisfactory psychometric properties and well-matched 
to the measured concepts. Nevertheless, methodological shortcomings 
significantly reduce validity in the study by Janssen et al. (2013). This study could 
benefit from the target intervention being compared to treatment as usual or 
another intervention. Including a comparison group would have enhanced the 
quality of conclusions about the utility of cardiac rehabilitation programme. 
Employing a randomized design would have also reinforced the conclusions and 
make the findings more clinically relevant. It would also have been helpful to 
understand better which components of cardiac rehabilitation programme are 
more likely to be linked with changes in illness perceptions. This information 
could be helpful because the content of cardiac rehabilitation programmes vary 
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vastly across settings (and studies) (Reid et al., 2013). It is possible that this 
variability explains a certain degree of inconsistencies across findings from 
different studies. These inconsistencies make it difficult to gather the findings and 
to make judgements about what types of interventions are likely to be the most 
effective.  
 Research conducted by O’Rourke and Hampson (1999) compared the 
utility of self-help cardiac rehabilitation programme (Edinburgh Heart Manual) 
against exercise and educational programme in participants with MI. The 
Edinburgh Heart Manual consisted of three core components: education, exercise 
and stress management (Lewin, Robertson, Cay, Irvine, & Campbell, 1992). 
Including a comparison group enabled O’Rourke and Hampson (1999) to show 
the target intervention was significantly more effective in changing participants’ 
maladaptive illness perceptions and improving their psychological well-being than 
usual care. The participants in the intervention group reported having greater 
sense of personal control over their illness and thought that their illness had fewer 
consequences in comparison to participants receiving standard care. Participants 
in the intervention group also reported feeling less anxious and less depressed. 
These findings demonstrate interventions that directly address illness perceptions 
can improve psychological well-being. These improvements, however, were not 
followed by reductions in utilisation of healthcare services (e.g. visits to GP).  It is 
difficult to make broader conclusions about the clinical utility of specific 
intervention because a number of shortcomings of this study. Firstly, the study did 
not employ a randomised control design, which is considered to be a gold 
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standard of intervention research (e.g. Torgerson & Torgerson, 2008). Secondly, 
the effect sizes for anxiety and depression were small (.08 and .11 respectively).  
Thirdly, the overall sample size was relatively small (N = 70) and the subsample 
on which the data for psychological distress were analysed was too small for this 
purpose (less than 8 participants). The subsample was so small because the 
authors excluded from the analysis all participants whose scores on the HADS did 
not reach clinical significance. Such small sample size is a significant 
disadvantage of the study increasing the likelihood of the type I error and 
subsequently substantially reducing the quality of findings.   
 Summary. Individual studies attesting the efficacy of interventions 
designed to change illness perceptions provide mixed and inconsistent results. 
These inconsistencies are due to a variety of methodological and conceptual 
differences across trials, such as different designs (e.g. RCT and non-RCT trials), 
use of different psychometric tools to measure the same concept (i.e. illness 
perceptions, depression or anxiety), use of different populations and/or 
interventions consisting of different components.  These differences hamper the 
generalizability of the findings and subsequently their clinical usefulness. Despite 
these differences majority of the studies indicate that explicitly addressing illness 
perceptions through targeted interventions can enhance participants’ recovery. 
Based on single studies, however, it is difficult to make specific conclusions about 
what interventions or components of interventions might work best in changing 
unhelpful illness perceptions. It is also difficult to make conclusions about how 
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any changes in illness perceptions might be related to changes in psychosocial 
outcomes. 
 
1.7. Previous Reviews Pertinent to the Current Meta-analysis 
 One way of overcoming methodological shortcomings of individual 
studies is to aggregate data and analyse findings from multiple individual studies. 
Meta-analysis is the means by which an aggregated outcome can be determined 
for a particularly area of study. Meta-analysis calculates effect sizes that can be 
interpreted and can inform health professionals and policy maker about 
empirically supported treatments in making judgements about the efficacy of 
interventions across different settings and populations with more confidence.  
Aggregating and systematically assimilating findings from a range of individual 
studies can add more scientific and clinical significance (Schmidt, 1996). Meta-
analysis have been used to produce the National Institute for Health and Care 
Excellence (NICE) guidelines on provision of secondary care for patients after MI 
(NICE, 2013). In the guideline number 172 NICE recommends that exploring 
patients’ illness representations should form a consistent part of any cardiac 
rehabilitation programmes (NICE, 2013).  
 In spite of meta-analysis contribution to clinical and research practice, the 
meta-analytic design is not free from weaknesses. For instance, the conditions 
under which meta-analysis can be conducted are still subject of scholars’ 
discussions. Some argue that combining studies that use different measures 
introduces too much heterogeneity and error (Bartolucci & Hillegas, 2010). 
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Others suggest that  aims of meta-analyses are to answer  broader research 
question than individual studies and therefore it is unavoidable and almost 
desirable that there is some level of heterogeneity (Borenstein et al., 2009). 
Another criticism is that the exact source of heterogeneity is almost impossible to 
detect because it might be linked with a number of unknown factors (Bartolucci & 
Hillegas, 2010). Finally, it can also be difficult to locate all the relevant 
publications and therefore the results of meta-analysis often represent only a small 
subsample of studies (Bartolucci & Hillegas, 2010).  
 Despite some of the weakness in meta-analytic design, it has been chosen 
as a design in the current investigation because there have so far been limited 
efforts to systematically gather and analyse findings from studies investigating 
efficacy of psychological interventions in changing maladaptive illness 
perceptions in CHD. To the author’s knowledge only two relevant articles were 
published: one systematic review and one meta-analysis (Goulding et al., 2010; 
French et al., 2006).  Other publications were concerned with integrating findings 
from studies attesting the importance of psychological factors or other 
psychologically informed interventions in CHD (e.g. Dusseldorp, van Elderren, 
Maes, Meulman, & Raaij, 1999; Foxwell, et al., 2013; Reid et al., 2013, 
McGilion, et al., 2014). Although the findings of these meta-analysis and 
systematic reviews are important contributions to the field, they did not explicitly 
consider illness perceptions. These reviews, therefore, will not be discussed in the 
present thesis. A brief narrative summary of previous systemic reviews and meta-
analysis pertinent to the current meta-analysis are presented in Table 1.2.
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Table 1.2.  
 
Narrative summary of previously published reviews in relation to illness perceptions (presented in alphabetical order).  
Authors 
Year of 
publication, 
country 
Type of review 
(meta-analysis 
vs systemic 
review) 
 
Overall aim of 
the review (as 
described) 
No of 
studies 
included/ 
Total 
Sample (N) 
Time period 
covered by the 
review 
Type of CHD Characteristics 
of intervention 
(if applicable) 
Brief outline of results 
Dickens et al., 
2013; 
UK; 
Systemic review 
and meta-
analysis 
 
 
To assess which 
components of 
psychological 
treatments are 
most effective in 
improving 
depression   
62 
N = 17,397 
Unspecified 
Studies included 
in the review 
from 1983 to 
2011 
Broad category 
of CHD 
 
 
All included 
studies were 
RCTs;  
Interventions 
varied in mode 
of delivery, 
number of 
sessions, most 
of the 
interventions 
delivered by 
MDTs 
Interventions with CBT component 
contributed to greater improvements 
in depression (SMD = .23; N =11); 
psycho-education, relaxation and 
problem solving components also 
significantly improve depression 
(SMD = .19; .15 and .34, 
respectively); 
There was no relationship between 
age, type of CHD and improvements 
in depression.  
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Foxwell et al. 
2013; 
UK; 
Systemic review 
 
 
 
 
 
 
 
To examine the 
relationship 
between illness 
perceptions, QoL 
and mood 
 
21; N = not 
calculated, 
Range from 
= 49 to 3130 
 
Unspecified; 
studies included 
in the review 
from 1996 to 
2011 
 
Broad category 
of CHD 
 
Not applicable  
 
Participants with more negative 
illness perceptions are more likely to 
report symptoms of depression and 
anxiety; poor illness understanding, 
more serious perception of the 
consequences of illness and 
perception of more chronic outcome 
are specifically linked with increased 
reports of symptoms of anxiety and 
depression  
 
French et al., 
2006; 
UK; 
Systemic review 
and meta-
analysis 
To examine which 
domains of illness 
perceptions 
contribute to 
attendance at 
cardiac 
rehabilitation 
programmes 
8; 
N = not 
calculated, 
Range from 
65 to 194 
Search period 
from 1970 to 
2005;  
Acute MI  Not applicable 
 
Positive illness perceptions contribute 
to higher rates of attendance at 
cardiac rehabilitation. Participants 
with acute MI who have a greater 
sense of control over their illness and 
symptoms and greater understanding 
of their illness are more likely to 
attend at the cardiac rehabilitations 
programmes.   
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Goulding et al., 
2010; 
UK; 
Systemic review 
To assess if 
interventions can 
change 
maladaptive 
illness perceptions  
13; 
N = not 
calculated 
Range from 
40 to 243 
Unspecified; 
studies included 
from 1977 to 
2007 
Broad category 
of CHD  
RCTs; 
Multifaceted 
interventions 
designed to 
change illness 
perceptions, 
knowledge and 
attitudes; 
Various modes 
of delivery  
Interventions with CBT component 
led to significant positive changes, 
but it was impossible to determine if 
they were more effective than other 
interventions. There was no clear 
indication of whether interventions 
deigned to change illness perceptions 
contribute to positive changes in 
psychosocial outcomes.  
 
 
Taylor et al., 
2011; 
Scotland; 
Systemic review 
 
To examine the 
impact of 
sociodemographic 
and psychological 
factors on 
adherence to 
cardiac 
rehabilitation 
programmes  
18; 
N = 8842 
Search period 
from 1990 to 
2009 
Broad category 
of CHD 
Not applicable  Studies were inconsistent in the 
reporting of socio-demographic 
variables. Age & gender were the 
most commonly reported variables; 
ethnicity least commonly reported. 
Younger participants were least likely 
to attend cardiac rehabilitation. For 
older participants the decision to 
attend was linked with a greater sense 
of control over their illness. 
Participants who perceived their 
illness as more debilitating and 
serious in consequences were more 
likely to attend unless they reported 
more symptoms of depression. 
CHD-Coronary Heart Disease; RCT-Randomised Controlled Trial, MDT-Multidisciplinary Team; CBT-Cognitive Behavioural Therapy; SMD-
standardised mean difference; QoL-Quality of Life; MI-Myocardial Infraction  
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 The findings from the French et al. (2006) and Goulding et al. (2010) 
reviews are inconclusive, incomplete and ambiguous. Goulding et al. (2010) 
statement reflects the tentativeness of the findings relatively well: ‘(…) Overall 
this suggests that it is possible to devise interventions which significantly and 
positively change maladaptive illness cognitions.’ (Goulding et al., 2010, p.995).  
This statement only tentatively indicates that psychological interventions may be 
effective in changing inaccurate illness perceptions in CHD. Furthermore, the 
interpretation of results on the basis of narrative synthesis of individual studies 
has been criticized as it is more likely to be prone to subjective bias of researchers 
who may be presenting a partisan view (Bartolucci & Hillegass, 2010). Narrative 
summary of findings from multiple studies is prone to a range of biases that are 
difficult to assess (Bartolucci & Hillegass, 2010). It is also difficult in systemic 
reviews to appropriately consider and make sense of conflicting findings. This 
challenge is relevant for a review by Goulding et al. (2010) who identified eight 
studies that yielded positive results, three studies that found no effect and one 
study with negative effects on changing illness perceptions. These narrative 
findings would have been enhanced by deriving effect sizes and confidence 
intervals to understand better effects of different treatments and the conditions 
under which interventions might work (Higgins & Green, 2011).  
 Furthermore, Goulding et al. (2010) concluded that studies testing out 
multifaceted interventions based on cognitive-behavioural model were also 
effective. It is not clear, however, whether such interventions were more effective 
than other types of interventions, such as psycho-education only or counselling. 
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Again the methodological shortcomings of systemic review do not permit any 
conclusions about the type of interventions that might be more effective in 
changing maladaptive illness perceptions.  
 Another significant limitation of the data produced by Goulding et al. 
(2010) is that it did not consider the effects of changing illness perceptions on 
other psychosocial outcomes, including depression and anxiety. The authors 
explained that this was because of the heterogeneity among studies. At the very 
least, however, the results of the review might have been enhanced by providing 
more detailed narrative summary of the findings from psychosocial outcomes. 
Goulding et al. (2010) pointed out heterogeneity among studies contributed to a 
decision to omit statistical data analysis. Borenstein et al. (2009), however, 
suggest that use of different measure to assess the same variable does not exclude 
quantitative summary of data. It might, therefore, have been possible to derive 
individual effect sizes of each component study contained within systemic review 
without focusing on the magnitude of the overall effect size. 
 In addition, by including only studies with random allocation design, 
Goulding et al. (2010) managed to control the heterogeneity among studies to 
some degree. However, including only studies with one design is considered 
controversial by some (Higgins & Green, 2011). On one hand, inclusion of only 
RCTs allows the reader to make fairly confident conclusions about the kind of 
interventions that might work best. This is because it is more likely that all studies 
maintain similar levels of methodological homogeneity.  On the other hand, the 
lack of studies with a different design (non-RCT) can sometimes be considered a 
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weakness as the authors potentially might have excluded a substantial number of 
studies that could lead to different conclusions (Borenstein et al., 2009).  
 A strengths of the systemic review by Goulding et al. (2010), however, is 
that it used a formal measure to assess the methodological quality of each study. 
Quality assessment is an important component of any systemic review and meta-
analysis because it enables the reader to make judgments about the quality of 
individual study (Higgins & Green, 2009).  
 The review by Goulding et al. (2010) is one of a few attempts to 
systematically accumulate studies within this field. It also provides initial 
evidence that psychological interventions might be effective in changing 
maladaptive illness perceptions in CHD. Furthermore, this review provides 
important information about the potential ways of improving research within this 
field, including using measures with satisfactory psychometric properties. Based 
on the systemic review by Goulding et al. (2010), however, it is difficult to 
ascertain which component of interventions might work best in changing 
maladaptive illness perceptions and negative psychosocial outcomes. This is 
mainly because of the methodological shortcomings of the narrative review which 
have been described above. 
 French et al. (2006) overcome some of the limitations identified in 
Goulding et al. (2010). Primarily, French et al. (2006) adopted a meta-analysis 
methodology to synthesize and analyse eight studies that examined the 
relationship between different dimensions of illness perception and attendance at 
cardiac rehabilitation programmes in participants with MI. Adopting meta-
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analysis as a methodology is a substantial improvement in attempts to make sense 
of findings from individual studies. It allowed French et al. (2006) to derive effect 
sizes and confidence intervals. This is important because it allowed for identifying 
patterns across studies and to account for sources of heterogeneity among studies 
(e.g. sampling error) and measurement errors (Borenstein et al., 2009; Schimdt, 
1996).  
 The meta-analysis by French et al. (2006), however, contains some 
substantial limitations. Firstly, its scope is limited to one outcome only-attendance 
at cardiac rehabilitation. Secondly, it focuses on the impact of illness perception 
on the cardiac rehabilitation attendance rather than considering which aspect of 
cardiac rehabilitation programmes might contribute to positive changes in 
maladaptive illness perceptions. Despite this somewhat narrow focus, French et 
al. (2006) found a small effect size for the relationship between positive illness 
perceptions and increased attendance at cardiac rehabilitation. Specifically, 
participants who believed that their illness is controllable and symptomatic and 
who felt that they understood their condition were more likely to attend the 
cardiac rehabilitation programme (see Table 1.2 for succinct summary). 
 While the findings from meta-analysis by French et al. (2006) are 
important and add substantially to the knowledge about the relationship between 
illness perception and attendance at cardiac rehabilitation programmes, there are 
other substantial limitations of this review. Firstly, changes in illness perceptions 
are likely to be associated with changes to other psychological and social 
outcomes, such as anxiety and depression (Cooper et al., 1999; O’Rourke & 
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Hampson, 1999; Platt et al., 2014; Stafford et al., 2009). Yet, French et al.(2006) 
did not consider a relationship between other psychosocial outcomes and illness 
perceptions. Secondly, French et al. (2006) focused their meta-analysis on a single 
group of participants with CHD (those who suffered MI and underwent CABG). It 
would have been helpful, however, to explore whether the association between 
changes in illness perceptions and attendance at cardiac rehabilitation programmes 
is also relevant to other groups of participants with CHD. Thirdly, French et al. 
(2006) did not investigate whether different types of psychological interventions 
are linked with changes in illness perception. Cardiac rehabilitation programmes 
vary across settings (Peterson & Kim, 2011). While some programmes are 
strongly embedded in psychological theories of maladaptive illness perceptions, 
others do not explicitly address psychological issues. This diversity, however, was 
not addressed by French et al. (2006). It also would have been helpful to find out 
whether psychologically based programmes lead to a larger reduction of 
maladaptive illness perceptions. Such information might have contributed to 
learning more about the mechanisms of change in illness perceptions. Finally, the 
sample of 906 participants is relatively small by meta-analysis standards (Higgins 
& Green, 2011). It is possible that including a wider category of participants with 
CHDs might have contributed to an increase in the effect size or alter the findings 
altogether. Finally, French et al. (2006) did not address the potential impact of 
socio-demographic variables on their findings. 
 Despite these shortcomings, the findings of the meta-analysis by French et 
al. (2006) are important because they provide initial evidence that positive 
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changes to illness perceptions can improve participants’ appropriate utilization of 
health care. These initial encouraging indications of a direct link between illness 
perceptions and attendance at cardiac rehabilitation suggest that more high quality 
meta-analysis needs to be conducted. Findings from the future meta-analyses 
could strengthen empirical and theoretical links between illness perceptions and 
psychosocial outcomes, such as depression and anxiety.   
 Recently, Taylor et al. (2011), however, have attempted to address some 
of the above-mentioned limitations. Taylor et al. (2011) conducted a systemic 
review into the socio-demographic and psychological factors that influence 
attendance at cardiac rehabilitation.  By narratively assimilating findings from 18 
studies, the authors demonstrated that socio-demographic factors, such as age and 
gender, play particularly important role in determining attendance at cardiac 
rehabilitation. Younger participants were thought to be at particular risk of non-
attendance. For older participants attendance at cardiac rehabilitation was more 
complex and related to specific domains of illness perceptions. For example, older 
individuals who perceived having more control over their illness were more likely 
to attend cardiac rehabilitation programmes. In general, participants (regardless of 
gender or age) who perceived their illness as more serious in consequences and 
appraised their symptoms as more debilitating were more likely to attend cardiac 
rehabilitation programmes; whereas depression predicted poor adherence to 
cardiac rehabilitation programmes. While these findings further emphasise the 
importance of psychological and socio-demographic factors in improving 
outcomes for individuals with CHD, a review by Taylor et al. (2011) has a 
59 
 
number of important limitations. Firstly, similarly to Goulding et al. (2010), it is 
only a narrative integration of findings. It is, therefore, subject to similar 
shortcoming, such as subjectivity in assimilation of findings. Secondly, the review 
included studies with non-random and random designs which further hampered 
the generalizability of findings (Borenstein et al., 2009). Thirdly, the review 
focused only on one outcome (i.e. attendance at cardiac rehabilitation).  It would 
have been helpful, however, to understand how cardiac rehabilitation programmes 
impact on other psychological outcomes. Finally, the review largely ignored the 
content of cardiac rehabilitation interventions. This is despite widely recognised 
variability in the content among cardiac rehabilitation programmes (e.g. Cooper et 
al., 1999). Nonetheless, the content of intervention is likely to be important in 
determining recovery outcomes.  
 In an attempt to understand better the factors that might improve 
psychological outcomes for people with CHD, Dickens et al. (2013) conducted a 
systematic review and meta-regression (i.e. assessment of the relationship 
between one or more study-level moderators) of 64 empirical studies (Borenstein 
et al., 2009). In particular Dickens et al. (2013) wanted to explore which 
components of psychological interventions were the most beneficial in improving 
symptoms of depression in individuals with CHD. Their meta-regression, 
however, did not look at illness perceptions. This might be considered as a 
limitation of the study because the reader is restricted in making conclusions 
about any potential mechanisms of change. The methodological strength of the 
meta-regression by Dickens et al. (2010) is that it included a fairly large number 
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of studies (compared to other reviews in this field). The overall sample size 
(N=17,397), however, was moderate in terms of meta-analysis standards.  
 Dickens et al. (2013) isolated 11 different components of interventions, 
including problem solving, exercise, skills training, general discussion, relaxation, 
relapse prevention, behavioural therapy or cognitive-behavioural therapy. 
Statistically comparing the effect sizes from different studies enabled Dickens et 
al. (2013) to conclude that interventions that were cognitive behavioural or 
included problems solving and relaxation components led to improvements in 
depression (with a small effect size). These findings, however, need to be 
interpreted with caution because of a large heterogeneity among studies (e.g. 
differences in severity of depression, gender/age difference). 
 In addition, the meta-regression by Dickens et al. (2013) was also 
narrowly focused on only one outcome (depression) which limits the extent to 
which the findings could be utilised by clinicians.  
 Dickens et al. (2013) did well, however, in setting up detailed inclusion 
and exclusion criteria for studies, particularly in relation to pre-determining 
different components of interventions. This allowed the authors to separate 
psychological components from non-psychological ones. Overall, although the 
meta-regression conducted by Dickens et al. (2013) did not take into consideration 
interventions designed to change illness perceptions, the study provided relatively 
encouraging evidence that cardiac treatments with psychological components may 
improve psychosocial outcomes (specifically low mood) in people with CHD over 
interventions that do not contain psychological elements. It seems reasonable, 
61 
 
therefore, to explore whether different components of interventions could play 
different role in changing illness perceptions.  
 
1.8. Overall Conclusions 
 The above summary and critical evaluation of individual studies, systemic 
reviews and meta-analyses demonstrates that there have been some considerable 
efforts made to systematically gather and evaluate the studies investigating the 
relationship between illness representations and psychosocial outcomes.  The 
findings from these individual studies, however, provide a mixed, inconsistent and 
sometimes a contradictory picture of how patients’ illness representations link 
with psychosocial outcomes, such as anxiety or depression. On the whole, 
individual studies point towards an importance of all dimensions of illness 
representations in emergence and maintenance of symptoms of anxiety and 
depression. For instance, single studies showed that participants who feel more in 
control of the symptoms associated with CHD and who appraise these symptoms 
as less negative and less severe in consequences are less likely to report feelings 
of anxiety and depression. Previous individual studies also demonstrated that 
illness perceptions are not rigid and can change over time and/or course of an 
illness. This dynamic nature of illness representations creates a possibility that 
they can be changed through interventions. Single studies conducted to date, 
however, have so far provided a complex and confusing picture of how the 
interventions might work in changing maladaptive illness representations.  
Previous systemic reviews and meta-analysis of psychological interventions 
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designed to target maladaptive illness representations have a number of 
methodological and theoretical limitations. Some reviews restricted their focus to 
one outcome (e.g. depression or attendance at cardiac rehabilitation programmes) 
and other reviews were limited to a narrative summary of the findings. There is, 
however, a sufficient number of data on a wider range of outcomes (e.g. illness 
representations, depression and anxiety) that could be systematically accumulated 
and analysed using quantitative methodology.  
 It is also important to highlight that no previous meta-analysis could be 
identified that examined whether interventions with psychological components 
could be more effective in changing illness representations. There is also a clear 
lack of meta-analyses that systematically investigated whether changes to illness 
perceptions are linked to psychosocial outcomes, such as depression and anxiety. 
Finally, there have been very limited attempts in systematically exploring the 
factors that may affect the efficacy of psychological interventions targeted at 
changing illness perceptions.  
 Taking into consideration the methodological and theoretical limitations 
identified in the above-mentioned literature review, the aim of the present 
investigation is to examine whether interventions with psychological components 
are more effective in changing illness perceptions than interventions that do not 
have psychological components. Another aim is to explore how illness 
perceptions relate to changes in psychosocial outcomes, such as depression and 
anxiety. The findings have a potential to broaden scholars’ and clinicians’ 
understanding of the interplay between representations of illness and psychosocial 
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outcomes. Improved understanding of this complex relationship can facilitate 
development of more targeted and holistic interventions which would consider 
medical and psychological needs of individuals with CHD.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
64 
 
1.9. Research Questions 
 1.9.1. Research question one.  
 Are interventions containing clearly identifiable psychological 
components more efficacious in changing illness perceptions than standard 
cardiac interventions without clearly identifiable psychological components?  
 
 1.9.2. Research question two.  
 Do interventions targeting illness perceptions contribute to positive 
changes in symptoms of depression and anxiety? 
 
 1.9.3. Research question three.  
 Are type of illness (chronic vs acute) and age linked with the efficacy of 
interventions designed to change illness perceptions? 
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2. Method 
2.1. Chapter Overview 
 This chapter starts with the description of a general approach to data 
collection, management and analysis and a brief outline of guidelines that were 
applied in designing and execution of the present meta-analysis. Next, the details 
of studies’ inclusion and exclusion criteria are described. This is followed by 
providing information about the process of searching and selection of relevant 
literature. The consecutive sections provide information about how the data has 
been extracted and coded to fit with the goals of the current meta-analysis. The 
strategies used in calculating effect sizes and analysing data are described next. 
Finally, the details of an approach used to assess heterogeneity and quality 
pertinent to any meta-analysis are described. 
 
2.2. General Methodological Approach  
 The present meta-analysis was guided by the procedures outlined by 
Borenstein et al. (2009), the Cochrane Collaboration and the PRISMA guidelines 
(Higgins & Green, 2011; Moher et al., 2009).  
 The Cochrane Collaboration criteria outline a protocol for preparing and 
conducting meta-analyses of trials of healthcare interventions (Higgins &Green, 
2011). This protocol sets out strategies on how to identify, select and summarise 
reviewed studies and how to analyse quantitative information. These stringent 
criteria help the researchers to make scientifically robust conclusions about the 
efficacy of specific treatment(s) (Higgins & Green, 2011).  
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2.3. Studies’ Inclusion/Exclusion Criteria  
 In the present meta-analysis studies were assessed as relevant according to 
pre-determined criteria specified by the Cochrane Collaboration Criteria (Higgins 
& Green, 2011).   
These criteria included:  
1) Type of participants 
 The present meta-analysis included studies conducted on adults of any age 
and gender who were diagnosed with at least one of the following CHD 
conditions: stable and unstable angina, myocardial infarction (MI), Acute 
Coronary Syndrome (ACS), Coronary Artery Disease (CAD) and conditions that 
require revascularisation procedures: Coronary Artery Bypasses Graft (CABG) 
and Percutaneous Coronary Interventions (PCI).  
2) Type of interventions  and comparisons  
Studies were included in the final analysis if they tested interventions 
designed to change maladaptive illness perceptions in coronary heart diseases 
(CHD). Although the author of the present meta-analysis frequently refers to 
maladaptive illness perceptions, other closely related terms were also considered. 
These terms included: illness attributions, beliefs and/or misconceptions.  
Cardiac interventions are multifaceted, consisting of psychological and 
non-psychological components, such as informal discussions, cardiology medical 
reviews, psycho-education, techniques based on specific therapeutic approaches, 
and/or telephone follow-ups.  It was, therefore, important that the present meta-
analysis reflected the multidimensional nature of cardiac interventions. 
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Interventions under review in the present meta-analysis consisted of the following 
components: a) psycho-education only, b) psycho-education combined with 
counselling techniques, c) psycho-education combined with cognitive-behavioural 
and/or motivational interviewing techniques, d) interaction or non-psycho-
educational contact with medical health professional (e.g. cardiologist or cardiac 
CNS) and/or e) telephone follow up.  
 Only studies with randomised control design were included because 
randomised controlled trials (RCTs) constrained the methodological heterogeneity 
among studies. Combining studies with different types of designs (e.g. quasi-
experimental and RCTs) would further increase heterogeneity among studies. This 
in turn would have an adverse impact on a quality of conclusions and 
generalizability of findings (Borenstein et al., 2009).   
 In terms of other specific study design characteristics, the study was 
included if it met the following criteria: 1) trials with or without comparison 
(medical and non-medical) treatments, and 2) cross-sectional and longitudinal 
designs.  All included studies had at least one follow-up time point which ranged 
from 1 to 12 months. In order to reduce heterogeneity amongst studies, the data 
closest to the most frequent time point was selected (Higgins & Green, 2011). In 
the present meta-analysis this time point was at 3 months. 
 Studies were not excluded based on their mode and frequency of delivery, 
treatment intensity and a type of the professional delivering the intervention. 
These methodological characteristics, however, were reported and discussed in the 
context of obtained effect sizes. 
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3) Types of outcomes  
 In the present meta-analysis any study was included that used a 
standardised or semi-standardized assessment measure of a primary outcome and 
at least one of the secondary outcomes. The primary outcome was a measure of 
illness perception/beliefs/attributions.  The secondary outcomes included 
measures of severity of anxiety and depressive symptoms. 
 
2.4. Data Sources 
 Data were extracted from the electronic databases, including PsycInfo, 
Medline, Web of Science, Scopus, Cumulative Index to Nursing and Allied 
Health Literature (CINAHL), Cochrane’s library and EMBASE. The searches 
covered the period of time from 1970 to the fourth week of August 2014. An 
additional search was conducted from September 2014 to November 2015. This 
timeframe was guided by previous systematic reviews and meta-analysis in the 
field of interventions designed to change illness perceptions in people with CHD. 
Additional hand-search was conducted of references lists of articles meeting 
inclusion criteria and previous relevant reviews (Lipsey &Wilson, 2001). The 
hand search included reference lists of previous systemic reviews and meta-
analysis as well as key previous empirical studies (e.g. Dusseldorp et al., 1996;  
French et al., 2006; Goulding et al., 2010). Relevant journals were also searched. 
These journals included: Journal of Advanced Nursing, Journal of Psychosomatic 
Research, and Psychosomatic Medicine. Finally, when necessary and appropriate 
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(e.g. when additional information was needed) contact was made with key authors 
in the field. The details of contacts can be found in Appendix C  (see Table A2.1). 
Due to limited resources only studies written in English and Polish (as this is the 
mother tongue of the author of the current meta-analysis) were included in the 
final analysis.   
 A breakdown of selected and excluded studies as well as reasons for 
exclusions can be found in a PRISMA flowchart in the Result section (see Figure 
3.1. in the Result section). 
 
2.5. Search, Screening and Selecting of Relevant Literature 
 Systematic search strategy was guided by core terms (see Table 2.1). 
These core pre-established terms helped in identifying appropriate studies 
pertinent to the research questions and kept the meta-analysis focused. These 
search terms were chosen through initial checks of previous studies and reviews 
(e.g. Foxwell et al., 2013).  Final results of literature search were stored in 
bibliographical software, the Mendeley Reference Manager version 1.12.2 (2014).  
 Electronic data sources were searched independently using OvidSP 
interface. The first step of search involved inputting pre-established core search 
terms with or without Boolean operators (‘AND’ and ‘OR’) and ‘wildcard’ 
symbol (*). The search terms were combined to maximise retrieval of records and 
to optimise unique search outcomes. A searching strategy was consulted with a 
university librarian specialising in systematic literature search.  
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 The next step included screening and selection of relevant studies guided 
by inclusion and exclusion criteria (Boland, Cherry & Dickson, 2014). The 
screening and selection of studies involved: 
1) Identification and deletion of any duplicate references within and across 
databases 
2) Screening all titles and abstracts applying inclusion and exclusion criteria  
3) Obtaining full text of selected research papers 
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Table 2.1.  
 
Search strategy used to search PsychInfo, Medline, Web of Science, Scopus, 
Cumulative Index to Nursing and Allied Health Literature (CINAHL), Cochrane’s 
library and EMBASE. 
 
Line Search term Search criteria 
1 Coronary heart disease OR CHD OR Coronary 
artery disease or CAD OR Angina OR Myocardial 
infraction or M OR Heart attack OR  Angioplasty 
OR Percutaneous coronary intervention OR PCI OR 
Coronary artery bypass graft OR CABG OR Acute 
coronary syndrome OR ACS (AND)  
 
Title, Abstract  
2 Illness percept* OR Illness misconception OR 
Illness cognit* OR Illness expect* OR Maladaptive 
thinking (AND)  
 
Abstract 
3 Psych* intervention OR Psychotherapy OR 
Treatment OR Cardiac rehabilitation OR 
Rehabilitation OR Therapy OR Cognitive 
behavioural therapy OR CBT OR Motivational 
Interviewing OR MI OR Behavioural therapy OR 
Cardiac programme OR Cardiac management  
(AND)  
 
Title, Abstract  
4 Depress* OR  Anxi* OR Mood OR (health related) 
Quality of life OR QoL OR Emotional well-being 
OR  Behav* (AND)  
Abstract 
5 Randomised controlled trial OR RCT OR Controlled 
trail OR  Random allocation OR Clinical trial OR 
Double blind method (AND)  
 
Title, Abstract  
6 1 OR 4 
 
Title, Abstract   
7 1 AND 2  
 
Title, Abstract   
8 2 AND 4 
 
Title, Abstract   
9 1 AND 3 AND 4 
 
Title, Abstract   
10  1 AND 2 AND 3 
 
Title, Abstract   
11 10 AND 5 
 
Title, Abstract   
12 9 AND 5  Title, Abstract   
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2.6. Data Extraction 
 All relevant information from each study were extracted and recorded in 
the SPSS data file. Each study was assigned a numerical ID. The information 
extracted included: study number, authors, design details, main characteristics of 
participants, CHD classification, intervention components,  illness perception 
measure, secondary outcomes measures, key findings and quality ratings.  A 
succinct summary of key characteristics of each study was also collated in a 
narrative table, which can be found in the result section (see Table 3.1 in Results 
section).  
 
2.7. Data Coding 
 All extracted studies’ characteristics were coded to ensure that necessary 
information was captured. Information was coded using a coding manual and 
coding form (see Appendix D  and E ).  The coding form and manual were 
designed specifically for the purpose of the present meta-analysis and were based 
on the guidelines provided by Lipsey and Wilson (2001). Additionally, a design of 
the coding form and manual was informed by the CONSORT 2010 checklist of 
information to include when reporting randomised trials, and the Cochrane 
Collaboration guidelines (Higgins & Green, 2011; Schulz, Altman, & Moher, 
2010). Coded data was transferred into the SPSS data file. The study 
characteristics were coded according to three categories: substantive, 
methodological and extrinsic variables (Sanchez-Meca & Marin–Martinez, 2010).  
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The coding form and manual contained also additional items aiding quality 
assessment. 
 The substantive variables relate to main research questions. In the present 
meta-analysis substantive variables included: 1) authors,  2) year of publication, 
3) type of publication (e.g. journal article, book chapter thesis or doctoral 
dissertation) 4) variable name, variable measures and scores for primary and 
secondary outcomes (e.g. illness perceptions, anxiety, depression),  5) the types of 
interventions (e.g. psycho-education only, psycho-education combined with 
counselling techniques, psycho-education combined with the CBT-based and/or 
motivational interviewing techniques, interactive/non-psycho-educational contact 
with medical professional, and/or telephone contact), 6) participants’ 
characteristics (e.g. sample size, age, gender, and ethnicity), and 7) the type of 
illness (chronic vs acute). 
 The methodological variables are linked to a study design. The 
methodological variables included in the present meta-analysis were: 1) study 
design (e.g. longitudinal/RCT) and 2) a nature of comparison group (e.g. no 
treatment, delayed treatment and alternative treatment).  In addition, raw data for 
study findings and each outcome variable was recorded (e.g. means, standard 
deviations, confidence intervals, t value and/or p value). When not provided in a 
paper a total mean for variable (i.e. age) was calculated using the following 
formula: ܯ =   ሺேଵ×ெଵሻ+ሺேଶ×ெଶሻேଵ+ ேଶ    
  
Where N1 sample size group 1;  
N2 Sample size group 2; 
          M1 mean for sample 1; M2 mean for sample 2 
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 The extrinsic variables are those that influence the results but they do not 
directly relate to either research questions or methodological aspects of the 
studies. Extrinsic variables in the present meta-analysis included: 1) mode of 
delivery (e.g. face to face, one to one, telephone), 2) duration of intervention (e.g. 
single consultation, multiple discreet sessions, and/or continuous programme), 3) 
type of health professional delivering the intervention (e.g. medical and/or mental 
health professional), 4) theoretical framework of the intervention, and 5) setting of 
the intervention (e.g. inpatient/outpatient).  
 The quality assessment items included: presentation of participant 
flowchart, information about randomisation procedure, blinding and allocation 
concealment, validated outcome measures, sample size calculation/consideration. 
 
2.8. Calculating and Interpreting Effect Size 
 The effect size is a statistic denoting a magnitude and a direction of a 
difference between two groups or variables (Borenstein et al., 2009). Effect size is 
obtained by subtracting two group means than dividing it by standard deviation or 
pooled standard deviation. The following formula represents how effect size is 
calculated: 
ܧ� =  ܯ௘ −  ܯ௖ �ܦ௣௢௢௟௘ௗ  . 
Effect size can be expressed in a variety of ways, such as difference between 
means (e.g. raw or standardized mean difference), correlation coefficient or as a 
percentage (Card & Casper, 2013). In the present meta-analysis conventional rules 
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of thumb were applied to interpret the magnitude of the effect size (small d ≤ .2; 
medium d = .50; large d ≥ .80) (Lipsey &Wilson, 2001).  
 In meta-analysis the effect sizes from different studies (and different 
samples) are pooled together to estimate the overall effect size for a specific 
population (Borenstein et al., 2009). In order to assimilate effect sizes from 
different studies that use different measures and samples, effect sizes need to be 
comparable (Card & Casper, 2013). In the present meta-analysis the effect sizes 
from different studies were pooled together using standardized mean difference 
(SMD) (i.e. Hedges’s g). SMD is particularly common statistical metric to express 
effect size in meta-analysis of controlled trails (Durlak, 209).  Hedges’s g was 
chosen over an alternative (Cohen’s d), because Hedges’ g is considered to be 
more accurate reflection of the relationship between variables. This is because it 
adjusts for potential  positive bias, such as small sample size (particularly when N 
< 20) (Card & Casper, 2013).  Hedges’s g is calculated based on difference 
between the means of two groups (e.g. intervention and control) (Card & Casper, 
2013). A positive value of Hedges’s g indicates that the intervention group 
obtained higher mean and the negative value depicts a higher score for the control 
group. 
Formula for adjusted Hedges’g is:   �௔ௗ௝௨௦௧௘ௗ = ͳ − ቀ ଷସௗ௙−ଵ ቁ . 
 
 In the studies that did not report the effect sizes, the commonly reported 
statistics were used to calculate Hedges’s g (Card & Casper, 2013).  An approach 
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described by Card and Casper (2013) was used to calculate these effect sizes. 
When means and standard deviations were not reported, the effect sizes were 
calculated from t and F statistics. Where necessary the standard error was 
converted into the standard deviation using the following formula: �ܦ = �ܧ ×  √ܰ 
 
2.9. Data Analysis  
 Data were stored and analysed using the Comprehensive Meta-Analysis 
Software (version 3.3.07; November 2014) and SPSS version 22 for Windows 
(SPSS, Chicago, IL, USA). 
 Effect sizes were grouped according to primary (illness perception) and 
secondary outcomes (depression and anxiety) that were selected to assess the 
efficacy of the interventions.   
 All studies reported one measure of each outcome. When the study 
reported data for subscales of the outcome (e.g. subscales scores corresponding to 
the dimensions of illness perceptions) a procedure suggested by Borenstein et al. 
(2009) was used to combine the scores. This approach was chosen because it is 
generally assumed that subscale scores are not independent of each other 
(Borenstein et al., 2009). It is, therefore, more appropriate to combine the 
subscales scores than to treat each subscale score as an independent entity. The 
derived combined score is treated as a unit of analysis in the meta-analysis 
(Borenstein et al., 2009). The combined effect size is derived firstly by calculating 
each subscales’ effect size and its variance. These subscales’ effect sizes are 
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finally used to compute a combined effect size (in the current meta-analysis 
marked as combined in the forest plots) (Borenstein et al., 2009).  
 Additionally, standard errors, 95% confidence intervals (CIs) range and p 
values were calculated for each effect size and the total effect sizes. Weighted 
effect sizes were calculated based on the inverse of the variance method (�௜ሻ 
(Borenstein et al., 2009). Small studies have larger standard errors and therefore 
they have a lower weighting than large studies.  
 The effect sizes were calculated within a random effects model 
(Borenstein et al., 2009). The random effect model assumes that treatment effects 
are randomly distributed across populations. This model was chosen because it 
allows for greater between- and within-study variability (Borenstein et al., 2009). 
 The effect sizes and their CIs were reported in quantitative format and 
graphical representations (i.e. forest plots). Graphical distribution of effect sizes 
and CIs was inspected visually for the presence of outliers.  
 
 2.9.1. Heterogeneity assessment. The variability of the effect sizes was 
assessed employing a heterogeneity (Q) statistics (Card & Casper, 2013). The 
heterogeneity value allows the researcher to assess the variability across effect 
sizes and to determine whether the variability among studies can be explained by 
sampling error (Borenstein et al., 2009). A significant Q value (p < .05) indicates 
that a distribution of effect sizes is significantly heterogeneous and that the 
researcher can reject the null hypothesis of homogeneity (Borenstein et al., 2009).  
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 The I² index was also calculated because the present meta-analysis was 
based on a relatively modest number of studies (and hence relatively low power) 
(N = 11) (Borenstein et al., 2009).  I² index provides information about the extent 
of variability in a distribution of effect sizes that might be due to heterogeneity 
(Borenstein et al., 2009). The value of I² indicates how much of the observed 
dispersion between effect sizes of studies is likely to be associated with real 
difference in the effect sizes.   I² ranges from 0 to 100%, with values around 25%, 
50% and 75% denote small, medium and large heterogeneity, respectively 
(Borenstein et al., 2009). The formula for I² is as follows: �ଶ =  �−ሺ௞−ଵሻ�  × ͳͲͲ. 
 Finally, the tau² statistic was used to assess the between-studies variance 
of effect sizes (Borenstein et al., 2009). This metric of heterogeneity was an 
important estimate of heterogeneity because the data analysis in the current meta-
analysis was conducted within a random effect model (Borenstein et al., 2009). 
Tau² value of .000 indicates no between-studies variance of effect sizes and values 
tau² >.000 indicate presence of between-studies variance (Borenstein et al., 2009). 
The significance level for tau² is the same as for the Q statistics, with p < .05 
indicating significant amount of between-study variance (Borenstein et al., 2009).  
  
 2.9.2. Moderator analysis. The impact of moderating variables on the 
effect sizes was also assessed within the random effect model. The effect sizes 
were grouped together into categories based on moderating variables. There were 
two moderating variables: the intervention strategy (studies which contained 
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clearly identifiable psychological component vs studies that did not contain 
clearly identifiable psychological component) and the type of illness (chronic vs 
acute) (for more information see Appendices D and E). The moderating variable 
of the intervention strategy and the type of illness was based on coding of studies 
(item: type of intervention strategy included) (see Appendices D and E). Studies 
classified as studies with clearly identifiable psychological component had to be 
coded as containing element of psycho-education combined with cognitive-
behavioural (CBT) and/or motivational interviewing techniques (see Appendix D  
and E ).  For each moderating analysis three summary effects were calculated: a 
total effect size and effect sizes for two subgroups.  
 Within the moderating analysis the total heterogeneity of effect sizes was 
separated into the heterogeneity of the distribution among the effect size within a 
category of moderating variables (��) and the heterogeneity between the category 
of moderators (�௕ሻ (Borenstein et al., 2009). Similarly to the heterogeneity 
assessment in the main analysis the I² and tau² metrics were calculated to depict 
the amount of heterogeneity (Borenstein et al., 2009).  
 
2.10. Quality Assessment 
 Quality assessment in the current meta-analysis involved assessment of the 
quality of individual studies and the quality assessment across studies (within the 
meta-analysis). 
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 2.10.1. Quality assessment on the individual study level. In the current 
meta-analysis the quality of each study was assessed using the RCT of 
Psychotherapy Rating Scale (RCT-PQRS) (Kocsis et al., 2010) (see Appendix F). 
This is a 25-item measure originally developed to assess healthcare interventions. 
This quality assessment tool has been chosen because it allows the researcher to 
rate the quality of all aspects of randomised controlled studies, focusing on 
internal and external validity (Kocsis et al., 2010). The RCT-PQRS has been also 
successfully used in previous meta-analysis (e.g. Thoma et al., 2012). Finally, the 
RCT-PQRS is relatively user friendly. The RCT-PQRS has very good 
psychometric properties, with inter-rater reliability of .79, the internal consistency 
(Cronbach α) of .88 and validity of .47 (Kocsis et al., 2010). The quality of each 
study was rated by two raters, the author and the supervisor. The ratings were 
done independently of each other and any disagreements were discussed. The IRR 
coefficient (Cronbach’s alpha) was r  = .84, indicating high levels of agreements 
between raters.  
 
 2.10.2. Publication bias. An integrative method of evaluating the quality 
of the meta-analysis is an assessment of publication bias. Publication bias 
expresses an idea that the final sample of the meta-analysis might have come from 
the biased publication and selection processes (Borenstein et al., 2009). This is 
because studies with large effect sizes and significant results are more likely to get 
published than studies with non-significant results and/or small sample sizes 
(Borenstein et al., 2009). If present the publication bias is likely to be carried over 
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to the meta-analysis. Publication bias is also affected by other factors, such as 
language bias (i.e.  including only studies published in English), available bias 
(i.e. studies published in journal with easy and/or free access are more likely to be 
selected) and/or citation bias (i.e when studies with significant results are more 
likely to be cited) (Boresetin et al., 2009). The purpose of statistically assessing 
the potential presence and the extent of publication bias in meta-analysis is to 
detect whether missing studies (i.e. studies omitted from the meta-analysis) are 
systematically different from the included studies (Borestein et al., 2009). The 
probability of the bias increases with smaller sample sizes.  
 In the current meta-analysis, a number of steps were undertaken to assess 
the presence/absence of publication bias.  Firstly, a funnel pot was derived and 
visually inspected for each outcome variable (illness perception, depression and 
anxiety). A funnel plot is a scatterplot of effect sizes from included studies against 
standard error of the effect size (Sterne & Harbord, 2004). Funnel plots are 
inspected for asymmetries in the distributions of the effect sizes. Any asymmetries 
indicate the presence of publication bias (Sterne et al., 2011). Typically, large 
studies can be located on the top of the plot around the mean of the effect size. 
Studies with small effect sizes can be found towards the bottom of the graph and 
are more likely to be spread broadly across (due to increase chance of larger 
standard error) (Borenstein et al., 2009). If the direction of the plot is towards the 
right (i.e. more effect sizes appear towards the right of the graph) then we could 
expect a gap on the bottom left, indicating that small studies with non-significant 
results are likely to be missing (Borestein et al., 2009).  
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 The second step in assessing the publication bias in the current meta-
analysis was to determine whether the obtained effect size is entirely an artefact of 
the publication bias (Borestein et al., 2009). In order to do this Rosenthal’s 
method of calculating fail-safe N was used. The fail-safe N allows the researcher 
to determine how many missing studies would need to be included in the meta-
analysis before the obtained effect size was statistically non-significant. The 
higher the number of missing studies in fail-safe N calculation, the lower the 
probability of the bias (Borenstein et al., 2009). The fail-safe N was calculated for 
all the effect sizes for all three outcomes in the current meta-analysis.  
 The third step in assessing the publication bias was to determine the 
impact of the bias and estimate what the effect would have been if the bias was 
absent. This was done using the Duval and Tweedie’s trim and fill method. The 
trim and fill method removes the most extreme small studies from the positive 
side of the plot and re-calculates the effect size at each point until the plot 
becomes more symmetrical around the new effect size (Borenstein et al., 2009). 
The trim and fill was applied to affect sizes of all three outcomes in the current 
meta-analysis.  
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3. Results 
 
3.1. Overview of the Chapter 
 This chapter presents the results from the analyses conducted on extracted 
data from studies investigating the efficacy of interventions design to change 
maladaptive illness perceptions in CHD. The PRISMA flowchart in Figure 3.1 
shows the numbers of studies entered into the meta-analysis. This is followed by a 
more detailed discussion of the characteristics of the studies that met the inclusion 
criteria. This is supplemented by a narrative summary in Table 3.1.The descriptive 
section considers important features of the studies entered into the meta-analysis, 
such as characteristics of participants, characteristics of interventions (and control 
treatments) and presentation of measures of primary and secondary outcomes. 
Next, the statistical analysis of effect sizes for each research question is presented. 
Statistical analysis of effect sizes for each research question includes presentation 
and narrative description of effect sizes and their confidence intervals, 
heterogeneity statistics (Q, I² and tau² metrics) and forest plots of effect sizes for 
each outcome. The association between age and effect sizes was tested using 
correlation with non-parametric tests. The final section of the results chapter 
involves assessment for publication bias. This assessment includes narrative 
description of funnel plots and statistical test of fail-safe N and Duval and 
Tweedie’s trim and fill (Borenstein et al., 2009).  
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3.2. Description of Included Studies 
 Figure 3.1 represents the PRISMA flowchart of the process and results 
from the search and selection of studies in the current meta-analysis. Studies 
published between 2002 and 2014 met the criteria for inclusion in the current 
meta-analysis. Table 3.1 shows main characteristics of all studies entered into the 
meta-analysis. All studies were published in English and in peer-reviewed 
journals. Five studies were conducted in the UK (studies 02, 03, 06, 07, 10), two 
studies were performed in the USA (study 08 and 09) and New Zealand, 
respectively (studies 01 and 11), one study was conducted in Canada (study 05) 
and one study came from China (study 04).  
 In this meta-analysis, 11 studies were included in total and the total sample 
size was 5, 267 participants with CHD, ranging from 65 (study 11) to 2905 (study 
08). 
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Number of records identified through 
electronic database searching 
N = 13078 
Publications identified by 
additional search 2014 to 
November 2015 
N =970 
Number of duplicates removed 
in electronic databases 
N = 3381 
Number of records screened 
by title and/or abstract  
N = 9697 (2 studies in Polish)  
Number of records 
excluded by title and/or 
abstract 
N =9663 + 934 from 
additional search 
 
Reasons for exclusions:      
Not in English 
Non-RCT design 
Quasi-experimental 
design 
Not targeting illness 
perceptions 
Medical intervention 
only 
Inappropriate sample 
Publish study protocol 
only 
 
Number of records 
identified through hand 
search and contact with 
authors 
N = 19 
Number of full-text 
articles assessed for 
eligibility 
N = 53 
Additional full-text 
articles assessed 
for eligibility 
N =36 
Number of records 
excluded 
N = 78 
 
Reasons for exclusions:  
Non-RCT design (e.g. 
quasi-experimental) 
Medical intervention 
only 
Lack of appropriate 
measures of primary 
and/or secondary 
outcome post 
intervention 
Intervention not 
targeting illness 
perceptions 
Lack of appropriate 
data  
 
Number of studies included in 
quantitative synthesis 
N = 11 
Figure 3.1.The  PRISMA Study Selection Flowchart.   
Adopted from Moher, D., Liberati, Al., Tetzalaff, J., Altman, D., & The PRISMA 
Group (2009). 
Additional studies 
included in 
synthesis  
N = 1 
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Table 3.1.  
 
Characteristics of RCT Studies Designed to Change Illness Perceptions in CHD Included in the Current Meta-analysis (in chronological order). 
 
Study ID, 
Author 
(publication 
year), 
country/ 
Quality 
score* 
Sample 
characteristics: 
size 
(intervention/ 
control), mean 
age, gender 
(f/m) 
CHD 
Diagnosis, 
Type of 
Illness  
(chronic vs 
acute) 
Intervention as 
Described (types 
of strategies 
included in 
treatment);  Type 
of Intervention 
Strategy 
 
Control 
Treatment  
Primary 
Outcome 
(measure  
used) 
Secondary 
Outcomes 
(measure 
used) 
Results (brief summary) 
Study 01, 
Pfaefflli et 
al. (2015),  
New 
Zealand/ 
30 
N = 123 (61/62) 
M = 59.5 
23F/100M 
Broad 
category of 
CHD; 
acute 
Text4Heart: text 
messages and web-
based intervention 
addressing risk 
factors, promoting 
life style changes;  
 
No psychological 
component  
 
Usual care: 
inpatient 
rehabilitation, 
encouragement 
to attend 
cardiac 
rehabilitation 
programme 
 
Illness  
perception 
(Brief IPQ)  
Depression 
(HADS) 
 
Anxiety 
(HADS) 
No changes have been 
reported in illness 
perceptions and depression 
post intervention. The 
intervention group reported 
more anxiety symptoms post 
intervention compared to 
control group. 
Study 02, 
Barley et al. 
(2014)  
UK/ 
36 
N = 81 (41/40),  
M = 65,  
29F/52M  
 
Broad 
category of 
CHD;  
acute 
Psycho-education 
combined  
with counselling 
techniques;  
Contains 
psychological 
component  
Outpatient 
follow up by 
GP/Practice 
Nurse + 
signposting 
Illness  
Perception 
(Brief IPQ)  
Depression 
(HADS) 
 
Anxiety 
(HADS) 
 
Illness perception: greater 
improvements in intervention 
group; Depression: both 
groups improved scores 
without group differences; 
Anxiety: reduced odds of 
depression  
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Study 03, 
O’Brien et 
al. (2014)  
UK/ 
36 
N = 1136 
(585/551); 
M = 63.58; 
316F/820M 
 
 
ACS;  
acute 
 
 
Psycho-education 
combined with 
cognitive 
behavioural 
therapy or 
motivational 
interviewing 
Contains 
psychological 
component 
 
In patient 
standard 
education  
ACS Response 
Index: three 
dimensions 
(knowledge, 
attitude & 
beliefs)  
None  Greater changes in 
knowledge, attitudes and 
beliefs in the intervention 
group, the speed of change in 
the intervention group was 
also faster 
Study 04, 
Yan et al. 
(2013) 
China/ 
39 
N = 124 (51/51) 
M = 64.27 
25F/77M 
 
MI;  
chronic 
Psych-education 
combined with 
counselling 
techniques;  
 
No psychological 
component 
 
Routine 
outpatient 
follow up 
Illness 
perceptions 
Chinese  
version of IPQ  
None Patients in intervention group 
had significantly modified 
their illness perceptions 
about personal and treatment 
control, timeline 
acute/chronic and identity of 
MI  
 
Study 05, 
Cossette et 
al. (2012) 
Canada 
35 
 
 
 
 
N = 242 
(121/121) 
M = 59.40  
35F/207M  
 
ACS; 
acute 
Psycho-education 
combined with 
counselling 
techniques; 
 
No Psychological 
Component 
 
Standard Care: 
medical 
outpatient 
follow up 
Illness 
perceptions 
(Revised IPQ) 
Anxiety 
(State-Trait 
Anxiety 
Inventory) 
 
 
Significant group difference 
in personal control 
dimension of illness 
perception, other dimensions 
non-significant; No 
significant group differences 
in anxiety or life style factors  
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Study 06, 
Furze et al. 
(2012) 
UK/ 
37 
N = 142 (70/72) 
M = 64.41 
67F/75M 
Angina; 
chronic 
Angina Plan: 
psycho-education 
combined with 
cognitive 
behavioural 
therapy or 
motivational 
interviewing 
techniques; 
 
Contains 
Psychological 
Component 
 
 
Standard care: 
discussion of 
risk factors, 
advice giving 
and 
signposting  
Angina-related 
misconceptions 
(York Angina 
Beliefs 
Questionnaire) 
Anxiety 
(HADS) 
 
Depression 
(HADS) 
Intervention group had 
significance modified their 
beliefs about angina, reported 
less symptoms of anxiety and 
depression 
Study 07, 
Furze et al. 
(2009), 
UK/43 
N = 204 
(100/104) 
M = 64.78 
40F/164M 
 
 
 
 
 
 
 
 
 
 
Patients 
waiting for 
CABG 
Heart Op 
Programme: 
psycho-education 
combined with 
cognitive 
behavioural 
therapy or 
motivational 
interviewing 
techniques;  
Contains 
psychological 
component 
 
Nurse led 
education and 
counselling 
intervention 
Cardiac  
Beliefs 
(York  
Cardiac  
Beliefs 
Questionnaire) 
Depression 
(Cardiac 
Depression 
Scale) 
 
 
Anxiety 
(State Trait 
Anxiety 
Inventory) 
Cardiac misperceptions and 
depression were significantly 
reduced after the intervention. 
The anxiety in intervention 
group did not improve 
significantly 
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Study 08, 
McKinley et 
al. (2009) 
USA/ 
32 
 
 
 
 
 
 
 
 
 
 
 
N = 2905 
(1480/1425) 
M = 67.20 
1129F/1776M 
ACS; 
acute 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Intervention 
focused around 
three components: 
informational, 
emotional and 
social. Psycho-
education 
combined with 
cognitive 
behavioural 
therapy or 
motivational 
interviewing;   
 
Contains 
psychological 
component 
Standard Care: 
medical follow 
ups and 
signposting  
 
 
 
 
 
 
 
 
 
 
 
 
 
Three domains 
of ACS 
misconceptions: 
knowledge, 
attitudes, and 
beliefs (the 
ACS Response 
Index)   
 
 
 
 
 
 
 
 
 
None Intervention group showed 
significant improvement in 
all domains of ACS 
misconceptions 
 
 
 
 
 
 
 
 
 
 
 
Study 09, 
Tullmann et 
al. (2007) 
USA/ 
21 
N = 115 (58/57) 
M = 73.80 
60F/55M 
 
 
 
 
Angina, MI 
& 
angioplasty 
Psycho-education 
combined with 
counselling 
techniques;  
 
No Psychological 
component 
Standard Care: 
detailed 
information 
not provided  
 
 
 
 
Response 
Questionnaire 
with 3 domains 
of Illness 
perceptions: 
knowledge, 
attitudes and 
beliefs  
Anxiety 
(Brief 
Symptom 
Inventory 
Anxiety 
Subscale) 
Intervention group obtained 
significantly higher scores for 
illness knowledge and beliefs 
but not for attitudes. There 
was no significant changes 
anxiety scores. 
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Study 10, 
Lewin et al 
(2002) 
UK/ 
31 
N = 130 (63/67) 
M = 67.20 
45F/85M 
 
Angina; 
acute 
The Angina Plan:  
psycho-education 
combined with 
cognitive 
behavioural 
therapy or 
motivational 
interviewing 
techniques;  
 
Contains 
Psychological 
Component  
 
Nurse-led 
education 
session with 
additional 
booklet 
Angina Beliefs 
(York Angina 
Beliefs 
Questionnaire) 
Anxiety 
(HADS) 
Depression 
(HADS)  
 
 
Patients in intervention group 
demonstrated significantly 
better improvements in scores 
on anxiety, depression; 
Patients in intervention group 
also reported less 
maladaptive illness 
perceptions post intervention 
 
Study 11, 
Petrie et al. 
(2002)  
New 
Zealand/ 
28 
 
 
 
 
N = 65 (31/34) 
M = 55.61  
18F/47M 
 
MI; 
acute 
Psycho-education 
combined with 
cognitive 
behavioural and/or 
motivational 
intervention 
techniques; 
 
Contains 
psychological 
component 
Standard Care: 
medical follow 
up and 
standard MI 
education  
 
 
 
 
Five domains of 
illness 
perceptions: 
consequence, 
timeline, 
control/cure, 
identity and 
distress  (IPQ)  
 
 
 
None 
 
 
 
 
 
 
 
 
 
Patients in intervention 
significantly modified  their 
illness perceptions in all 
domains of  illness 
perception  
 
 
 
N-total number of participants; CHD-Coronary Herat Disease; CABG-Coronary Artery Bypass Grafting; ACS- Acute Coronary Syndrome; MI-
Myocardial Infraction; HADS- Hospital Anxiety and Depression Scale; IPQ-Illness Perception Questionnaire; *quality rating based on the RCT-
Psychotherapy Quality Rating Scale (higher scores indicated higher quality). 
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 3.2.1. Participants. Five studies included patients with angina and MI 
(study 04, 06, 09, 10, 11). One study included patients waiting for CABG (study 
07), two studies included patients with broad definition of CHD (study 01 and 02) 
and three studies included patients with ACS (study 03, 05, 08).  Sixty six percent  
of the total sample were males (N = 3457). With an exception of one study (study 
09) all of the studies had a higher percentage of males. The mean age of 
participants was 64.06 years (SD = 4.79), ranging from 55.61 to 73.80 (see Table 
3.1). Five studies did not report ethnicity at all (study 03, 05, 06, 10 and 11). In 
the remaining studies the ethnicity was defined and categorised differently, 
rendering it impossible to accumulate the findings together.  
 
 3.2.2. Characteristics of interventions. All interventions were designed 
to change patients’ maladaptive illness perceptions around CHD and were based 
on the Leventhal’s self-regulation model of illness behaviour (Diefenbach & 
Leventhal, 1996). The control condition involved standard usual care (e.g. cardiac 
rehabilitation) in all of the studies. Interventions in six studies contained clearly 
identifiable psychological component, such as cognitive-behavioural therapy 
and/or motivational interviewing (studies 02, 03, 06, 07, 10 and 11).  
 The setting of intervention delivery varied across studies. Nine studies 
were delivered as outpatient interventions (studies 01, 02, 04, 07-11) and three 
studies involved both inpatient and outpatient sessions (study 03, 05 and 06). The 
mode of delivery was relatively consistent across studies. All studies, except study 
01, included face to face and individual sessions.  
92 
 
 Treatment duration varied across studies. Three studies included a single 
contact session (study 03, 08 and 09), four studies involved multiple discrete 
sessions (study 02, 04, 05 and 11), and four studies were structured as continuous 
programmes (study 01, 06, 07, and 10). Intervention was delivered by non-mental 
health professional (e.g. nurse or cardiologist) in 10 studies. Only one study 
explicitly recognised involvement of mental health professional (health 
psychologist) in the treatment delivery (study 11). For more information about the 
distribution of effect sizes across different characteristics of the interventions 
please see Table 3.2. 
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Table 3.2.  
 
Effect sizes for Illness Perceptions Grouped by Intervention Characteristics.  
 
 
Characteristics of interventions 
 
Study ID 
 
 01 02 03 04 05 06 07 08 09 10 11 
 
Setting  
of delivery 
outpatient -.117 -.187  .484   .466 .219 .651 .243 .249 
Inpatient and  
outpatient 
 
  .192  .011 .437      
 
 
Mode of  
delivery 
Face to face  
and individual 
 
 -.187 .192 .484 .011 .437 .466 .219 .651 .243 .249 
Text message,  
web-based 
 
-.117           
 
 
Treatment  
duration 
Single session   .192     .219 .651   
Multiple discrete session  -.187  .484 .011      .249 
Continuous  
programme 
-.117     .437 .466   .243  
*Effect Size expressed as Hedges’s g.        
01 - Pfaeffli et al.(2015)            
02 - Barley et al.(2014) 
03 - O’Brien et al. (2014) 
04 - Yan et al. (2013) 
05 - Cossette et al. (2012) 
 
06 - Furze et al. (2012) 
07 - Furze et al (2009) 
08 - McKinley et al. (2009) 
 
09 - Tullmann et al. (2007) 
10 - Lewin et al. (2002) 
11 - Petrie et al. (2002) 
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3.2.3. Primary Outcome 
 All studies tested primary outcome of illness perceptions using measures 
with satisfactory psychometric properties. The measures were also well matched 
to the type of CHD and sample characteristics, enhancing internal validity of 
studies.  Five studies used different versions of the Illness Perception 
Questionnaire, such as Brief IPQ (Study 01and 02), Chinese version of IPQ (study 
04), Revised-IPQ (study 05) and a full version of IPQ (study 11) (Broadbent, 
Petrie, Main & Weinman, 2006; Moss-Morris, et al., 2002; Weinman, Petrie, 
Moss-Morris, & Horne, 1996; Yan et al., 2013). Two studies used ACS Response 
Index (study 03 and 08) (Riegel et al., 2007). Two studies used York Angina 
Beliefs Questionnaire (study 06 and 10) and one study applied York Cardiac 
Beliefs Questionnaire (study 07) (Furze et al., 2003). One study used Response 
Questionnaire (study 09) (Goff et al., 1998) (see Table 3.1). 
 The reported statistics also varied across studies. Five studies reported pre- 
and post- intervention means and standard deviations for intervention and control 
groups (01, 04, 05, 08 and 11). Three studies reported difference in means and 
standard deviation between pre- and post- conditions for each group (study 03, 09 
and 10). Three studies presented difference in means and p values post 
interventions (study 02, 06 and 07). 
 
3.2.4. Secondary outcomes 
 Depression. Five studies measured symptoms of depression (study 01, 02, 
06, 07 and 10). All of these studies used self-report measures with satisfactory 
psychometric properties. Four studies used Hospital Anxiety and Depression 
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Scale (HADS) (study 01, 02, 06 and 10), and one study used Cardiac Depression 
Scale (study 07) (see Table 3.1) (Hare & Davis, 1996; Zigmond and Snaith, 1983) 
 The effect size for two studies was calculated based on pre- and post- 
treatment means and standard deviations for each group (study 01 and 02). Two 
studies presented difference in means and p values post intervention (study 06 and 
07). One study reported change in means for each group (study 10). 
 
 Anxiety. Symptoms of anxiety were assessed in seven studies (study 01, 
02, 05, 06, 07, 09 and 10). Four studies used HADS as a measure of severity of 
symptoms of anxiety (study 01, 02, 06 and 10) (Zigmond & Snaith, 1983). Two 
studies used State Trait Anxiety Inventory (study 05 and 07) and one study used 
Anxiety Subscale from Brief Symptom Inventory (study 09) (see Table 3.1) 
(Derogatis & Malisaratos, 1983; Spielberg, Gorsuch, Lushene, Vagg, & Jacobs, 
1983).   
 Pre- and post- treatment means and standard deviations for each group 
were reported by three studies (study 01, 02 and 05). Two studies reported 
difference in means and standard deviations for each group (study 09 and 10). 
One study presented difference in means and p value post intervention (study 06). 
Finally, the effect size for one study was calculated using mean difference 
between pre- and post- and confidence intervals (study 07). 
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3.3. Research Questions 
 All effect sizes were expressed as Hedges’s g metric. This effect size 
metric was chosen because all of the included studies reported data from measures 
on the continuous scales (Borenstein et al., 2009).   
 
 3.3.1. Research Question One: Are Interventions with Psychological 
Components More Effective in Changing Illness Perceptions than Standard 
Cardiac Interventions without Clearly Identified Psychological Component? 
 In order to test the above research question a meta-analysis was conducted 
with illness perceptions as an outcome variable, the individual studies as units of 
analysis and the intervention strategy (psychological component vs no 
psychological component) as a moderator variable.  Six studies were identified 
which contained psychological component (Barley et al., 2014; O’Brien et al., 
2014; Furze et al., 2012; Furze et al., 2009; Lewin et al., 2002; Petrie et al., 2002). 
The remaining studies were classified as not having clearly identifiable 
psychological component (Pfaeffli et al., 2015; Yan et al., 2013; Cossette et al., 
2012; McKinley et al., 2009; Tullmann et al., 2007).  
 The effect sizes and associated statistics are displayed in Table 3.3. Three 
separate effect sizes were calculated. The overall effect size was small (Hedges’s 
g = .239) with relatively narrow confidence intervals (95% CI = .114 to .365). The 
effect size for subgroup of studies of interventions without psychological 
component was also small (Hedges’s g = .224) with relatively wide confidence 
intervals (95% CI = .016 to .432). The effect size for the subgroup of studies of 
interventions with psychological component had a moderately small effect size 
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(Hedges’s g = .248) and relatively wide confidence intervals (95% CI = .090 to 
.406) (see Figure 3.2). 
 There was a non-significant amount of heterogeneity in the distribution of 
the total effect size (Q(10) = 20.955, p = .067) and in the distribution of studies of 
interventions with psychological component (Q(5) = 7.998, p = .156).  The I² was 
moderate for the distribution of total effect sizes and small for the distribution of 
effect size for the subgroup of studies of interventions with psychological 
component (I² = 52.279 % and I² = 37.487 %, respectively). The dispersion 
between studies was relatively small with tau² = .014 for the overall effect size 
and for the subgroup of studies of interventions without psychological component, 
indicating small dispersion between studies.  The amount of heterogeneity among 
studies of interventions without psychological component was statistically 
significant (Q(4) = 12.900, p = .012), indicating that there is substantial 
heterogeneity among effect sizes in this subgroup of studies. The I² = 68.992 %, 
indicating moderate amount of dispersion among effect sizes in this subgroup. 
 The moderator analysis revealed a non-significant amount of heterogeneity 
within the overall effect size (QT(10) = 20.955, p =.067), indicating that the effect 
sizes were homogeneous. Similarly, a dispersion of the effect sizes between 
groups was statistically homogeneous (QB(1) = .057, p = .811). This means that 
the subgroups’ effect sizes were not statistically different. There was evidence of 
significant dispersion across effect sizes within each of the subgroups (QW(9) = 
20.898 , p = .013).  
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 Summary of findings for the research question one. The moderator 
analysis has shown all effect sizes to be positive and small, indicating that 
interventions designed to change maladaptive illness perceptions lead to positive 
changes. Further, there was no statistically significant difference in subgroups’ 
effect sizes, indicating that interventions with psychological components are not 
more efficacious in changing maladaptive illness perceptions than interventions 
without psychological components. The amount of heterogeneity for the total 
effect size and the effect size for the subgroup of studies with no psychological 
component was significantly large.  This significant amount of heterogeneity 
makes it more difficult to draw any certain conclusions about the group 
differences. 
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Table 3.3 
 
Summary Data for Weighted Effect Sizes (Hedges’s g) and related statistics 
for Illness Perception Grouped by Intervention Strategy. 
 
Outcome 
variable  
Moderator  N Hedges’s g 
(95%CI) 
Q Statistics 
(df)  
P 
value  
I² % tau² 
 
 
Illness 
perception 
 
 
 
 
 
 
 
No Psych 
Component  
5 .224 
(.016; .432) 
12.900 (4) .012 68.992 .035 
Psych 
Component 
6 .248 
(.090; .406) 
 7.998 (5) .156 37.487  
  
.014 
Total 11 .239 
(.114; .365) 
QT = 20.955 
(10) 
 
QW =20.898 
(9) 
 
QB = .057 
(1) 
 
.067 
 
 
 
.013 
 
.811 
52.279    .014 
All studies tested within a random-effect model  
N = total number of studies; df- degrees of freedom; QT  = Total heterogeneity,  
Q < .05; QB = Heterogeneity between studies; QW  = Heterogeneity within studies 
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Group by
Intervention Strategy
Study  Illness perception Statistics for each study Hedges's g and 95% CI
Hedges's Standard Lower Upper Relative R
g error Variance limit limit Z-Value p-Value weight
No Psych Component Cossette 2012 Combined 0.011 0.128 0.016 -0.241 0.262 0.085 0.932 21.88
No Psych Component McKinley 2009 Combined 0.219 0.037 0.001 0.146 0.292 5.870 0.000 30.99
No Psych Component Pfaeffli 2014 IP -0.117 0.179 0.032 -0.468 0.235 -0.650 0.515 16.74
No Psych Component Tullmann 2007Combined 0.651 0.191 0.036 0.277 1.024 3.411 0.001 15.76
No Psych Component Yan 2013 Combined 0.484 0.205 0.042 0.083 0.885 2.367 0.018 14.63
No Psych Component 0.224 0.106 0.011 0.016 0.432 2.115 0.034
Psych Component Barley 2014 IP -0.187 0.221 0.049 -0.619 0.245 -0.848 0.396 10.41
Psych Component Furze 2009 CB 0.466 0.141 0.020 0.189 0.743 3.295 0.001 19.31
Psych Component Furze 2012 AB 0.437 0.187 0.035 0.070 0.805 2.332 0.020 13.30
Psych Component Lewin 2002 AB 0.243 0.175 0.031 -0.100 0.586 1.387 0.165 14.65
Psych Component O'Brien 2014 Combined 0.192 0.059 0.004 0.075 0.308 3.224 0.001 37.89
Psych Component Petrie 2002 Combined 0.249 0.364 0.132 -0.464 0.962 0.684 0.494 4.44
Psych Component 0.248 0.081 0.006 0.090 0.406 3.079 0.002
Overall 0.239 0.064 0.004 0.114 0.365 3.731 0.000
-2.00 -1.00 0.00 1.00 2.00
Figure 3.2. Effect sizes (Hedges’s g) for Illness Perceptions Grouped by Intervention Strategy Derived from RCT Studies Designed to 
Change Illness Perceptions in CHD. 
Note. Combined refers to the multiple outcomes (subscales) combined within study. IP-Illness Perception, CB-Cardiac Beliefs, AB-
Angina Beliefs. 
 
Control Intervention 
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  3.3.2. Research Question Two: Do Interventions Targeting Illness 
Perceptions Contribute to Positive Changes in Symptoms of Depression and 
Anxiety? 
 Two separate meta-analyses were run, one for studies that reported data on 
depression and one for studies that reported data on anxiety. All effect sizes and 
associated statistics can be found in Table 3.4. 
 
 
 
 
 
 
 
 
Table 3.4. 
 
Summary Data for Weighted Effect Sizes (Hedges’s g) and related statistics for 
Depressive and Anxiety Symptoms.  
 
Outcome 
variable  
N Hedges’s g 
(95%CI) 
Q 
Statistics 
(df)  
P value  I² % tau² 
Depression  5 -.089 
(-.409; .231) 
16.787  
(4) 
.002 76.173 .100 
Anxiety  7 .204 
(.046;.363) 
9.583 
(6) 
.0143 37.390 .017 
All studies tested within a random-effect model  
N = total number of studies; df- degrees of freedom; Q < .05 
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 Effect sizes of depressive symptoms. The total weighted effect size was 
negative and small (Hedges’s g = -.089) with relatively wide confidence intervals 
(95% CI = -.409 to .231), indicating that there was no support for the efficacy of 
interventions designed to change illness perceptions for treating depression. Three 
studies had negative effect sizes within small to moderate range and two studies 
had positive effect sizes (see Figure 3.3).  The weighting of the effect size was 
relatively evenly spread and ranged from 17.85 to 22.14 with studies with the 
largest sample having the largest weighting.  Studies with larger weighting were 
more precise in estimations of effect sizes (Borenstein et al., 2009). 
 There was a substantial and significant amount of heterogeneity among 
studies (Q(4) = 16.787, p =.002). The I² for the total weighted effect size indicated 
large amount of dispersion among the effect sizes (I² = 76.173%), indicating that 
approximately 76% of the observed variance between studies is due to real 
differences in the effect size. The between-studies variance was moderate with 
tau² = .100.  
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Study name Statistics for each study Sample size Hedges's g and 95% CI
Hedges's Standard Lower Upper Relative R
g error Variance limit limit Z-Value p-Value Treatment Control weight w
Barley 2014 -0.216 0.221 0.049 -0.649 0.217 -0.978 0.328 41 40 17.85
Furze 2012 -0.298 0.186 0.035 -0.664 0.067 -1.602 0.109 57 58 19.70
Pfaeffli 2014 0.074 0.179 0.032 -0.278 0.425 0.411 0.681 61 62 20.08
Lewin 2002 -0.442 0.177 0.031 -0.788 -0.096 -2.504 0.012 63 67 20.23
Furze 2009 0.374 0.141 0.020 0.098 0.650 2.655 0.008 100 104 22.14
-0.089 0.163 0.027 -0.409 0.231 -0.547 0.584
-1.00 -0.50 0.00 0.50 1.00
Control Intervention
Figure 3.3. Effect Sizes (Hedges’s g) for Depressive Symptoms Derived from RCT Studies Designed to 
Change Illness Perceptions in CHD.  
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 Effect sizes for anxiety symptoms. The total effect size was small 
(Hedges’s g = .204) with relatively wide confidence intervals (95% CI = .046 to 
.363). The weighting of the effect sizes was relatively evenly spread, ranging from 
10.02 to 19.67.  
 There was a non-significant amount of heterogeneity among effect sizes 
(Q(6) = 9.583, p = .143).  The I² for the total effect size indicated moderate 
amount of dispersion among the effect sizes (I² =37.390), indicating that 
approximately 37% of observed variance between studies is due to real 
differences in the effect sizes. The between-studies variance was also non-
significant with tau² = .017, indicating non-significant dispersion between studies. 
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Study Statistics for each study Hedges's g and 95% CI
Hedges's Standard Lower Upper Relative R
g error Variance limit limit Z-Value p-Value weight
Barley 2014 -0.186 0.221 0.049 -0.619 0.246 -0.844 0.399 10.02
Cossette 2012 0.160 0.128 0.016 -0.092 0.411 1.243 0.214 19.67
Furze 2009 0.097 0.140 0.019 -0.177 0.370 0.691 0.489 18.04
Furze 2012 0.626 0.190 0.036 0.254 0.998 3.298 0.001 12.41
Lewin 2002 0.358 0.176 0.031 0.014 0.703 2.038 0.042 13.73
Pfaeffli 2014 0.186 0.180 0.032 -0.166 0.538 1.034 0.301 13.36
Tullmann 2007 0.177 0.186 0.034 -0.187 0.541 0.955 0.340 12.79
0.204 0.081 0.007 0.046 0.363 2.522 0.012
-1.00 -0.50 0.00 0.50 1.00
Control Intervention
Figure 3.4. Effect Sizes (Hedges’s g) for Anxiety Symptoms Derived from RCT Studies Designed to Change Illness   
Perceptions in CHD. 
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 Summary of findings for research question two. The meta-analysis of 
studies that presented data on depressive symptoms revealed a non-significant 
effect size, indicating no effect for the interventions aimed at reducing depression. 
The Q statistics indicated significant amount of dispersion among effect sizes. 
Thus, it is likely that the sample size was too small to detect any meaningful 
changes and provide an accurate reflection of dispersion among effect sizes.  
 On the other hand, there was a small positive effect size for anxiety 
symptoms, indicating that interventions designed to change maladaptive illness 
perceptions contributed to small but significant positive changes in anxiety 
symptoms in patients with CHD. There was also a moderate but non-significant 
amount of dispersion among the effect sizes for symptoms of anxiety. However, 
caution needs to be applied when interpreting these results due to relatively small 
sample size. 
 
 3.3.3. Research Question Three: Are the Type of Illness and Age 
Linked with the Effectiveness of Interventions Designed to Change Illness 
Perceptions?  
 The above research question was tested by applying a meta-analysis, with 
illness perceptions as outcome variable, individual studies as a unit of analysis 
and a type of illness (chronic vs acute) as a moderator variable. The samples of 
eight studies were classified as including participants with acute CHD (Pfaeffli et 
al., 2015; Barley et al., 2014; O’Brien et al., 2014; Cossette et al., 2012; McKinley 
et al., 2009; Tullmann et al., 2007; Lewin et al., 2002; Petrie et al., 2002). The 
remaining three studies of the sample were classified as including patients with 
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chronic CHD (Yan et al., 2013; Furze et al., 2012; Furze et al., 2009). There were 
two studies with negative effect sizes within the acute subgroup; the remaining 
effect sizes were all positive (see Figure 3.5).  
 The effect sizes and associated statistics are displayed in Table 3.5. Three 
separate effect sizes were calculated. The total effect size was moderately small 
(Hedges’s g = .247) with relatively narrow confidence intervals (95% CI = .147 o 
.347).  The effect size for a subgroup of studies classified as acute was small 
(Hedges’s g = .168) with relatively wide confidence intervals (95% CI = .051 to 
.285). The effect size for a subgroup of studies classified as chronic was moderate 
(Hedges’s g = .462) with narrow confidence intervals (95% CI = .268 to .656) 
(see Figure 3.5). 
 There was a significant amount of heterogeneity in the distribution of the 
total effect size (Q(10) = 20.955, p = .021) and in the distribution of effect sizes 
for the subgroup of studies classified as acute (Q(7)=14.281, p = .046). The I² was 
within the moderate range, indicating a moderate amount of dispersion among the 
distribution of the effect sizes (I² = 52.279 for the total effect size and I² = 50.983 
for the subgroup of studies classified as acute). This means that approximately 
52% of dispersion across all of the studies and 50% of dispersion among studies 
in the subgroup of studies classified as acute is likely to be due to real differences 
in the effect sizes.  The dispersion between studies was relatively small with tau² 
= .014 for total effect size and tau² = .011 for the effect sizes of the subgroup of 
studies classified as acute. The amount of heterogeneity in a distribution of the 
effect sizes in the subgroup of studies classified as chronic was small and 
statistically non-significant (Q(2) = .030, p = .985). The I² = 0% and tau² = 0, 
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indicated no substantial amount of dispersion among the distribution of the effect 
sizes and between studies. 
  The dispersion of the effect sizes between subgroups was 
statistically heterogeneous, indicating that the subgroups’ effect sizes were 
different (QB (1) = 6.646, p = .010). This means that the differences between 
subgroups’ effect sizes are statistically significant. There was, however, no 
evidence of significant dispersion across effect sizes within each of the subgroups 
(QW (9) = 14.311, p = .112).  
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Table 3.5. 
 
Summary Data for Weighted Effect Sizes (Hedges’s g) and related statistics for 
Illness Perception Grouped by Type of Illness. 
 
Outcome 
variable 
Moderator N Hedges’s g 
(95%CI) 
Q Statistics 
(df)  
P 
value  
I² % tau² 
 
 
 
 
 
 
 
Illness 
Perception  
Acute 8 .168 
(.051; .285) 
14.281 (7) .046 50.983 .011 
Chronic
 
3 .462 
(.268; .656) 
.030 
(2) 
.985 0 .000 
 11 .247 
(.147; .347) 
QT = 20.955 
(10) 
 
QW  =14.311  
(9) 
 
QB = 6.645  
(1)  
.021 
 
 
.112 
 
 
.010 
52.279 .014 
 
All studies tested within a random-effect model  
N = total number of studies; df- degrees of freedom;  
QT  -Total heterogeneity, QB - Heterogeneity between studies;  
QW  - Heterogeneity within studies; Q  < .05  
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Group by
Type of Illness
Study  Illness perception Statistics for each study Hedges's g and 95% CI
Hedges's Standard Lower Upper Relative Re
g error Variance limit limit Z-Valuep-Value weight w
acute Barley 2014 IP -0.187 0.221 0.049-0.619 0.245 -0.848 0.396 6.00
acute Cossette 2012Combined 0.011 0.128 0.016-0.241 0.262 0.085 0.932 13.07
acute Lewin 2002 AB 0.243 0.175 0.031-0.100 0.586 1.387 0.165 8.60
acute McKinley 2009Combined 0.219 0.037 0.001 0.146 0.292 5.870 0.000 29.17
acute O'Brien 2014 Combined 0.192 0.059 0.004 0.075 0.308 3.224 0.001 24.82
acute Petrie 2002 Combined 0.249 0.364 0.132-0.464 0.962 0.684 0.494 2.49
acute Pfaeffli 2014 IP -0.117 0.179 0.032-0.468 0.235 -0.650 0.515 8.30
acute Tullmann 2007Combined 0.651 0.191 0.036 0.277 1.024 3.411 0.001 7.56
acute 0.168 0.060 0.004 0.051 0.285 2.814 0.005
chronic Furze 2009 CB 0.466 0.141 0.020 0.189 0.743 3.295 0.001 48.85
chronic Furze 2012 AB 0.437 0.187 0.035 0.070 0.805 2.332 0.020 27.79
chronic Yan 2013 Combined 0.484 0.205 0.042 0.083 0.885 2.367 0.018 23.35
chronic 0.462 0.099 0.010 0.268 0.656 4.676 0.000
Overall 0.247 0.051 0.003 0.147 0.347 4.827 0.000
-1.00 -0.50 0.00 0.50 1.00
Control Intervention 
Figure 3.5. Effect sizes (Hedges’s g) for Illness Perceptions Grouped by Type of Illness Derived from RCT Studies Designed to Change 
Illness Perceptions in CHD. 
Note. Combined refers to the multiple outcomes (subscales) combined within study. IP-Illness Perception, CB-Cardiac Beliefs, AB-Angina 
Beliefs. 
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 In order to test the second part of the third research question a correlation 
was conducted with the effect sizes for illness perception and age as outcome 
variables. Firstly, the data were tested for normal distribution by using the 
Kolmogorov-Smirnov test.  Age was normally distributed (M = 64.07, SD = 
4.799) however, the effect sizes were not normally distributed (M = .63, SD = 
1.448). Therefore, a non-parametric test (Spearman’s correlation coefficient) was 
used to test the hypothesis.  There was a non-significant relationship between age 
and effect size, r = .305, p =.361 (two-tailed), N = 11.  
 
 Summary of the findings for research question three. The moderator 
analysis revealed that studies with a sample characterised as chronic had a larger 
effect size than studies with the sample identified as acute. The acute subgroup, 
however, had a moderate amount of dispersion among effect sizes. The amount of 
heterogeneity within a subgroup of studies classified as chronic was very small, 
but caution needs to be taken when interpreting the results from the analysis of the 
effect sizes from this subgroup because of the small sample size. There were no 
statistically significant correlations between age and the effect size for illness 
perception.  
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3.4. Publication Bias  
 In order to assess for the potential impact of unpublished or unidentified 
studies on the findings in the current meta-analysis, funnel plots were computed 
and visually inspected for all outcome variables (illness perceptions, depression 
and anxiety) (see Figures 3.6; 3.7 and 3.8). The initial visual inspection of the 
funnel plots for all outcome variables indicates evidence of publication bias as 
shown by a relative absence of small studies with positive and negative effects on 
both sides of the plot.
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Figure 3.6. Funnel Plot of Standard Error by Hedges’s g for Illness Perception. 
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    Figure 3.7. Funnel Plot of Standard Error by Hedges’s g for Depressive Symptoms. 
115 
 
 
 
                                 
 
-2.0 -1.5 -1.0 -0.5 0.0 0.5 1.0 1.5 2.0
0.0
0.1
0.2
0.3
0.4
St
an
da
rd
 
Er
ro
r 
Hedges’s g 
Figure 3.8. Funnel Plot of Standard Error by Hedges’s g for Anxiety Symptoms. 
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 The fail-safe values were calculated for all outcome variables. The fail-
safe N estimates the number of studies that would need to be additionally 
retrieved and included into the analysis to reduce the p-value to the point when it 
became statistically non-significant (Borenstein et al., 2009). The fail-safe N 
ranged from 12 to 160, indicating that particularly for anxiety variable substantial 
number of studies with null statistical findings would need to be included within 
any analysis to reduce the effects to the point of non-significance (see Table 
3.6).The fail-safe N for depression was not calculated (as there was no effect 
detected). In order to investigate this finding further a Duval-Tweedie’s trim and 
fill method was used. The trim and fill method resulted in imputed two additional 
effect sizes on the right side of the plot, resulting in the correct pooled effect size 
of .16 for depression. 
Outcome variable N Fail-Safe N 
Illness perceptions 11 106 
Anxiety 7 12 
Table 3.6. 
Results of the Fail-safe N Analysis. 
Note. N refers to the total number of studies included in the original analysis. The 
criterion effect size level used to calculate fail-safe N was p = .05, two tails. 
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 The Duval-Tweedie’s trim and fill method was also used to calculate an 
estimate unbiased effect size for anxiety symptoms and illness perceptions. For 
anxiety symptoms the trim and fill analysis showed that no studies needed to be 
added to obtain an unbiased effect size. The Duval-Tweedie’s trim and fill 
analysis for illness perception has shown that in order to obtain the unbiased 
effect size (Hedges’s g = .202) only one additional study would need to be 
included.  
 
 Summary of findings from the assessment of publication bias. The 
inspection of funnel plots and associated statistical analysis revealed a presence of 
publication bias. Overall, small studies with positive and negative effect sizes are 
likely to be missing due to publication bias. It was estimated that t there are about 
160 potential studies missing in order to reduce the effect size to the point of non-
significance for anxiety and 12 studies missing for illness perception. 
 
3.5. Summary of the Results  
 Overall, the results of the analysis in the current meta-analysis indicate 
that there are no statistically significant differences in effect sizes for interventions 
with and without psychological component in terms of maladaptive illness 
perceptions. The overall findings also indicated that the interventions designed to 
change maladaptive illness perceptions contribute to positive changes in anxiety 
symptoms, but not in depressive symptoms. It is likely, however, that both 
analyses (particularly the analysis of effect sizes from studies that presented data 
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on depressive symptoms) might have been affected by the small sample sizes. It is 
also difficult to draw certain conclusions about the impact of the type of illness on 
the changes in illness perceptions due to the small sample size of the subgroup of 
studies classified as chronic. Bearing in mind this small sample size, the results of 
the meta-analysis indicated a positive and moderate effect size for studies with 
samples characterised as chronic. However, the sample size is quite small and two 
out of three studies included in this meta-analysis are by the same research team 
thus caution is urged in interpreting these results. There were no statistically 
significant correlations between age and effect size. Overall results of the meta-
analysis, however, ought to be interpreted with caution due to the substantial 
amount of heterogeneity among the effect sizes and the relatively small sample 
size reported here.  
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4. Discussion 
 
4.1. Chapter Overview 
 This chapter presents the results of the current meta-analysis within the 
context of previous research and theory. Firstly, a detailed discussion of findings 
from each research question is presented. This is followed by a presentation of  
the methodological weaknesses of the  meta-analysis. Finally, implications for 
clinical practice and future research are proposed. 
 
4.2. Contextualising the current meta-analysis within the existing 
evidence-base 
 4.2.1. Research question one: Are interventions with psychological 
component more efficacious in changing illness perceptions than standard 
cardiac interventions without clearly identified psychological component? 
 The current meta-analysis demonstrates that psychological and non-
psychological interventions designed to change illness perceptions report small 
effect sizes in reducing maladaptive illness perceptions (Hedges’s g = .239). The 
subgroup analysis revealed that there were no statistically significant differences 
in effect size (Hedges’s g = .248) for interventions with psychological 
components, such as motivational interviewing and/or cognitive-behavioural 
therapy compared to interventions without an identified psychological 
intervention component (Hedges’s g = .224). As such in the current meta-analysis 
interventions with psychological components were not shown to be more 
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efficacious in changing maladaptive illness perceptions compared to the 
interventions without psychological components.  
 The results from the current meta-analysis add to the findings of previous 
systematic reviews and meta-analyses but raise questions about the certainty with 
which conclusions about treatment outcomes can be made (e.g. French et al., 
2006; Goulding et al., 2010). For example, Goulding at al. (2010) were only able 
to reported tentative results and concluded that studies containing features of 
cognitive-behavioural therapy lead to significant and positive changes in illness 
beliefs. However, this is a preliminary finding because of the small number of 
studies on which this conclusion was reached (only three). As it was a textual 
review of the literature the ‘data’ is less compelling than that reported in the 
current meta-analysis. As one may expect, the certainty with which to judge the 
data from this current meta-analysis is also likely to be affected by the small 
sample size reported here. Nevertheless, the current meta-analysis results reported 
here suggest no significant subgroup difference in the efficacy of interventions 
with and without psychological components. The present finding might indicate 
that in challenging maladaptive illness perceptions in CHD, non-specific elements 
of both interventions (psychological and non-psychological) may play an equally 
important role. This also might suggests there may be a need to refine the focus 
and nature of psychological interventions in order to maximise efficacy.   
 The findings from the present investigation with regards to the efficacy of 
interventions designed to change dysfunctional illness perceptions extend 
evidence suggesting that targeted interventions can benefit individuals with CHD 
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(Dickens et al., 2013; Whalley et al., 2011).  Some of the previous meta-analyses 
had a relatively weak theoretical base.  This is a significant shortfall because well-
specified theoretical context in meta-analysis allows for revision and/or 
confirmation of existing theories underlying the efficacy of particular treatments 
(i.e. treatments for individual affected by CHD) (Borenstein et al., 2009). Data 
from some of the previous meta-analyses have reported a relatively weak link 
with specific theories (e.g. Whalley et al., 2011). For example, Whalley et al. 
(2011) in their meta-analysis demonstrated psychological interventions led to 
small and moderate improvements in symptoms of depression. However, due to 
the poorly specified theoretical context of the meta-analysis by Whalley et al. 
(2011), it is difficult for the readers to hypothesise about the potential mechanisms 
behind reported effect sizes for treatment interventions.  
 It is possible that a reduction in maladaptive illness perceptions is 
achievable through use of a wide range of interventions strategies, both 
psychological and non-psychological in nature.  This may be because 
interventions designed to challenge maladaptive illness perceptions are likely to 
impact upon a dual level (cognitive and emotional) consistent with that proposed 
in Leventhal’s model (Diefenbach & Leventhal, 1996; Wearden & Peters, 2008). 
It is possible, for example, that some of the techniques can be more helpful on the 
cognitive level, such as information provision and/or thought challenging can help 
participants reappraise perception of health threat and subsequently encourage 
more problem-solving coping mechanisms (Meas & Karoly, 2005). If this 
desirable coping strategy is evaluated as helpful in managing CHD, the individual 
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more appropriate emotional response (e.g. reduction of anxiety) may follow. 
Simultaneously, other components (e.g. active listening) might work better 
towards addressing emotional distress around an illness (i.e. the unhelpful 
emotional representation of illness based on concerns) (Harvey & Lawson, 2009).  
 The discrepancy between findings reported in the current meta-analysis 
and previous results published in single studies provides a strong justification for 
this meta-analysis. Data from single studies can provide valuable information, but 
they often are believed to be insufficient in drawing more certain conclusions 
about the efficacy of specific interventions. Although the results from single 
studies can lead to statistically significant findings, individual studies by 
themselves can bias our understanding of what is efficacious especially where the 
research literature is small and developing as in this current area. Meta-analysis 
can often lead to contradictory findings with that understood from results of 
individual studies (Borenstein et al., 2009). The results of meta-analysis, however, 
carry more clinical value due to its cumulative and systematic nature in data 
collection and analysis (Borenstein et al., 2009).  
 Furthermore, the current findings that interventions targeting maladaptive 
illness perceptions can facilitate positive but small effects may be consistent with 
a view that  in order to develop a successful intervention to change maladaptive 
illness perceptions in CHD it is necessary to actively engage with participants in 
interventions (Lin et al., 2012; Thomson, Bowling & Moss, 2001). It may be that 
studies that empower participants to be active agents in their treatment are likely 
to lead to a successful cardiac intervention (Lin et al., 2012). It is also possible 
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that treating people as active agents in their treatment allows them to successfully 
utilise on different components of cardiac interventions regardless whether they 
are psychological or non-psychological in nature (Diefenbach & Leventhal, 1996; 
McAndrew et al., 2008). 
 Additionally, the analysis of data from the first research question has some 
methodological strengths and weakness. A strength of the data is the relatively 
narrow confidence intervals which inform the reader about the precision of the 
estimated effect sizes (Higgins & Green, 2011). Narrow confidence intervals point 
towards more precise estimation of the effect size (Higgins & Green, 2011). The 
confidence intervals for the total and subgroup effect sizes for the first research 
question were within a narrow range, indicating the effect sizes were relatively 
precise estimation of the true effect sizes. This means that the reader can be 
relatively (95%) confident that interventions with psychological components 
reduce dysfunctional illness perceptions (Borenstein et al., 2009; Higgins & Green 
2011).  
 
 
 4.2.2. Research question two: Do interventions targeting illness 
perceptions contribute to positive changes in symptoms of depression and 
anxiety?  
 The second research question was partially supported by the current meta-
analysis. The effect size for studies that reported data on anxiety were small but 
significant and positive (Hedges’s g = .204). Thus indicating that interventions 
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designed to change illness perceptions contribute to significant and positive 
changes in symptoms of anxiety in individuals with CHD. On the contrary, the 
effect size for studies that reported symptoms of depression were non-significant 
(Hedges’s g = -.089). This was an unanticipated finding suggesting interventions 
designed to change illness perceptions do not contribute to positive changes in 
symptoms of depression.  
 The findings from the current meta-analysis are partially consistent with 
previous evidence from single studies and reviews (e.g. Dickens et al., 2013; 
Juergens et al., 2010). That is, previous research has demonstrated mixed results 
for the efficacy of cardiac interventions in reducing symptoms of anxiety and 
depression (e.g. Broadbent et al., 2009; Furze et al., 2009; Lewin et al., 2002). 
While some studies demonstrated non-significant trends of cardiac interventions 
in reducing symptoms of depression and anxiety (e.g. Lewin et al., 2002), other 
studies demonstrated interventions can contribute to positive changes either to 
symptoms of depression and/or to symptoms of anxiety (e.g. Furze et al., 2009; 
O’Rourke & Hampson, 1999). These inconsistencies in the conclusions from 
previous research are likely to reflect a bias related to small sample sizes (e.g. 
Furze et al., 2009). This lack of sufficient power was also reflected in some of the 
previous meta-analysis. For example, Reid et al. (2013) in their meta-analysis of 
six studies reported psychological interventions significantly reduced symptoms 
of anxiety but not symptoms of depression in participants with CHD. Previous 
meta-analysis with a large number of studies, however, (i.e. N = 60) demonstrated 
a small effect for reduction of depressive symptoms. Specifically, a meta-
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regression by Dickens et al. (2013) demonstrated that psychological interventions 
contributed to positive changes in depressive symptoms in participants with CHD.  
The meta-analyses by Dickens et al. (2013) and Reid et al. (2013), however, did 
not look specifically at interventions designed to change illness perceptions. The 
current meta-analysis is unique in that it is the only meta-analysis that could be 
found that quantifies the link between interventions designed to change illness 
perceptions and changes in psychological outcomes of individuals with CHD. The 
current finding that interventions designed to change illness perceptions 
contribute to a reduction in symptoms of anxiety but not symptoms of depression 
are important because they suggest that a positive change in psychological 
outcomes in patients with CHD is likely to reflect a complex nature of the 
relationship between illness representations and psychological outcomes (Harvey 
& Lawson, 2009; Peterson & Kim, 2011). These complexities might be related to 
a number of factors, such as how individuals process different dimensions of their 
illness, illness-related factors and/or relationship between depression and anxiety 
(Greco et al., 2014; Harvey & Lawson, 2009; Patel et al., 2013). It is possible, for 
example, that changes in depressive symptoms are more difficult to detect due to a 
more complex relationship with illness perceptions (Simmonds, Tyle, Walters & 
Rose, 2013). It is also possible that depressive symptoms in participants who also 
report more maladaptive illness perceptions are much more resistant to change 
(Furze et al., 2005). Furze et al. (2005) in their examination of a link between 
changes in illness perceptions and depression found that reduction in unhelpful 
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illness perceptions did not correspond to positive changes in symptoms of 
depression. 
 It might be easier to alleviate symptoms of anxiety by addressing 
maladaptive illness perceptions because there might be a more direct link between 
participants’ health threat appraisal and emotional response to this threat (i.e. 
anxiety) (Maes & Karoly, 2005). Depressive symptoms, however, might make it 
more difficult for individual with CHD to engage in the process of change (Furze 
et al., 2005; Hare, Toukhsati, Johansson, & Jaarsma, 2013; Maes & Karoly, 
2005). Participants who report more symptoms of depression might rely more on 
emotion-focus coping strategies in making sense of their illness and to help them 
cope with it. It is also possible that individuals whose coping with CHD is 
complicated by symptom of depression have less capability to self-monitor and 
regulate their coping behaviours (Maes & Karoly, 2005).  
 The current findings that interventions targeting illness perceptions 
contribute to a reduction in symptoms of anxiety, but not depression need to be 
interpreted with caution because of the substantial methodological shortcomings 
in the current meta-analysis but they are intriguing and may suggest the need for a 
component analysis of outcome studies. It is also likely that the precision of the 
effect size reported in the current meta-analysis was affected by the small sample 
size (N = 5 and N = 6  studies for depressive and anxiety symptoms respectively) 
(Borenstein et al., 2009).  The data analysis for symptoms of depression, in 
particular, was likely to be affected by the small sample size and the large amount 
of heterogeneity in a dispersion of effect sizes. Given that the total effect size for 
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depression is likely to be an imprecise estimation, it seems more appropriate to 
consider the effect sizes for each study separately. Studies with the smallest 
sample size (e.g. Barley et al., 2014’s sample size was N = 81) had a negative 
effect size with wide confidence intervals, suggesting that the effect sizes from 
Barley et al. (2014) study for symptoms of depression and anxiety was unlikely to 
be a precise estimation of true effect size (Borenstein et al., 2009). It is, therefore, 
possible that the analysis of depressive symptoms was the most affected by the 
imprecise estimation of effect sizes from single studies because of the relatively 
small sample size in each of these studies (Borenstein et al., 2009). 
 Another factor that might have affected the results for the second research 
question is a use of measures of depression that were not sensitive enough to 
detect differences. Studies that used HADS as a measure of symptoms of 
depression had a smaller effect sizes compare to studies which used alternative 
measures, such as Cardiac Depression Scale (Barley et al., 2014; Furze et al., 
2009; Zigmond & Snaith, 1983). This is an interesting qualitative finding which 
might indicate that commonly used measures to detect symptoms of depression in 
health settings (e.g. HADS) may not be sensitive enough to reliably assess these 
symptoms in patients with CHD (Haddad et al., 2013).  
 
 4.2.3. Research question three: Are type of illness and age linked with 
the efficacy of interventions designed to change illness perceptions?  
 To the authors knowledge this is the first meta-analysis to attempt to 
address the impact of the type of illness on changes in maladaptive illness 
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perceptions. However, addressing the third research question was challenging 
because of a complex nature of participants’ illnessand a relatively small sample 
size (particularly in the context of subgroup analysis). 
 When examining impact of presentation of illness (acute versus chronic) in 
changing illness perception (see table 3.5), the overall effect size is small but 
significant (Hedges’s g = .247). The effect size for a subgroup of studies classified 
as chronic (Hedges’s g = .462) is significant and moderate and the effect size is a 
subgroup of studies classified as acute is significant but and very small (Hedges’s 
g = .168). However, comparison of subgroups’ effect sizes are not appropriate in 
the current meta-analysis, because the estimation of the effect size for a subgroup 
of studies classified as chronic is likely to be affected by type II error due to the 
small sample size (N = 3). It is, therefore, more appropriate to consider the effect 
sizes for individual studies for a subgroup of studies classified as chronic. These 
effect sizes are significant and moderate (please refer to Figure 3.5. in the Result 
chapter). Taking this into consideration the aforementioned effect sizes indicate 
that participants identified as having chronic illness are significantly more likely 
to benefit from interventions designed to change illness perceptions than 
participants with acute illness. Further, the testing of the association between 
changes in illness perceptions and age does not demonstrate significant 
relationship.  
 The current results demonstrating that interventions targeting illness 
perceptions are significantly more efficacious for participants whose illness can be 
classified as chronic compared to participants with acute illness is in line with 
129 
 
previous research. Findings from previous individual studies indicated that illness 
severity is associated with illness perceptions. Greco et al. (2014) and Steca et al. 
(2013) found that participants with more severe illness (measured by LVEF1) 
reported more unhelpful illness perceptions and more psychological distress. 
These findings are also confirmed in the investigation by Aalto et al. (2005), who 
used a proxy measure of illness severity (derived from CHD risk factors, 
comorbidities and use of medication). More importantly, Aalto et al. (2005) 
demonstrated that illness severity was associated with changes to illness 
perceptions over time. Participants with less severe illness reported greater 
reductions in unhelpful illness perceptions.  
 Although the findings from the current meta-analysis must be interpreted 
with caution, they are consistent with previous research. The difference in effect 
sizes obtained in the current meta-analysis by presentation  of illness (acute versus 
chronic) suggest this may be an important factor determining possible change in 
illness perceptions. One explanation for that finding of a difference in outcome in 
illness perceptions by presentation of illness is that perhaps the high levels of 
perception of threat in participants who are acutely unwell make it more difficult 
for them to engage in interventions. It is also possible that illness perceptions in 
participants who suffer from acute illness are more resistant to change (Aalto et 
al., 2005), whereas those with a chronic presentation have lived with the illness so 
long that they wish to invest in coping interventions so as to improved their 
quality of life.  
                                                          
1
 Left ventricular ejection fraction; it is a proportion of blood pumped out the left 
ventricle at each heartbeat 
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 The current meta-analysis reports no association between age of 
participants and changes in illness perceptions. This finding may be due to a small 
sample size in the present meta-analysis. This finding is contradictory to some 
previous research. Other investigations attested that older age participants were 
more likely to identify aging as a causal factor of CHD, indicating that age may 
play a role in the development and maintenance of illness perception (e.g. Grace 
et al., 2005; Juergens et al., 2010). Taylor et al. (2011) also found a link between 
age and rates of participation in cardiac rehabilitation programmes  In this 
systematic review Taylor et al. (2011) demonstrated that participants who are 
younger and older are at the highest risk of dropping out from interventions.   
 While interpreting the results from the analysis of the third research 
question caution must be applied because of methodological shortcomings such as 
the aforementioned sample size. There is also an unusually small amount of 
dispersion among the effect sizes within the subgroup of studies classified as 
chronic, indicating it is not appropriate to interpret the total effect size for this 
subgroup. This means that dispersion among the effects sizes obtained for the 
subgroup of studies classified as acute and the overall effect size is likely to be 
affected by sampling error (Bartolucci & Hillegas, 2010). 
 Another methodological shortcoming that could have affected the results 
of the third research question is the operationalisation of variable of type of illness 
in the current meta-analysis. Previous research focused on illness severity, which 
was assessed using physical markers, mainly LVEF (Greco et al., 2014; Pibarot & 
Dumesnil, 2012; Steca et al., 2013). This is in contrast to the current investigation, 
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in which the type of illness was categorised as either acute or chronic based on a 
proxy measure. This was a pragmatic decision because studies included in the 
current meta-analysis did not include any measure of illness type. The measure of 
the type of illness in the current meta-analysis was derived from a combination of 
factors, including frequency of symptoms, classification of severity of cardiac 
problems and a proportion of reported risk factors. This multifactorial 
categorisation of type of illness was informed by previous research and guidelines 
(e.g. Jopson, & Moss-Morris, 2003; The Criteria Committee for the New York 
Heart Association, 1994).  While LVEF might be a more objective measure of 
illness severity, the classification in the current investigation might reflect better 
the complexity of CHD. This is because it takes into consideration a range of 
factors involved in determining the complexity of CHD (Khot et al., 2003). 
Further there is also a subtle difference in conceptualisation of the variable. The 
operationalisation in the current meta-analysis is more likely to be consistent with 
a theoretical appreciation of illness perceptions (Harvey & Lawson, 2008). For 
example, a timeline domain of illness representation directly refers to patients’ 
perception of illness duration (acute or chronic) (Harvey & Lawson, 2008).  
 Overall, the results from the third research question are inconclusive and 
suggest methodological limitations in the literature. It is not possible to 
definitively state whether type of illness (acute versus chronic) is a contributing 
factor in changing in maladaptive illness perceptions. Likewise age does not 
statistically significantly impact on the efficacy of interventions in the current 
meta-analysis. 
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4.2.4. Summary  
 Overall, the results of the current meta-analysis indicate that psychological 
interventions may be effective at the level of small effect sizes when changing 
maladaptive illness perceptions within cardiac populations and may contribute to 
positive changes in symptoms of anxiety. However, interventions designed to 
change maladaptive illness perceptions do not contribute to significant changes in 
symptoms of depression. The present meta-analysis also does not demonstrate any 
support for the relationship between changes in illness perceptions and age. 
Finally, the link between changes in illness perceptions and the type of illness 
(chronic vs acute) is complex and unclear based on the data here. Taking into 
consideration these methodological weaknesses the results of the current meta-
analysis need to be interpreted with caution.  
  
4.3. Methodological Strengths and Weaknesses 
 4.3.1. Meta-analysis as a design 
 Meta-analysis affords the opportunity to bring clarity of understanding to a 
research literature composed of separate clinical trials, and allows an opportunity 
to examine whether there are new understandings to be derived from interventions 
designed to change illness perceptions in CHD. Interpreting effect sizes derived 
from multiple studies is theoretically and clinically more valuable than 
interpreting results from individual studies (Humphrey, 2011; Schmidt, 1996). 
Whilst a meta-analytic design is a definite strength of the current investigation 
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there are a few important caveats in the use of meta-analysis designs that are 
relevant for understanding findings from the current investigation.  
 Firstly, the process of selection and coding of the included studies was 
conducted by one person only (the main author). This approach is more prone to 
errors and biases, such as omission of important studies, selective approach to 
data extraction and/or selective reporting bias (i.e. reporting data for a selection of 
subtests of outcomes) (Rothstein & Bushman, 2015). Substantial efforts were 
made by the main author to control the extent to which these biases affected early 
stages of data extraction in the present meta-analysis. These efforts included 
having the, the primary academic supervisor for this thesis independently 
reviewing eligibility criteria, seeking contact with the field experts to identify any 
potential unpublished studies, designing the coding manual and coding form using 
Cochrane guidelines and with pre-specified eligibility criteria, and conducting 
bias analysis (e.g. publication bias) (Higgins & Green, 2011). Despite that a range 
of preventative strategies was adopted conducting double coding might have 
enhanced the quality of the extracted information. This was difficult to achieve, 
however, due to the limited personal resources on the current project.  
 A selection bias might have also affected the outcomes of the current 
meta-analysis at the data extraction stage. For example, two studies had to be 
excluded due to the insufficient or inaccurate data reporting (e.g. missing data for 
primary outcome). The efforts to source the unreported data directly from the 
authors of the studies were unsuccessful. Therefore, these studies had to be 
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excluded from the present meta-analysis (Broadbent, et al., 2009; Broadbent, 
Leggat, McLachlan, & Kerr, 2013).  
 The shortcomings resulting from the absence of double coding and 
selection bias were to a certain degree counterbalanced by a relatively well-
developed searching strategy and the quality assessment conducted by two 
independent raters. A university librarian specialising in systematicic literature 
searching was also consulted to optimise searching terms, strategy and location. 
Choosing a range of databases and other sources (e.g. journals) relevant for social 
and health science helped to identify studies published across different types of 
publication types. This, in turned, enhanced retrieval of the optimal proportion of 
relevant studies (Humphrey, 2011).  
 Another indicator of a good quality meta-analysis is a presence of a 
measure to assess the quality of included studies. In the current meta-analysis a 
well-designed tool (RCT-Psychotherapy Quality Rating Scale) was used (Kocsis 
et al., 2010). The RCT-PQRS has been successfully used in the quality assessment 
in previous meta-analysis of clinical trials (e.g. Gerber et al., 2011; Thoma et al., 
2012). In order to further enhance quality ratings for individual studies in the 
present meta-analysis an inter-rater reliability (IRR) was calculated, indicating 
that on average studies included in the current meta-analysis are of satisfactory 
quality.  
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4.3.2. Sampling strategy   
 The criteria for sample selection in the current meta-analysis warrant a 
more detailed consideration. Firstly, the selection criteria based on the 
characteristics of participants can be considered as a strength of the present meta-
analysis. This is because these criteria are embedded in previous research into the 
illness perceptions in CHD (e.g. Foxwell et al., 2013; French et al., 2005). For 
example, studies that involved participants with heart failure were excluded 
because the content and types of illness perceptions is believed to be qualitatively 
different in participants with heart failure. (It is likely that these differences relate 
to a more sudden and acute onset and unpredictable course of the illness) 
(Goodman et al., 2013). However, participants with other types of CHDs (e.g. 
angina, MI or patients post-revascularisation procedures) are thought to develop 
closely-related illness perceptions (Goulding et al., 2010). It is, therefore, more 
appropriate to include patients with these types of CHDs under one umbrella of 
CHD. This was also successfully done in a previous meta-analysis (e.g. Whalley 
et al., 2014). Finally, the sampling strategy in the current meta-analysis based on 
characteristics of participants also allowed for the maintenance of the right 
balance between the sensitivity and specificity of the current meta-analysis 
(Humphrey et al., 2011).   
 On the other side, sampling of studies based of the types of outcomes 
might be considered to be a weakness and a source of marked amount of 
heterogeneity in the current meta-analysis.  Firstly, different measures of 
assessing primary outcome were gathered together in the present meta-analysis. 
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While the majority of studies used different versions of the same measure (Illness 
Perception Questionnaire), other studies used different measures, e.g. York 
Angina Beliefs Questionnaire, (Furze et al., 2003). Accumulating findings in the 
meta-analysis based on different measures is considered to be controversial by 
some scholars who argue that it makes the comparisons across the studies more 
prone to errors (Lipsey & Wilson, 2001). On the other hand, excluding studies 
because of use of different measures of the same outcome can contribute to the 
omission of important studies and consequently incorrect conclusions (Borenstein 
et al., 2009). In the current meta-analysis a decision to gather data from different 
measures of the same outcome was balanced by the fact that measures were 
relatively well validated and matched to the characteristics of the participants. For 
example, the study by Lewin et al. (2002) used the York Angina Beliefs 
Questionnaire to test illness perceptions in participants with angina. In addition, in 
order to further counterbalance the use of different assessment methods in the 
same outcome within the present meta-analysis, effect sizes were presented using 
the same statistical metric i.e. Hedges’s g, (Borenstein et al., 2009).  
 Furthermore, the individual studies in the current meta-analysis presented 
different types of data for primary outcome. For instance, while the study by 
Pfaeffli et al. (2015) presented a total score for the Brief- IPQ, a study by Petrie et 
al. (2002) provided scores for each of the subscales of IPQ separately.  This is a 
source of heterogeneity in the current meta-analysis. In order to overcome these 
differences in data presentation a statistical procedure suggested by Borenstein et 
al. (2009) was adopted. In this procedure effect sizes are combined across 
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outcomes. While this procedure allowed for the studies with multiple outcomes to 
be included in the meta-analysis, it is possible that deriving combined effect sizes 
statistically, increased the amount of heterogeneity in the present meta-analysis.  
 The above-mentioned weaknesses in selecting studies based on the 
characteristics of outcomes might have been counterbalanced to a certain degree 
by better criteria in sampling based on the characteristics of interventions. 
Including studies with the RCT design improved the specificity of the current 
meta-analysis by restricting a number of irrelevant studies being identified. This 
strategy has an advantage of controlling for the potential sources of heterogeneity 
among studies (Humphrey, 2011). On the other hand, excluding studies with 
alternative designs (e.g. qualitative and quasi-experimental) could have potentially 
contributed to omitting some important studies. Given, however, the variability 
within the assessment measures of outcomes it seemed reasonable to limit other 
potential sources of the heterogeneity and focus on one type of design.  
 The sampling issues discussed above are common dilemmas for 
researchers conducting meta-analysis (Borenstein et al., 2009; Higgins & Green, 
2011). The judgment decisions required to be made about the design of meta-
analysis reflect the nature of meta-analytic design. Despite shortcomings in the 
design of the current meta-analysis, this investigation is unique as it is the first 
meta-analysis (to the author’s knowledge) to attempt to qualitatively and 
systematically gather data from studies attesting to the efficacy of interventions 
deigned to change illness perceptions.  
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 4.3.3. Sample size  
 Sample size is a relative weakness of the current meta-analysis, 
particularly in the context of the analysis being conducted within a random-effect 
model. The relationship between sample size and power in meta-analysis is 
influenced by multiple factors (Borestein et al., 2009). On the whole, larger 
samples are more desirable when conducting analysis within a random-effect 
model (Borenstein et al., 2009). This is because the random effect model 
estimates two sources of errors (within studies and between studies) (Borenstein 
et al. 2009).  
 In addition, the sample in the current meta-analysis is likely to be too 
small to detect meaningful difference for the subgroup analysis (Borenstein et al., 
2009). Although the total sample of the current meta-analysis of 11 studies is 
relatively small in meta-analysis terms, it is still, nevertheless, one of the largest 
meta-analyses conducted examining interventions targeting maladaptive illness 
perceptions in CHD. 
 In the current meta-analysis, a total number of participants is also 
relatively small (N = 5,267) in meta-analysis terms. The minimal number of 
participants required to conduct meta-analysis is still disputed by scholars 
(Borenstein et al., 2009). While some argue that only meta-analysis with 
exceptionally large samples can yield meaningful results, others suggest that even 
with small samples meta-analysis can provide important insight into the particular 
phenomena (Borenstein et al., 2009; Eggar & Smith, 1997).   
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 4.3.4. Statistical approach  
 Statistically combining the effect sizes for the subscales of illness 
perceptions questionnaire might be considered to be a weakness in the current 
meta-analysis. Whilst there is an ongoing debate whether combining across 
multiple outcomes is appropriate in the meta-analysis, Borenstein et al. (2009) 
argue that treating each of the outcomes separately is also problematic. Firstly, the 
subscales of the illness perception questionnaires are not independent of each 
other as they form part of the whole domain of illness perceptions. Therefore, it 
would have been inappropriate to separate the subscales. Secondly, treating each 
subscale as the separate outcome would have been inappropriate as studies with 
more outcomes (i.e. more subscale scores) would have had more weighting. This, 
in turn, would have led to an incorrect estimation of total effect size and its 
precision. In view of these arguments, it seemed more suitable to statistically 
combine effect sizes across subscales and to conduct the meta-analysis on 
combined effect sizes.  
 Choosing a random-effect model for statistical data analysis might be 
considered a strength as well as a weakness of the current meta-analysis. On one 
hand, the random effect model is more likely to address naturally occurring 
variations across studies (Borenstein et al., 2009). On the other hand, the 
application of the random effect model is sometimes considered to be 
controversial in meta-analysis with small number of studies (Borenstein et al., 
2009). Despite a relatively small sample size in the current meta-analysis, a 
random-effect model seems appropriate because it provides more accurate 
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weighting of the effect sizes from individual studies. This is because there is a 
wide spread in the size of samples across the included studies (Borenstein et al., 
2009).  
 
 4.3.5. Summary  
 Overall, the present meta-analysis has a number of methodological 
strengths. These strengths include, well-thought through process of literature 
search, pre-established criteria for data selection and extraction, and use of 
measures to control the sources of biases, such as quality assessment of individual 
studies, assessment of publication bias, and attempts to make contact with the 
experts in the field. However, there were also important weaknesses identified. 
The main methodological weakness that might have affected the interpretation of 
the findings from the current meta-analysis is the fact that the outcomes were 
gathered across different assessment measure and combined across outcomes. The 
lack of double coding of extracted data and relatively small sample size are also 
shortfalls in the present meta-analysis. 
 
4.4. Implications  
 4.4.1. Clinical Implications 
 The findings of the current meta-analysis provide evidence that cardiac 
interventions lead to reduction of maladaptive illness perceptions. However, there 
is no evidence that interventions with clearly identifiable psychological 
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components report statistically significant improvements compared to 
interventions without psychological components. Considering findings from the 
current meta-analysis in the context of previous research and Leventhal’s model 
of illness representations, the current findings gain more clinical meaning 
(Diefenbach & Leventhal, 1996). A clinical implication of the current findings are 
that cardiac rehabilitation programmes may benefit from being more explicitly 
linked with interventions designed to reduce distress. Traditionally cardiac 
rehabilitation focus on physical exercise, however, it is clear from the findings of 
the current meta-analysis that addressing patients’ psychological needs is equally 
important and the target here may be missed.  The lack of difference between 
psychological and non-psychological interventions raises important questions 
about the other potential factors that might influence treatment efficacy. 
Therapeutic techniques informed by motivational interviewing and/or cognitive 
behavioural therapy have been shown to be effective in treatment of a range of 
mental health difficulties related to physical health (Rollick, Miller & Butler, 
2008; Taylor, 2006). It is possible that successful and skilful administration of 
such techniques might play an important role in the efficacy of cardiac treatments. 
Another implication for practice might be, therefore, that nurses and non-mental 
health professionals delivering these interventions might need additional training 
and appropriate supervision when using techniques to improve outcome. It is also 
possible that the successful administration of psychological techniques may 
require programmes to consist of a larger number of sessions or more 
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idiosyncratic approach (i.e. focus on individual patients’ unhelpful illness 
perceptions) within each session.    
 The current meta-analysis demonstrates that interventions designed to 
change illness perceptions may contribute to positive changes in symptoms of 
anxiety, but not depression.  Symptoms of depression might complicate a process 
of change and rehabilitation. This suggests that interventions designed to change 
illness perceptions ought to target depression as well as illness perceptions. 
Clinically, this might mean that patients presenting with symptoms of depression 
might need more multidisciplinary approach to treatment that can help them to 
build a more detailed and psychologically focused understanding of their illness.   
 Another issue emerging from the current findings is an impact of the type 
of illness on the efficacy of interventions designed to change maladaptive illness 
perceptions.  An important clinical implication from the findings of the current 
meta-analysis is that patients with more acute illnesses are more likely to struggle 
to change the perceptions of their illness. This potentially might be an important 
factor to bear in mind when assessing patients’ suitability for cardiac interventions 
and consequently predicting their prognosis. Patients with more acute illness 
might present with higher levels of distress and find it more difficult to engage in 
treatment. It seems, therefore, that patients’ suitability for treatment should be 
preceded by thorough assessment of medical and psychological needs. Current 
guidelines for secondary care after MI suggest that treatment should take into 
consideration patients’ psychological needs and that psychological therapy should 
not be offered routinely (NICE, 2013).  
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 Finally, some potentially important clinical implications emerge from the 
methodological shortcomings of the studies included in the current meta-analysis. 
For example, it is possible that commonly used measures of assessment of 
symptoms of anxiety and depression (i.e. HADS) are not sensitive enough to 
reliably detect levels of distress in patients with CHD. It is possible that more 
population specific measures (e.g. Cardiac Depression Scale) might be more 
clinically helpful (Hare & Davies, 1996).  Clinicians should, therefore, exercise 
caution when clinically interpreting the scores obtained by patients from measures 
such as HADS (Zigmond & Snaith, 1983). 
 
 4.4.2. Implications for Future Research  
 Taking into consideration the limited number of meta-analyses within the 
area of interventions designed to change illness perceptions in CHD there are a 
number of potential avenues for future empirical research and meta-analyses. 
Future research could be enhanced by addressing some of the methodological 
shortcomings and ambiguities identified in the current meta-analysis.  
 First the adoption of a consensus measure for indexing illness 
representations and the same for when measuring anxiety and depression 
comorbid with CHD is urgently required.  
 Secondly, outcomes from the analysis of publication bias in the current 
meta-analysis indicate missing studies that may have important information. Thus 
it is suggested that negative results publishing needs to be brought forward by 
researchers.  
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 Thirdly, future meta-analyses could be significantly enhanced by including 
more studies. This could be done in a number of ways. For example, more single 
studies into the efficacy of interventions designed to change illness perceptions 
need to be conducted.  Additionally, the inclusion/exclusion criteria could also be 
adjusted in order to enhance sample size.   
 Finally, future research should focus on further clarifying which 
components of cardiac interventions designed to change illness perceptions are 
likely to contribute to the largest changes in illness perceptions. Another research 
question that could be asked is whether interventions with psychological 
components lead to more reduction in symptoms of depression and anxiety 
compared to interventions without clearly identifiable psychological component. 
In future, meta-analyses might also focus on establishing whether other factors 
(e.g. socio-demographic, type of illness) have an impact on the efficacy of 
interventions designed to change illness perceptions.   
 
4.5. Overall Conclusions  
 The aim of this meta-analysis is to gather evidence from single studies in 
order to assess whether interventions with psychological component are more 
effective in changing dysfunctional illness perceptions than interventions without 
psychological component. The current meta-analysis also aims at establishing 
clearer picture of how interventions designed to change unhelpful illness 
perceptions contribute to changes in symptoms of anxiety and depression. The 
final goal of the current meta-analysis is to determine whether factors, such as age 
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and the type of illness play a role in the efficacy of interventions designed to 
change maladaptive illness perceptions. The current meta-analysis proposes that 
answering these research questions was important because it would shed a better 
light on the mechanisms of change in interventions designed to change 
maladaptive illness perception in CHD. 
 Overall, there was a mixed pattern of results. The interventions included in 
the meta-analysis yielded a small effect in terms of reducing maladaptive illness 
perceptions. However, there are no statistically significant differences in the effect 
sizes reported for cardiac interventions with psychological components compared 
to those interventions without psychological component.  
 Additionally, the current meta-analysis confirms that interventions 
designed to change illness perceptions lead to positive changes in symptoms of 
anxiety, but not depression. While the effect size for symptoms of anxiety was 
significantly positive, the effect size for symptoms of depression was negative and 
non-significant. This might indicate that there is a more direct link between 
maladaptive illness perceptions and anxiety.  
 Furthermore, the current meta-analysis does not demonstrate any link 
between age and changes in maladaptive illness perceptions. The link between 
changes in dysfunctional illness perceptions and the type of illness was also 
unclear. It is possible that participants with acute CHD have a greater perception 
of threat which might make the illness perceptions more resistant to change.  
 The current findings, however, need to be interpreted with caution because 
of some important methodological shortcomings. These shortcomings include 
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relatively small sample size (in meta-analysis terms), large amount of dispersion 
among the obtained effect sizes and inconsistent in reporting of data across single 
studies.  
  
5. Ethical Considerations 
 This chapter provides a brief description of ethical issues pertinent for the 
current meta-analysis.  
 The considerations of ethical issues in the present meta-analysis relates to 
maintaining high levels of integrity and adequacy in reporting data. This is 
important because it is generally believed that the findings from the meta-analysis 
carry more weight and offer more accurate estimates of the importance of the 
particular research area (Rosenberg, 1994). The author of the current meta-
analysis made every effort to select, report and analyse data in a transparent 
format.  Additionally, the design and the execution of current meta-analysis is 
guided by a number of pre-existing formal recommendations on how to conduct 
high quality meta-analysis, such as the Cochrane guidelines and the PRISMA 
principles (Higgins & Green, 2011; Moher et al., 2009). These guidelines help in 
ensuring that high standard was maintained in collection, selection and analysis of 
data.  
 Finally, wherever possible the process of selecting data was monitored by 
employing additional quality assurance measures, such as employment of the 
RCT-PQRS for individual studies and deriving an index of inter-rater reliability 
(Koscis et al., 2010). 
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 Overall, the search strategy focused on identifying relevant literature for 
links between illness perceptions and psychological outcomes and interventions 
designed to change illness perceptions. An additional search was conducted to 
identify previous systemic reviews and meta-analysis pertinent to the main 
research questions. The main databases searched included PsycInfo, Medline, 
Cochrane’s Library and EMBASE. The search covered the period from 1970 to 
July 2014. The above-mentioned databases were chosen because they broadly 
cover the fields of psychiatry and (clinical health) psychology, which were 
relevant for the current research questions.  
 The core search terms focused around identifying literature relevant to 
illness perceptions, Coronary Heart Disease, psychological interventions, 
psychological outcomes (e.g. anxiety and depression) and meta-analysis/systemic 
reviews. For example, in order to identify relevant literature for illness 
perceptions terms, such as illness misconceptions, illness cognitions, illness 
expectations and maladaptive thinking were also included. The core terms for 
‘psychological interventions’ also included terms such as cardiac 
rehabilitation/programme/management, cognitive behavioural therapy, 
psychotherapy, behavioural therapy. Finally, in order to identify studies conducted 
with participants with relevant illness, terms such as angina, myocardial 
infraction, percutaneous coronary intervention and coronary artery bypass graft 
were included. If and when relevant, terms were combined using Boolean 
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operators (‘AND’ and ‘OR’) and wildcard symbol (*). This strategy ensured that 
the optimal number of relevant studies was identified. Further screening and 
selection of relevant literature involved screening titles and abstracts and 
obtaining full texts of relevant papers.   
 In additional, the list of references and relevant journals were also 
searched. These journals included Journal of Advance Nursing, Heart, and 
Cardiovascular Disorders.  
 In total, eight studies investigating the link between illness perceptions and 
psychological outcomes and six studies testing the efficacy of interventions 
designed to change illness perceptions were retrieved. Finally, five relevant meta-
analysis and systemic reviews were identified.  
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Table A1.1  
Studies of illness perceptions and psychosocial outcomes in CHD (in alphabetical order). 
Study authors, 
publication year, 
country 
Sample characteristics 
(size, sex, age, CHD 
type) 
 
Design/Length 
of Follow-up 
Outcomes Assessed  Results 
Byrne, Walsh, & 
Murphy (2005), 
Ireland  
 
 
 
 
N=1084, 1047/564 
(M/F), Broad spectrum 
of CHD 
Cross-sectional Illness Perceptions 
(IPQ-R) 
Health related 
behaviours (exercise, 
smoking, alcohol, diet 
Medication adherence 
(Medication Adherence 
Report Scale 5) 
 
Participants with more emotional 
representations of their illness, perception 
of poorer personal control over their 
illness and treatment were less likely to 
engage in physical exercise.  
Chronic perception of illness was related 
to medication adherence.  
 
Furze, Lewin, 
Murberg, Bull, & 
Thompson (2005), 
UK 
N=131, 81/52(M/F), MI  Cross-sectional,  
1 year follow-up 
Maladaptive Illness 
(York Angina Beliefs 
Questionnaire) 
Depression (HADS) 
Anxiety (HADS) 
Physical Functioning 
(Seattle Angina 
Questionnaire) 
  
Participants with more maladaptive beliefs 
about angina were more anxious and 
depressed, and reported more physical 
disabilities.  
Changes to maladaptive beliefs were 
associated with improvements in physical 
functioning and fewer depressive and 
anxiety symptoms. 
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Grace et al. (2005), 
Canada 
N=661,504/157(M/F), 
ACS 
Cross-sectional Illness Perception 
(IPQ-R) 
Depression (HADS) 
Functional Capacity 
(Duke Activity Status 
Index) 
Chronic illness time course, greater 
consequences and perceived lower control 
over treatment and cure was linked with 
higher depressive symptoms for man. 
Perceived chronic, longer illness was 
linked with higher depressive symptoms in 
woman.  
 
Greco et al. (2014), 
Italy 
N=75, 60/15(M/F), 
Heart Disease 
Cross-sectional, 
2 month follow-
up 
Illness Perceptions 
(Brief Illness 
Perceptions 
Questionnaire) 
Depression (Cognitive 
Behavioural 
Assessment) 
 
Participants with stronger perceptions of 
symptoms intensity reported more  
symptoms of depression and this was 
sustained over time.  
Juergens, Seekatz, 
,Moosdorf, Petrie & 
Rief, (2010) 
Germany 
N=56, 44/12 (M/F), 
patients undergoing 
CABG 
Cross-sectional,  
3 month follow-
up 
Illness beliefs ( IPQ-R) 
Depression (HADS) 
Health-Related Quality 
of Life (Short Form-12) 
Participants who perceived their illness as 
more chronic and with more serious 
personal consequences & who were more 
distressed by their illness were more likely 
to report higher levels of physical 
disability quality of life) (poorer and 
depressive symptoms. 
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Stafford, Berk, & 
Jackson, (2009) 
Australia 
N=193, 156/37(M/F), 
CAD 
Cross-sectional, 
9months follow-
up 
Illness Perceptions 
(IPQ-R) 
Depression (HADS) 
Health-Related Quality 
of Life (HRQoL) 
(Short Form-36) 
More depressive symptoms were linked 
with perception of poorer personal control 
and greater personal consequences of the 
illness. 
Improved HRQoL was associated with 
fewer beliefs about negative consequences 
of illness and less chronic illness course. 
 
Steca et al. (2013), 
Italy 
N=172, 131/41 (M/F), 
Heart Disease 
Cross-sectional Illness Perceptions 
(Brief-IPQ) 
Depression (Cognitive 
Behavioural 
Assessment) 
Participants with more negative illness 
perceptions reported more depressive 
symptoms. 
 
 
 
Whitmarsh, 
Koutantji, & Sidell 
(2003)  
UK 
N=93, 71/22(M/F), MI Cross-sectional  Illness perception 
(IPQ) 
Depression(HADS) 
Anxiety(HADS) 
Coping (Coping 
Orientation to 
Problems Experienced) 
Attenders obtained higher scores on 
identity consequence & causal attributions 
subscale of IP 
Attenders scored higher on depression & 
anxiety & used more emotion-focused 
problem solving strategies.  
 
HADS = Hospital Anxiety and Depression Scale; IPQ = Illness Perception Questionnaire; IPQ-R = Illness Perceptions Questionnaire-
Revised; Brief-IPQ = Brief Illness Perceptions Questionnaire 
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Table A2.1.  
 
Details of contacts made with scientists/researchers requesting additional information (presented in chronological order). 
 
Authors contacted (Study 
ID if appropriate) 
 
Date Contacted Reason for contact Response/ 
outcome 
Prof John Weinman 
 
 
 
 
21/08/2014 Contacted as an expert in the area, asking if he was aware of 
any pertinent papers that are ongoing trials or were due to be 
published  
 
No response  
Prof Robert Lewin (Study 
10)  
21/10/2014 Request for clarification on measure of illness perception  Author replied with additional 
information 
  
Leila Pfaeffli  
(study 01) 
16/11/2015 Clarification on measure of illness perception   Author replied with additional 
information 
  
Dr Elizabeth  Broadbent 
 
Contact from 
06/10/2015 to  
27/12/2015 
Request for additional data for papers: 
 
(1) Broadbent, E., Ellis, C. J., Thomas, J., Gamble, G., & Petrie, 
K. J. (2009). Further development of an illness perception 
intervention for myocardial infarction patients: a randomized 
controlled trial. Journal of Psychosomatic Research, 67(1), 17–
23. 
 
No data provided, studies 
excluded  
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(2) Broadbent E., Leggat, A., McLachlan, A., & Kerr, A. 
(2013). Providing carsiovascular risk management information 
to acute coronary sundrome patients: A Randomised Trial. 
British Journal of Health Psychology, 18, 83-94.  
 
 
Dr Elizabeth  Barley,  
Prof. Anthony  Mann   
Prof. Andre Tylee  (study 
02) 
18/12/2015 
07/01/2016 
Request for additional data for illness perception measure  Authors responded; 
Unable to get data  
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CODING MANUAL1 
Reference: write a complete reference in APA format.  
Write study id in the format 00. 
Study ID: Write study id in the format 00. Assign a unique identification number 
to each study. If the report contains two independent studies than add a decimal to 
the study ID to distinguish between studies and code each studies independently.  
Type of publication: specify the type of publication  
1) journal article 
2) book chapter 
3) thesis or doctoral dissertation  
4) conference paper  
5) unpublished data provided by authors  
6) other (specify:_____________) 
 
Year of publication:  write publication year 
 
Study details 
Study design:  
1) Experimental RCT design randomly assigns individuals to groups and 
randomly assigns the groups to treatment or control  
2) Longitudinal follows individuals over a period of time and it involves 
collecting outcome data at specified time points or continuously. 
                                                          
1
 Adopted from Lipsey and Wilson (2001). Informed by the COONSORT 2010 checklist of 
information to include when reporting a randomised trial and Cochrane Collaboration guidelines 
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3) Cross-sectional design involves collecting data from group(s) of 
individuals at a single time point.  
 
Age range: if not provided by authors put N/A 
Mean and SD age of participants: if not provided by authors put N/A; note data 
provided for experimental and control group and total sample. 
 
 Type of coronary heart disease of participants: specify which one of the 
following types of CHD was included in the report. There can be more than one 
category within each study. This grouping of CHD has been described by 
Capewell and colleagues (2008) and it describes medical conditions that involve 
narrowing of coronary arteries through gradual build-up of fatty material 
(atheroma) within their walls.  If the report does not specify put not specified. 
1) angina 
2) myocardial infraction (MI) 
3) acute coronary syndrome 
4) coronary artery disease 
(CAD) 
5) conditions that require 
revascularisation procedures: 
coronary artery bypasses graft 
(CABG) and percutaneous 
coronary interventions (PCI). 
6) broad category of CHD 
7) Not specified  
 
Type of participants’ illness: specify the type of participant’s illness. The type of 
the illness is determined based on the authors reporting the following information: 
a) At least four cardiovascular risk factors reported, e.g. current smoker, high 
cholesterol, hypertension, diabetes, high BMI, family history of CHD 
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b) Current medication intake, e.g. beta-blockers, statins, ACE inhibitors, 
nitrates 
c) Hospitalization  
d) Symptoms frequency, e.g. frequency of angina episodes per week 
e) Formal classification of severity of cardiac problems , such as New York 
Heart Association Functional Classification or Canadian Cardiovascular 
Society Grading of Angina 
If information is not provided, write N/A 
1) Acute (code acute if at least two of the above  categories is reported in 
the study) 
2) Chronic  
 
  
 
Total Sample Size, sample size in treatment group and sample size in control 
group: specify a sample size reported at the start of the study. At the later time 
you are asked to code the sample size relevant to the outcome data that are 
reported.  
 
Type of intervention startegies included. There is a great variability within the 
content and the intervention startegies across studies of interventions targeted at 
changing illness perceptions in cardiac problems. I will first provide general 
description of each category and then give specific examples of commonly 
encounter intervention startegies and how they would be coded. Typically, there 
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will be multiple strategies used within a given study. This coding category refers 
to the collective use of intervention startegies and NOT each strategy separately.  
1) Psycho-education only: This category refers to didactic/educational 
information giving to participants as a main or dominant intervention 
strategy. Common subjects covered in psycho-educational interventions in 
the cardiac area include: risk factors, impact of the life style, explanation 
of symptoms. Studies coded in this category can also include group 
discussions, physical exercise, and/or skill-building techniques.  
2) Psycho-education combined with counselling techniques: This category 
reefers to startegies that combine information giving with basic 
counselling techniques, such as active listening, supportive talking and/or 
encouragement  
3) Psycho-education combined with cognitive-behavioural (CBT) or 
motivational interviewing techniques: This category refers to strategies 
that combine the techniques focused on information giving (didactic 
component) with the skill-based interventions, such as the techniques 
based on the CBT therapies (e.g. (progressive muscular) relaxation, 
cognitive restructuring, goal orientated problem solving, self-monitoring 
of poor lifestyle habits. This can be delivered in the face to face, group or 
telephone format.  
4) Interaction or non-psycho-educational contact with medical professionals 
(e.g. cardiologist or cardiac CNSs). This category refers to the 
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individual/group contact with non-mental health professional that involves 
standard medical review and is focused on the interactive approach to 
intervention without a clearly identifiable psych-education component. 
5) Telephone follow-up: This refers to any (e.g. reinforcing) telephone 
contacts with any health professional that is done either in between the 
sessions or post-intervention. 
Examples of common intervention startegies used and how they would typically 
be coded:  
i. Explanation of the pathophysiology of specific condition (e.g. myocardial 
infraction) and/or explanation of common symptoms → coded as a 
psycho-education only category. 
ii. Addressing illness perceptions using encouragement or active listening, 
verbal praise for appropriate behaviour,  
iii. Addressing common misconceptions about different aspects 
symptoms/illness/medical procedures, broadening patients understanding 
of causes and consequences of the illness, relaxation exercise, active 
exercises that require patients to think about how changing life style 
factors could contribute to developing an illness, developing plans of 
minimizing future risks, or balancing prons and cons of change→ this 
should be coded as psycho-education combined with cognitive-
behavioural (CBT) techniques or motivational interviewing category. 
However, when a specific component (e.g. physical exercises) is not based 
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on the CBT or motivational interviewing principles and do not involve 
information giving, it should be coded as one of the other options 
(whichever is deemed more appropriate) .  
iv. Giving (medical) advice and medical consultations and taking physical 
measures, such as BMI or ECG,  should be coded as interaction or non-
psycho-educational contact with medical professionals 
v. Reinforcing in-between sessions or post-discharge telephone calls will be 
coded as telephone follow-ups. 
 
Confidence of judgement on the intervention startegies included. The rating is 
based on the level of details provided by a given study’s authors and how 
explicitly this information is provided. If the topics covered in each session are 
described in details and explicitly than this should increase the confidence of the 
rating.  
 
Theoretical framework: Specify the theoretical framework of the intervention. If 
the authors do not provide this information or it is unclear from the description of 
the intervention select option 3.  
 
Nature of comparison group: This category refers to the type of comparison 
group employed in the research study.  
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1) No treatment control: This category is selected when there is no evidence 
of any kind of control group during or afterwards of the study.  
2) Delayed control (waiting list): This category is selected when a control 
group is a sub-sample placed on the waiting list for intervention or when 
the contact is limited to screening or application only.  
3) Alternative treatment: This category indicates that an alternative 
intervention (medical and non-medical) was administered to control group. 
This could include provision of psycho-education materials (giving leaflets 
or brochures), treatment as usual and/or routine medical care. It is 
important that the nature of the treatment is described.  
 
Mode of delivery: This item refers to the way that the intervention is delivered. 
Select one or more of the following delivery modes:  
1) Individual 
2) Group 
3) Face to face 
4) telephone  
 
 
Setting of intervention: specify where the intervention took place: inpatient, 
outpatient or both settings. If one of the sessions, for example first one, took place 
before discharge and the remaining were conducted at patient’s home or at the 
outpatient hospital clinic than code 3) 
1) inpatient 
2) outpatient 
3) inpatient and outpatient 
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Duration of intervention: This category refers to a number of sessions and the 
time intervals between sessions at which the intervention was presented. Select of 
one the following categories:  
1)  Single session: choose this category if the intervention consisted of only 
one session 
2) Multiple discrete sessions: choose this category if the intervention was 
delivered over more than one session at unequal time intervals between 
sessions or duration of the session varied form session to session. For 
example, six sessions with weekly and fortnightly time intervals over eight 
weeks. 
3) Continuous programme: choose this category if the intervention was 
delivered continuously for a given period of time. For example, an 
interventions with one hour-long session on weekly basis for eight weeks. 
 
Number of intervention sessions: This item refers to a total number of sessions 
of a given intervention. Specify a number.  
 
Follow up presented: tick one of the boxes (yes/no) to specify if the follow up 
was present  
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Timings of the follow up: write the period of time(s) at which follow-up(s) have 
taken time. For example, 6 months and 12 months post intervention. Report the 
study length in time units (weeks/months) reported by the authors of the report 
 
Type of professionals delivering the intervention: Select one or both of the 
following options: 
1) mental health professional: refers to those professionals who have mental 
health training background, e.g. councillor, psychologist or mental health 
nurses.  
2) non-mental health professional : refers to those professionals who do not 
have training in mental health, e.g. cardiac CNS or cardiologist.  
 
Recruitment: Total length of the study: This item refers to the total length of 
the study including any follow-up periods. Write the study length in time units 
(weeks/months) reported by the authors of the study.   
 
Randomisation: This item refers to method used to generate the random 
allocation sequence. Provide information about how the randomisation was done 
and what methods have been used.  
 
Allocation concealment mechanism: This item refers to the mechanisms used to 
implement the random allocation sequence. Provide information on how the 
allocation concealment was managed in the study and how it was implemented 
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(e.g. who generated the random allocation sequence, who assigned participants to 
interventions)  
 
Blinding: Tick one of the boxes to specify if the blinding was done. Provide any 
additional information about blind procedure (e.g. who was blinded and how)  
  
Empirical findings of the study/effect size information 
 
Participant flow chart presented? Tick one of the boxes (yes/no) to specify if 
the participant flow chart was presented for each group  
 
Relevant information presented in the participant flow chart? Tick one of the 
boxes (yes/no) to specify if the flow chart contained all necessary and relevant 
information (i.e. the number of participants who were randomly assigned in each 
group, received intended treatment and were analysed for primary outcome).  
 
Equivalent of scores between groups at baseline tested: Note whether the data 
analysis included tests for equivalent of scores between groups at baseline. 
Typically F or t statistical tests are usually used to test for equivalence. If 
differences were found select one of the following options and provide brief 
information:  
Differences considered, tested and judged as statistically non-significant  
Differences found, statistically significant and meaningful  
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Accounting for baseline scores: Report whether the authors used statistical 
techniques that accounted for baseline difference. If the authors accounted for 
baseline difference selects one of the following options:   
With gains scores or change scores between pre- and post-test (the most common 
test employed here is t test of F test) 
By using covariate analysis (e.g. ANCOVA or MANCOVA) 
By using repeated measures analysis (e.g. MANOVA) 
Other (specify:__________________) 
 
 
Note that direct comparison of pre- and post-tests scores is not considered to 
account for baseline differences, but it is one of the most common types of data 
analysis.  
 
Primary Outcome variable 1: Write the name of the variable  
Name of Measure: write the name of the measure used 
Data available: Select on or both of the following options for what data are 
available in the report:  
1) Post-test 
2) Follow up 
 
Type of outcome data presented: Select one of the following options: 
 
1) means and sds 
2) t value or F-value 
3) p value 
4) chi-square 
5) frequencies or proportions 
6) effects size (what type): _________________ 
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This data is the data on which the effect size is based on. 
Page Number or Table where raw data are found: Write where the information 
can be found  
 
Treatment group sample size and control Group sample size: Write in the 
number a sample size for each group  
 
Raw data favours: Select one of the following options to specific which of the 
groups is favoured by raw data:  
1) Treatment group 
2) Control group 
3) Neither (groups are equal)  
4) Cannot tell or statistically insignificant report only  
 
Provide values for raw data on mean, standard deviations (SDs), proportions or 
frequencies for treatment and control groups.   
 
Significance test: Write a numerical value for the significance test used in the 
study. It could be one of the following options: 
1) t-value ____ 
2) F-value (df for the numerator must be 1) ______ 
3) Chi-square value (df = 1) ______ 
 
Effect size calculated: Write down the numerical value of the effect size 
calculated and the confidence intervals for it.  
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Secondary outcome variable 1, secondary outcome variable 2, secondary 
outcome variable 3, and secondary outcome variable 4: If the study tested 
more than one secondary outcome specified by this meta-analysis than repeat the 
process of data recording similar to the primary outcome.  
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CODING FORM1 
Reference:   
Study ID: 
Type of Publication: 
7) journal article 
8) book chapter 
9) thesis or doctoral dissertation  
10) conference paper  
11) unpublished data provided by authors  
12) other (specify(:_____________ 
 
Year of publication: ___ 
 
Study details 
Study design: 
1) Experimental (RCT) 
2)  Longitudinal 
3) Cross-sectional  
Age Range of Participants: 
Mean and SD Age of Participants: M=   ____; SD=___ 
Gender of Participants:  
females and males                  males only                  females only  
 
 
 
                                                          
1
 Adopted from Lipsey and Wilson (2001). Informed by the CONSORT 2010 checklist of 
information to include when reporting a randomised trial and Cochrane Collaboration guidelines 
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Type of coronary heart disease (CHD) of participants:  
1) angina 
2) myocardial infraction (MI) 
3) acute coronary syndrome 
4) coronary artery disease 
(CAD) 
5) conditions that require 
revascularisation procedures: 
coronary artery bypasses 
graft (CABG) and 
percutaneous coronary 
interventions (PCI). 
6) broad category of CHD 
7) Not specified 
 
Type of participants’ illness: 
1) Acute 
2) Chronic 
 
Total Sample Size: N=____      
Sample Size in treatment group: N= ____ 
Sample Size in Control group: N=_____ 
 
Type of Interventions startegies 
included in treatment: 
1) psycho-education only 
2) psycho-education combined 
with counselling techniques  
3) psycho-education combined 
with cognitive-behavioural 
and/or motivational 
interviewing techniques  
4) interaction or non psycho-
educational contact with 
medical health professionals 
(e.g. cardiologist or cardiac 
CNS) 
5) telephone follow up  
6) information not provided  
 
Confidence of judgment on 
intervention strategies included 
(based on level of details 
provided):  
1) very low 
2) low 
3) moderate 
4) high 
5) very high 
 
 
 
 
Theoretical framework:  
1) Leventhal’s self-regulation model of illness behaviour 
2) Other (specify______) 
3) Not specified 
 
 
Nature of comparison group: 
1) no treatment control 
2) delayed control (waiting list) 
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3) alternative treatment (specify:__________________) 
 
Mode of delivery: 
1) individual  
2) group 
3) face to face 
4) telephone 
 
Setting of intervention: 
4) inpatient 
5) outpatient 
6) inpatient and outpatient 
 
Duration of intervention: 
1) single session 
2) multiple discrete sessions  
3) continuous programme  
Number of intervention sessions (specify): ______ 
Follow up present:          YES                          NO      
Timings of the follow up (specify):  ________ 
 
Type of the professional delivering the intervention: 
3) mental health professional (specify________) 
4) non-mental health professional (specify_____)  
 
Recruitment: Total length of study (including follow up): 
___________________ 
 
Randomisation (specify method used for randomisation: 
_______________________________________________________________) 
 
Allocation concealment mechanism (specify mechanism used to implement the 
random allocation sequence_________________________________________)  
Blinding:     
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Yes                         No  
 
(specify how blinding was done and at what level_________________________) 
 
 
 
 
Empirical findings of the study/effect size information 
 
Was the participant flow chart presented?    
 
Yes                     No    
 
Was all the relevant information presented in the participant flow chart? 
Yes                     No  
 
Was the equivalence of scores between groups at baseline tested?  
 
1) No 
2) Yes: differences considered, tested and judged as statistically non-
significant 
3) Yes: differences found, statistically significant and meaningful 
(explain further: 
____________________________________________________________
____________________________________________________________
_________________) 
 
Did analysis account for baseline scores?  
 
1) No 
2) Yes with gains scores or change scores 
3) Yes by using covariate analysis (e.g. ANCOVA) 
4) Yes by using repeated measures analysis (e.g. MANCOVA) 
5) Other (specify:__________________) 
 
 
 
 
Results 
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Primary Outcome variable 1: ___________________________(variable name)  
Name of Measure used:  _____________________________________ 
Data Available for: 
3) Post-test 
4) Follow up 
 
Type of Outcome Data Presented (circle all that apply): 
7) means and sds 
8) t value or F-value 
9) p value 
10) chi-square 
11) frequencies or proportions 
12) effects size (what type): 
__________________ 
 
 
 
Page Number or Table where raw data are found: __________ 
 
Treatment group sample size: N 
=___ 
Control Group sample size: N 
=_____ 
 
Raw data favours:  
5) Treatment group 
6) Control group 
7) Neither 
8) Cannot tell or statistically insignificant report only  
 
Post-test data (e.g. M, SDs, proportions or frequencies) 
 
Treatment group Control group 
 
 
Significance test: 
4) t-value ____ 
5) F-value (df for the numerator must be 1) ______ 
6) Chi-square value (df = 1) ______ 
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Effect size calculated: 
1) Effect size (specify): _________________________ 
2) Confidence interval (Specify): ____________________ 
Secondary outcome variable 1: ______________________ (variable name)  
Name of Measure used:  _____________________________________ 
Data Available for: 
1) Post-test 
2) Follow up 
 
Type of Outcome Data Presented (circle all that apply): 
1) means and sds 
2) t value or F-value 
3) p value 
4) chi-square 
5) frequencies or proportions 
6) effects size (what type): 
__________________ 
 
Page Number or Table where raw data are found: __________ 
 
Treatment group sample size: N 
=___ 
 
Control Group sample size: N 
=_____ 
 
Raw data favours:  
1) Treatment group 
2) Control group 
3) Neither 
4) Cannot tell or statistically insignificant report only  
 
Post-test data (e.g. M, SDs, proportions or frequencies) 
 
Treatment group Control group 
 
Significance test: 
1) t-value _______ 
2) F-value (df for the numerator must be 1) ______ 
3) Chi-square value (df = 1) _____ 
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Effect size calculated: 
1) Effect size (specify): _________________________ 
2) Confidence interval (Specify): ____________________ 
 
  
Secondary outcome variable 2: ____________________ (variable name)  
Name of Measure used:  _____________________________________ 
Data Available for: 
1) Post-test 
2) Follow up 
 
Type of Outcome Data Presented (circle all that apply): 
1) means and sds 
2) t value or F-value 
3) p value 
4) chi-square 
5) frequencies or proportions 
6) effects size (what type): 
_________________
 
Page Number or Table where raw data are found: __________ 
 
Treatment group sample size: N 
=___ 
Control Group sample size: N 
=_____ 
 
Raw data favours:  
1) Treatment group 
2) Control group 
3) Neither 
4) Cannot tell or statistically insignificant report only  
 
Post-test data (e.g. M, SDs, proportions or frequencies) 
 
Treatment group Control group 
 
Significance test: 
1) t-value _____ 
2) F-value (df for the numerator must be 1) _______ 
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3) Chi-square value (df = 1) ______ 
  
Effect size calculated: 
1) Effect size (specify): _________________________ 
2) Confidence interval (Specify): __________________ 
 
 
Secondary outcome variable 3: _______________________ (variable name)  
Name of Measure used:  _____________________________________ 
Data Available for: 
1) Post-test 
2) Follow up 
 
Type of Outcome Data Presented (circle all that apply): 
1) means and sds 
2) t value or F-value 
3) p value 
4) chi-square 
5) frequencies or proportions 
6) effects size (what type): 
__________________
 
Page Number or Table where raw data are found: __________ 
 
Treatment group sample size: N 
=___     
  
Control Group sample size: N 
=____
Raw data favours:  
1) Treatment group 
2) Control group 
3) Neither 
4) Cannot tell or statistically insignificant report only  
 
Post-test data (e.g. M, SDs, proportions or frequencies) 
 
Treatment group Control group 
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Significance test: 
1) t-value ________ 
2) F-value (df for the numerator must be 1) _______ 
3) Chi-square value (df = 1) ________ 
 
Effect size calculated: 
1) Effect size (specify): _________________________ 
2) Confidence interval (Specify): ____________________ 
 
 
Secondary outcome variable 4: ________________________ (variable name)  
Name of Measure used:  _____________________________________ 
Data Available for: 
1) Post-test 
2) Follow up 
 
Type of Outcome Data Presented (circle all that apply): 
1) means and sds 
2) t value or F-value 
3) p value 
4) chi-square 
5) frequencies or proportions 
6) effects size (what type): 
__________________
 
Page Number or Table where raw data are found: __________ 
 
Treatment group sample size: N 
=___     
 Control Group sample size: N 
=____
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Raw data favours:  
1) Treatment group 
2) Control group 
3) Neither 
4) Cannot tell or statistically insignificant report only  
 
Post-test data (e.g. M, SDs, proportions or frequencies) 
 
Treatment group Control group 
 
Significance test: 
1) t-value _______ 
2) F-value (df for the numerator must be 1) _______ 
3) Chi-square value (df = 1) _______ 
 
Effect size calculated: 
1) Effect size (specify): _________________________ 
2) Confidence interval (Specify): ___________________ 
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RCT of Psychotherapy Quality Rating Scale (RCT-PQRS)1  
Description of subjects 
Item 1.  Diagnostic method and criteria for inclusion and exclusion 
0 = poor description and inappropriate method/criteria 
1 = full description or appropriate method/criteria 
2 = full description and appropriate method/criteria 
 
Item 2.Documentation or demonstration of reliability of diagnostic methodology 
 
0 = poor or no reliability documentation 
1 = brief reliability documentation (documentation in the literature is 
sufficient, even if it is not explicitly cited) 
2 = full reliability documentation (documentation of within-study 
reliability necessary) 
 
Item 3. Description of relevant comorbidities 
 
0 = poor or no description of relevant comorbidities 
1 = brief description of relevant comorbidities 
2 = full description of relevant comorbidities 
 
Item 4. Description of numbers of subjects screened, included, and excluded 
 
0 = poor or no description of numbers screened, included, and excluded 
1 = brief description of numbers screened, included, and excluded 
2 = full description of numbers screened, included, and excluded 
 
Definition and delivery of treatment 
 
Item 5. Treatment(s) (including control/comparison groups) are sufficiently 
described or referenced to allow for replication 
 
0 = poor or no treatment description or references 
1 = brief treatment description or references (also if full description of one 
group and poor description of another) 
2 = full treatment description or references (manual not required) 
 
Item 6. Method to demonstrate that treatment being studied is treatment 
being delivered (only satisfied by supervision if transcripts or tapes are 
explicitly reviewed) 
 
0 = poor or no adherence reporting 
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1 = brief adherence reporting with standardized measure or full adherence 
reporting with non-standardized measure (eg, non-independent rater) 
2 = full adherence reporting with standardized measure (must be 
quantitative and completed by an independent rater) 
 
 
Item 7. Therapist training and level of experience in the treatment(s) under 
Investigation 
 
0 = poor description and underqualified therapists 
1 = full description or well-qualified therapists 
2 = full description and well-qualified therapists 
 
Item 8. Therapist supervision while treatment is being provided 
 
0 = poor description and inadequate therapist supervision 
1 = full description or adequate therapist supervision 
2 = full description and adequate therapist supervision 
 
Item 9. Description of concurrent treatments (eg, medication) allowed and 
administered during course of study (if patients on medication are 
included, a rating of 2 requires full reporting of what medications were 
used; if patients on medications are excluded, this alone is sufficient for a 
rating of 2). 
 
0 = poor or no description of concurrent treatments 
1 = brief description of concurrent treatments 
2 = full description of concurrent treatments 
 
Outcome measures 
 
Item 10. Validated outcome measure(s) (either established or newly standardized) 
 
0 = poor or no validation of outcome measure(s) 
1 = brief validation of outcome measure(s) (shown or cited) 
2 = full validation of outcome measure(s) (shown or cited) 
 
Item 11. Primary outcome measure(s) specified in advance (although does 
not need to be stated explicitly for a rating of 2) 
 
0 = poor or no specification of primary outcome measure(s) in advance 
1 = brief specification of primary outcome measure(s) in advance 
2 = full specification of primary outcome measure(s) in advance 
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Item 12. Outcome assessment by raters blinded to treatment group and with 
established reliability 
 
0 = poor or no blinding of raters to treatment group (eg, rating by 
therapist, nonblind independent rater, or patient self-report) and reliability 
not reported 
1 = blinding of independent raters to treatment group or established 
reliability 
2 = blinding of independent raters to treatment group and established 
reliability 
 
 
Item 13. Discussion of safety and adverse events during study treatment(s) 
 
0 = poor or no discussion of safety and adverse events 
1 = brief discussion of safety and adverse events 
2 = full discussion of safety and adverse events 
 
Item 14. Assessment of long-term post-termination outcome (should not 
be penalized for failure to follow comparison group if this is a waitlist 
or non-treatment group that is subsequently referred for active 
treatment) 
 
0 = poor or no post-termination assessment of outcome 
1 = medium-term assessment of post-termination outcome (2-12 months 
posttermination) 
2 = long-term assessment of posttermination outcome (≥12 months 
posttermination) 
 
Data analysis 
 
Item 15. Intent-to-treat method for data analysis involving primary 
outcome measure 
 
0 = no description or no intent-to-treat analysis with primary outcome 
measure 
1 = partial intent-to-treat analysis with primary outcome measure 
2 = full intent-to-treat analysis with primary outcome measure 
 
 
Item 16. Description of dropouts and withdrawals 
 
0 = poor or no description of dropouts and withdrawals 
1 = brief description of dropouts and withdrawals 
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2 = full description of dropouts and withdrawals (must be explicitly 
Item 17. Appropriate statistical tests (e.g., use of Bonferroni correction, 
longitudinal data analysis, adjustment only for a priori identified 
confounders) 
 
0 = inappropriate statistics, extensive data dredging, or no information 
about appropriateness of statistics 
1 = moderately appropriate, though unsophisticated, statistics and/or 
moderate data dredging 
2 = fully appropriate statistics and minimal data dredging in primary 
Findings 
 
Item 18. Adequate sample size 
 
0 = inadequate justification and inadequate sample size 
1 = adequate justification or adequate sample size 
2 = adequate justification and adequate sample size 
 
Item 19. Appropriate consideration of therapist and site effects 
 
0 = therapist and site effects not discussed or considered 
1 = therapist and site effects discussed or considered statistically 
2 = therapist and site effects discussed and considered statistically 
 
Treatment assignment 
 
Item 20. A priori relevant hypotheses that justify comparison group(s) 
0 = poor or no justification of comparison group(s) 
1 = brief or incomplete justification of comparison group(s) 
2 = full justification of comparison group(s) 
 
Item 21. Comparison group(s) from same population and time frame as 
experimental group 
 
0 = comparison group(s) from significantly different population and/or 
time frame 
1 = comparison group(s) from moderately different population and/or 
time frame 
2 = comparison group(s) from same population and time frame 
 
Item 22. Randomized assignment to treatment groups 
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0 = poor (eg, pseudo-randomization, sequential assignment) or no 
randomization 
1 = adequate but poorly defined randomization procedure 
2 = full and appropriate method of randomization performed after 
screening and baseline assessment 
 
Overall quality of study 
 
Item 23. Balance of allegiance to types of treatment by practitioners 
 
0 = no information or poor balance of allegiance to treatments by study 
therapists (eg, therapy in experimental and control groups both 
administered by therapists with strong allegiance to therapy being tested 
in the experimental group) 
1 = some balance of allegiance to treatments by study therapists 
2 = full balance of allegiance to treatments (eg, therapies administered by 
therapists with allegiance to respective techniques) 
 
Item 24. Conclusions of study justified by sample, measures, and data 
analysis, as presented (note: useful to look at conclusions as stated in 
study abstract) 
 
0 = poor or no justification of conclusions from results as presented or 
insufficient information to evaluate (eg, sample or treatment insufficiently 
documented, data analysis does not support conclusions, or numbers of 
withdrawals or dropouts makes findings unsupportable) 
1 = some conclusions of study justified or partial information presented to 
evaluate 
2 = all conclusions of study justified and complete information presented 
to evaluate 
Item 25. Omnibus rating: please provide an overall rating of the quality of 
the study, taking into account the adequacy of description, the quality of 
study design, data analysis, and justification of conclusions. 
 
1 = exceptionally poor 
2 = very poor 
3 = moderately poor 
4 = average 
5 = moderately good 
6 = very good 
7 = exceptionally good 
 
